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1.1 History 
Toxoplasma gondii is an obligate intracellular parasite that was first described by Charles 
Nicolle and Louis Manceaux in 1908 in the Ctenodactylus gundi, a hamster-like rodent. 
Nicolle and Manceaux found the protozoan in tissues of a gundi, which was used for 
Leishmaniasis research in the laboratory of the Pasteur Institute in Tunis. They realised that 
they had discovered a new organism and named it Toxoplasma gondii based on the 
morphology. The name Toxoplasma is based on taxon, which means arc or bow and plasma, 
which means life and image. Gondi may have resulted from a misspelling of the original host 
the Ctenodactylus gundi (Nicolle and Manceaux, 1908, 1909). 
In the same year as Nicolle and Manceaux, Splendore discovered the same parasite in 
Brazil in a rabbit, but he identified it first as Leishmania (Ferguson, 2009).  
1.2 Taxonomy and classification 
T. gondii is an apicomplexan coccidian parasite. Apicomplexa are intracellular parasites 
that have a polarised cell structure and a complex of organelles in the apical end (see further). 
Coccidia are single-celled obligate intracellular parasites that infect the intestinal tract of their 
hosts. Toxoplasma gondii belongs to the family of Sarcocystidae with other members, like 
Sarcocystis, Neospora, Hammondia and Besnoitia.  
 
Toxoplasma gondii belongs to (from: http://www.ncbi.nlm.nih.gov/Taxonomy/): 
Domain: Eukaryota 
Kingdom: Alveolata 
Phylum: Apicomplexa; Levine, 1970 
Class: Coccidia 
Subclass: Eucoccidiorida 
Order: Eimeriorina 
Family: Sarcocystidae 
Genus: Toxoplasma  
Species: Toxoplasma gondii 
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1.3 Toxoplasma diversity and subtyping  
It is known since long that strains of T. gondii vary in virulence for mice. Since the 
development of molecular typing techniques, the genetic variation in T. gondii strains could 
be linked to the phenotypic differences. The first typing experiments showed that mouse 
virulent strains all belonged to a single clonal genotype, whereas the less virulent ones 
showed more variability (Sibley, Boothroyd, 1992). Typing more strains showed that the 
population of T. gondii is highly structured and that nearly all strains could be grouped into 
one of three clonal lineages (type I, II and III) (Darde et al., 1992; Howe, Sibley, 1995; 
Sibley, Boothroyd, 1992). Direct oral infectivity to other intermediate hosts via tissue cysts 
may explain their successful expansion (Khan et al., 2006a; Su et al., 2003). 
Lots of genotyping methods have been developed. They are usually based on the analysis 
of polymorphous loci. Their use has indicated a rather unusual population structure. 
The first studies on strain typing were based on multilocus enzyme electrophoresis 
(MLEE), which is an important tool to study genetic relationships. Variations in alleles of 
housekeeping genes encoding enzymes can be detected by estimating variations in the net 
electrophoretic charges of the polypeptides, which results in different mobilities and distinct 
bands when run on a gel. This method has a low resolution all arising from the fact that 
enzymatic phenotype diversity is merely a proxy for DNA sequence diversity. Polymorphic 
enzymes were used to characterize T. gondii isolates of which most were collected in France. 
They were grouped into four major zymodemes (patterns of isoenzymes) i.e.: Z1, Z2, Z3 and 
Z4 (Darde et al., 1992a, 1992b). Despite the specificity of this test it requires a large number 
of purified parasites, which strengthened the need for new techniques.  
Later typing methods were using microsatellite (MS) markers (Ajzenberg et al., 2002a, 
2002b). MS sequences are tandem repeated segments of short DNA that tend to occur in non-
coding DNA. MS markers are sensitive, reliable and amenable to high-throughput analyses; 
however, the difficulty of this technique is the possible influence of contaminating host DNA, 
which can be a significant source of variability (Sibley et al., 2009).  
Another analysis is based on restriction fragment length polymorphism (RFLP) of 
specific genetic loci. This worldwide used method for genotyping of T. gondii is based on a 
PCR amplification followed by the digestion of the DNA sample by restriction enzymes. The 
resulting restriction fragments are separated according to their lengths by gel electrophoresis. 
Isolates, primarily collected from North America and Europe, were characterized using RFLP. 
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15 
This analysis classified T. gondii into three genetic lineages, designated as Type I, Type II and 
Type III (Ajzenberg et al., 2002a; Ajzenberg et al., 2002b; Howe and Sibley, 1995). 
These three genotypes differ less than one percent in their genomic sequence (Sibley and 
Boothroyd, 1992). However, they differ in virulence in mice. Type I strains (e.g. the RH 
strain) are lethal in outbred mice: one type I tachyzoite injected intraperitoneally (IP), is able 
to kill mice (Lethal dose (LD) 100 % = 1). Furthermore, infection with type I strains has been 
associated with severe or atypical ocular toxoplasmosis in infected immunocompetent adults 
and they are overrepresented in congenital infections (Grigg and Boothroyd, 2001; Howe and 
Sibley, 1995). In contrast, type II (e.g. the PRU strain) and III (includes avirulent strains like 
the VEG strain) strains are less virulent with a LD 100 ≥ 103 tachyzoites IP (Sibley and 
Boothroyd, 1992). Type II strains account for most clinical toxoplasmosis cases in 
immunocompromised patients (Grigg and Boothroyd, 2001). Type III strains were found in 
patients with ocular toxoplasmosis (Fux et al., 2003).  
A simplified typing method based on nested-PCR of RFLPs at the SAG2 locus, encoding 
tachyzoite surface antigen P22, was sufficient for characterizing clinical isolates from 
North America and Europe that belong to the same clonal lineage and have an identical 
genetic background (Howe et al., 1997). However, this genetic marker has limited power to 
distinguish parasite isolates and was furthermore inaccurate for recombinant and exotic 
strains. Many polymorphisms can be missed by RFLP markers because they are based on the 
variation of restriction enzymes sites (Sibley et al., 2009; Su et al., 2006).  
All of the above methods underestimate the true rate of polymorphism. In contrast, direct 
sequencing reveals the complete genetic diverseness such as single nucleotide 
polymorphisms (SNPs), small insertions and deletions (Bontell et al., 2009; Frazao-Teixeira 
et al., 2011). This method demonstrated a much larger genetic diversity in T. gondii, which 
forms an advantage in the typing of new discovered exotic strains (Frazao-Teixeira et al., 
2011). Increased costs and the need for sophisticated technology are the major drawbacks of 
this technique, but on the other hand, more cost-effective typing methods could be developed 
to detect alleles, once the population structure for a given region is known.  
A 15-MS multiplex assay, was developed by Ajzenberg et al. (2010), to compare two 
isolates and to determine if they are genetically identical or not. This can be useful for the 
determination of the common source of infection in an outbreak or to trace laboratory 
contamination or to reveal mixed infections. A first genetic screening should rapidly 
distinguish type II, III or atypical strains. A second level of discrimination is the 
fingerprinting level, to discriminate closely related strains belonging to the same lineage. The 
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15-MS multiplex assay is a rapid genotyping method which aims to ensure both levels of 
genetic discrimination of T. gondii isolates in a single PCR assay using 15 MS markers 
located on 11 different chromosomes of the parasite (Ajzenberg et al., 2010). 
1.4 Structures and cell invasion 
T. gondii occurs in three infectious stages i.e.: tachyzoites, which are responsible for the 
spread during acute infection, bradyzoites, which sustain the chronic infection and sporozoites 
within the oocysts, which disseminate in the environment. These three stages are haploid; 
tachy- and bradyzoites show an asexual division. The sexual cycle occurs in the enterocytes of 
cat intestines with the formation of diploid oocysts, which form the sporozoites as a result of 
meiosis. The role of bradyzoites and sporozoites is to transmit infection between hosts 
(Ferguson, 2004). A tachyzoite and bradyzoite are represented in Figure 1.1. 
1.4.1 Tachyzoites 
The tachyzoite is the rapidly multiplying stage of the parasite. It is crescent shaped with a 
funnel shaped anterior end and a convex posterior end. The size of a tachyzoite is about 
2 x 6 µm. It has a complex structure with various organelles and inclusion bodies.  
The tachyzoites can infect and replicate in all mammalian and avian cells except in 
mammalian red blood cells. The infection of a host cell consists of the following steps 
(Figure 1.2): after the identification of a host cell, the tachyzoite moves towards the cell by 
gliding, flexing, undulating or rotating. The tachyzoite glides over the cell membrane, probes 
the host cell with the conoidal (a small cone-shaped structure comprised of a spiral of novel 
filaments), followed by indenting the plasmalemma of the host cell. The initial binding 
between the parasite and the host cell is mediated by surface antigen 1 (SAG-1). Next, the 
microneme proteins connect the apical end with the host cell surface. SAG-2 is involved in 
the apical orientation, which is essential for invasion (Nichols et al., 1983). 
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Figure 1.1: Schematic drawing of a tachyzoite (left) and a bradyzoite (right) of T. gondii. The  
drawings are composites of electron micrographs. Reprinted from Dubey et al. (1998) with permission 
of the publisher. 
 
The next step is the formation of the moving junction. This moves along the tachyzoite 
during his penetration into the host cell. The whole procedure is mediated by Ca
2+
dependent 
events of the conoid protrusion (Bonhomme et al., 1992).  
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Figure 1.2: Conceptual model of Toxoplasma invasion. 
Adapted from: http://www.biostat.jhsp.edu/bkafsack/Bioinformatics/  
1. Cellular recognition and initial contact with the host cell membrane mediated by Surface 
Antigens (SAG). 
2. Gliding of the parasite along the host cell and release of microneme proteins (MIC).  
3. Once there is an apical attachment, rhoptry neck proteins (RON) and apical membrane antigen 1 
(AMA 1) form a multimeric complex for the apical orientation. 
4. Formation of a moving junction between tachyzoite membrane and the host cell (Besteiro et al., 
2011). 
5. - 7. Penetration into the host cell results in rhoptry protein and myosin A (MyoA) secretion and 
formation of the parasitophorous vacuole (PV), with the secretion of the romboids (ROMs) (Besteiro 
et al., 2011). 
During the formation of moving junctions, microneme proteins (MIC), rhoptry proteins 
(Besteiro et al., 2011) and dense granules (GRA) are released. The microneme secretion is 
rapidly up-regulated when T. gondii makes contact with the host cell, which confirms its role 
in motility, migration and invasion (Carruthers and Tomley, 2008). Furthermore the parasite 
invasion is blocked when the microneme secretion is blocked (Carruthers et al., 1999). Once 
the penetration of the conoid starts, the parasitophorous vacuole (PV) is formed by the 
secretion of rhoptry proteins (ROPs) (Besteiro et al., 2011). Dense granule-associated proteins 
(GRA-associated) are secreted once the parasite resides in the parasitophorous vacuole and 
are present in the parasitophorous vacuolar space and in the parasitophorous vacuole 
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membrane. GRA proteins promote the maturation of the parasitophorous vacuole and 
optimize the cellular environment to fit the requirements for growth and persistence of the 
parasite in host tissues (Bougdour et al., 2013; Carruthers and Sibley, 1997). They mediate the 
formation of a tubular intravacuolair network for exchanges between the host cell cytoplasm 
and the parasitophorous vacuole. Sibley et al. (1995) describe the role of this membranous 
nanotubular network as to establish a metabolic connection with the host cell. Once this is 
accomplished, the tachyzoites begin to divide asexually in the parasitophorous vacuole by 
endodyogeny, a mode of reproduction characterized by the synchronous production of two 
daughter progenies within each mother cell (Morrissette and Sibley, 2002; Nishi et al., 2008). 
Tachyzoites replicate inside a cell with a generation time of 6 to 9 h until egress, usually after 
64 to 128 parasites have accumulated (Radke and White, 1998). A variety of factors such as, 
the growth of the tachyzoites, the death receptor ligation in infected cells and 
micro-environmental changes, due to the host immune response (interferon-gamma, nitric 
oxide), lead to the rupture of the host cell whereafter the tachyzoites infect new neighbouring 
host cells (Ferguson, 2004; Ji et al., 2013). The exit is mediated by the parasite secreted 
T. gondii perforin-like protein 1 (TgPLP1) (Kafsack et al., 2009).  
The rates of invasion and growth depend on the T. gondii strain and the host cells. After 
entry of tachyzoites into a host cell, there is a variable lag phase before the parasite starts 
endodyogeny, and this lag phase is partly strain dependent (Appleford and Smith, 1997; 
Dubey, 2010). The virulent RH strain has a shorter lag phase than the mouse virulent strains 
ENT and Martin, but, the ENG strain tachyzoites divide more rapidly than RH tachyzoites, 
although they all belong to the clonal lineage type I (Appleford and Smith, 1997). 
The tachyzoites undergo stage conversion to a semidormant stage, known as bradyzoites, 
settled in tissue cysts, due to environmental stress and the host immune response (Sibley et 
al., 2009).  
1.4.2 Bradyzoites 
The bradyzoite is an encysted, slowly dividing stage of the parasite. The size is 
approximately 5-8.5 x 1-3µm. Young tissue cysts contain only two bradyzoites and measure 
barely 5 µm while older ones can contain thousands of bradyzoites formed by endodyogeny 
(Dubey, 2010). Cyst-like structures appear as early as three days after infection with 
tachyzoites, and become numerous by day 6 (Dubey and Frenkel, 1976). Although tissue 
cysts appear in visceral organs such as lungs, liver and kidneys, they are found predominantly 
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in the central nervous system
 
and in muscle tissue, where they may stay for the host’s life 
(Black and Boothroyd, 2000). The development of tissue cysts throughout the body defines 
the chronic stage of the asexual cycle. The conversion of bradyzoites to tachyzoites and vice 
versa is important for T. gondii’s life cycle (Dubey, 2006). The trigger of the T. gondii 
encystation and the molecular mechanisms for the switch from tachyzoite to bradyzoite 
remain unknown. During the transformation to bradyzoites, T. gondii modifies its morphology 
and possibly its metabolism to adjust to the environmental changes (Tomavo, 2001). 
The infectivity of bradyzoites differs from one animal to animal. Cats can shed millions of 
oocysts after ingesting only one bradyzoite, whereas 100 bradyzoites may not be enough to 
infect mice by the oral route (Dubey, 2001). 
Upon entering a new host cell, bradyzoites appear unable to produce new generations of 
bradyzoites or sporozoites but default immediately to tachyzoite development (Dubey, 1997). 
1.4.3 Sporozoites within oocysts 
Sporozoites are present in sporulated oocysts. Only domestic and wild Felidae shed 
oocysts in their faeces. The sporulation takes place in the environment within 1 to 5 days after 
shedding, depending on temperature and humidity. Each sporulated oocyst contains two 
ellipsoidal sporocysts and each sporocyst contains four sporozoites See 1.5.1 “Life cycle in 
definitive host, the cat”. Oocysts become infectious after sporulation and can remain 
infectious for several months under favourable conditions (Dubey, 1998).  
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1.5 Life cycle 
Splendore wrote in 1908: “I think that it will be impossible to determine a specific 
classification of this new protozoa(n) before the whole life cycle is known, and I hope to 
discover this in my future research….” (Splendore, 1908). The elucidation of the life cycle 
was indeed essential to establish that T. gondii is a coccidian parasite. Unfortunately, 
Splendore was not able to clarify the whole cycle, but he discovered the basics of the 
parasite’s life cycle. The final resolution of the T. gondii life cycle took place approximately 
60 years after his prophetic words, with the discovery in the late 1960s of the central role of 
the cat as a definitive host in spreading oocysts through its faeces (Robert-Gangneux and 
Darde, 2012). All related species of the Apicomplexa have similar complex two-host life 
cycles that alternate between definitive (sexual propagation) and intermediate hosts (asexual 
replication). Toxoplasma gondii has a remarkable extremely wide range of intermediate hosts 
that includes all birds and mammals. Sexual propagation is limited to members of the cat 
family (Felidae) (Black and Boothroyd, 2000). The T. gondii life cycle consists of multiple 
stages that fluctuate between proliferative and latent. As described before, there are three 
different infectious stages of T. gondii: the tachyzoites, responsible for the acute infection; the 
bradyzoites, responsible for the chronic infection, and the sporozoites within the oocysts 
(Dubey, 1998). 
1.5.1 Life cycle in the definitive host, the cat and other Felidae. 
Felidae, including domestic cats, can shed oocysts after a T. gondii infection with any of 
the three infectious stages. The prepatent period (time to the shedding of oocysts after initial 
infection) and the amount of oocyst shedding depend on the stage of the ingested parasites 
varying from 3 to 18 days after ingestion and is not dependent of the dose. Cats with a 
T. gondii primary infection can shed up to 10
6
 oocysts per day with their faeces for a period of 
two weeks at most. Less than 50% of the cats shed oocysts after ingesting tachyzoites or 
oocysts, whereas nearly all cats shed oocysts after ingestion of tissue cysts.  
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Figure 1.3: Schematic representation of the life cycle of T. gondii.  
a: macrogamont; b: macrogamete; c: microgamete. Adapted from Ferguson (2004). 
 
After ingestion of tissue cysts or oocysts, the wall of the tissue cysts or oocysts is digested 
by the proteolytic enzymes secreted in the stomach and the small intestine. The released 
bradyzoites/sporozoites penetrate the epithelial cell of the small intestine where they 
differentiate into the rapidly dividing tachyzoite stage during the enteroepithelial cycle with 
the development of numerous generations of T. gondii for dissemination throughout the body 
(Figure 1.3). After a few asexual generations in the feline small intestinal epithelial cells, five 
morphologically different stages of the parasite develop by schizogony followed by 
gametogony. Each stage (schizont A to E) will multiply during several generations in the 
epithelium (Figure 1.4) (Dubey, 1998; Dubey and Frenkel, 1972). The sexual cycle starts two 
days after tissue cyst ingestion by a Felidae. How gamonts exactly appear has not yet been 
determined. The gamete formation is probably induced by merozoites (not in Figure 1.4) 
released by schizont stages D and E. 
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Figure 1.4: Coccidian cycle of T. gondii. Reprinted from Dubey and Frenkel (1972) with permission 
of the publisher. 
Three to 15 days after ingestion, micro- (male) and macro- (female) gamonts appear in the 
small intestines, mostly in the ileum (Dubey et al., 1998). The macrogamonts will mature into 
macrogametes. During the microgametogenesis, microgametes are produced by several 
nuclear divisions. Microgametes have 2 flagellae that make them able to swim to the 
macrogametes. A mature female and male macrogamete fertilise to a zygote, which becomes 
surrounded by a thick wall. The oocyst is formed. On maturity, infected epithelial cells 
rupture and discharge oocysts in the intestinal content and subsequently via the faeces into the 
environment (Ferguson et al., 1979a). The prepatent period (time to the shedding of oocysts 
after initial infection) varies from 3 to 10 days after the ingestion of tissue cysts, and can be as 
long as 18 days after ingestion of oocysts or tachyzoites. 
Once outside the body, sporulation of oocysts takes place within 1 to 5 days, depending on 
temperature and humidity (Dubey et al., 2011; Dubey and Frenkel, 1972; Ferguson et al., 
1979b, c). During sporulation, the 2 sporoblasts, each with two nuclei, elongate and two 
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ellipsoidal sporocysts are formed (Figure 1.3). The sporozoite formation begins when two 
dense plaques or analagen appear at both ends of the sporocysts. Each nucleus divides into 
two and is incorporated into the elongating sporozoite analagen (Dubey and Frenkel, 1972; 
Ferguson et al., 1979c). Oocysts are highly infectious after maturation. When oocysts are 
ingested by a cat, the cycle can start again. Sporulated oocysts can survive for several months 
in moist conditions. 
1.5.2 Life cycle in the intermediate hosts, including humans and cats 
The asexual phase can take place in humans and each warm-blooded animal, including 
cats, acting as intermediate hosts (Wong and Remington, 1993). After ingestion, the 
sporozoites, present in the oocysts, or the bradyzoites, in tissue cysts will infect the intestines 
and, as already mentioned for Felidae, undergo stage conversion to tachyzoites. In contrast to 
Felidae, no differentiation to schizonts occurs in other species. The tachyzoites disseminate 
through the body during the acute phase of the infection and convert into bradyzoites 
encapsulated in tissue cysts (Dubey et al., 1998). When infectious tissue cysts, present in raw 
or undercooked meat are ingested, their wall is dissolved by proteolytic enzymes in the 
stomach and the small intestine. As previously described, the released bradyzoites penetrate 
the small intestinal wall and finalise the asexual cycle. 
In our literature review we only discuss the situation in humans and in sheep and pigs, 
because it is mainly in these hosts that T. gondii infection causes clinical symptoms and 
reproductive disorders. Furthermore, pork and mutton are considered as an important source 
of human toxoplasmosis. Although the seroprevalence in pigs is low, pork can still be 
considered as a source for human toxoplasmosis as meat of one pig is eaten on average by 300 
consumers and is used in many meat preparations (Fehlhaber et al., 2002).  
Ovine toxoplasmosis is described in the second chapter of this thesis.  
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Figure 1.5: Sources of human Toxoplasma infection. Reprinted from Robert-Gangneux (2014) with 
permission of the publisher.  
1.5.2.1 Toxoplasma gondii infection in humans 
1.5.2.1.1 Clinical aspects of toxoplasmosis 
Toxoplasma gondii is capable of producing a wide range of symptoms. Clinical signs are 
depending on the ability of the host immune system to limit the spread, and on the number of 
released parasites. In most immunocompetent persons the cell-mediated immune response can 
control the infection, so that it usually passes unnoticed (Gazzinelli et al., 1993). Sometimes, 
flu-like symptoms develop such as fever, swollen lymph nodes, muscle aches,... , but it may 
take weeks or months before symptoms of infection appear, if they appear at all and this even 
though the parasites grow and multiply immediately after entering the body. 
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It is thought that once someone becomes infected with T. gondii, the infection remains in 
the body for life, usually in a latent (inactive) form that won't cause side effects or harm. The 
infection can reactivate when the immune system becomes compromised, e.g. by HIV 
infection, cancer and/or immunosuppressive therapies. In humans with a weakened immune 
system, Toxoplasmosis can even be fatal. 
Toxoplasma has also a clinical impact on the unborn foetus (Dubey, 2010). When a 
pregnant woman acquires toxoplasmosis during pregnancy - even without symptoms - and 
remains untreated, there is a chance that she will pass the infection on to the developing foetus 
(Hay and Hutchison, 1983). Successful pregnancy requires the maternal host to develop a 
balance between a tolerance to the semi-allogenic foetus and the immune reactivity to protect 
the mother against infections. The exact mechanisms for the tolerance remains poorly 
understood (Alijotas-Reig et al., 2014). A T-helper 1 (Th1)/Th2 response at the foeto-
maternal interface is required. During pregnancy, placental cells invade the uterine wall to 
form cotyledons. This stimulates CD4+ and CD8+ lymphocytes, macrophages and plasma 
cells. Despite these responses, the pregnancy is unaffected. It is possible that these 
interactions lead to a Th2 immune response, dominated by IL-10 production, rather than a 
Th1 response that could lead to rejecting of the foetus. However, down-modulation of the Th1 
response means an increase in maternal susceptibility to T. gondii and, in the meantime a 
down-modulation of the mechanism that controls the parasite replication and promotes 
congenital transmission due to a decreased production of IFN-gamma and a depletion of NK 
cells (Krishnan et al., 2013). Kravetz (2013) mentioned that about five percent of non-
immune pregnant women may acquire toxoplasmosis, with a ten to 100 % risk of vertical 
transmission to the unborn child. This indicates that a normal functioning intact immune 
system is absolutely essential for controlling the parasite. 
Unborn children who become infected during their mother's first trimester tend to have the 
most severe symptoms of congenital toxoplasmosis. In other words, the risks of transmission 
to the baby are higher later in pregnancy, but the risks for lesions to the foetus as a 
consequence of infection are greater earlier in pregnancy (Kravetz, 2013). Women who 
acquire the infection before pregnancy will rarely pass the infection on to their unborn baby 
because they will have built up immunity bringing the infection to latency. However, if a 
pregnant woman, who had been infected previously, becomes immunocompromised by 
therapy or by an infection, the parasite can become reactivated (Tenter et al., 2000). Up to 
90 % of children born with congenital toxoplasmosis have no clinical signs early in infancy, 
but a large percentage will show signs of infection months to years later. Apart from early 
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death after birth, long-term symptoms may develop such as, mental or motoric retardation, 
hydroencephalitis, jaundice, anaemia, enlarged liver and/or spleen, hearing loss,… (Fayer, 
1981). The few babies who show clear signs of infection at birth or shortly after birth may be 
born prematurely and are unusually small at birth. Congenital infected children are also at 
high risk for eye damage involving the retina, resulting in severe vision problems, which may 
appear in early childhood or during adolescence (Kijlstra and Petersen, 2014). 
1.5.2.1.2 Epidemiology 
In a study done in 2008, toxoplasmosis appeared as the fifth most important foodborne 
zoonotic pathogen in Belgium after Salmonella spp., Campylobacter spp., Listeria 
monocytogenes and verocytoxigenic Escherichia coli (FAVV, 2008). Furthermore, in the 
United States there is a yearly incidence of 3000 human cases; the associated economic 
impact is estimated at €5.98 billion per year (Buzby and Roberts, 1997), representing the sum 
of the medical costs, special education and residential-care costs, and the social costs due to 
unemployment and the lost productivity. 
The European Food Safety Authority (EFSA) recommended in 2007 that, in order to 
better evaluate the disease risk of toxoplasmosis in member states, there is a need to improve 
data collection on surveillance and monitoring of T. gondii in animals and food products for 
human consumption (EFSA, 2007). The seroprevalence of T. gondii in humans is 
approximately 50% in Belgium (Vanhaesebrouck et al., 2003). In Scandinavian countries, 
Great Britain, the US and Canada, the seroprevalence is only 10 to 15 % (Jones et al., 2001). 
Possible reasons for this lower prevalence are other culinary habits, consumption of meat 
from “indoor farmed” animals and more frequent consumption of frozen meat (Cook et al., 
2000; Foulon et al., 1994). The frequency of maternal seroconversion in the EU is two (e.g. 
Norway) to eight (e.g. France, Belgium, Austria) per 1,000 pregnancies. The overall risk of 
foetal T. gondii transmission during maternal infection is 20-30 %. This risk increases 
significantly with increasing gestational age. Congenital infection during the first five weeks 
after conception is very rare (Emna et al., 2006; Press et al., 2005).  
The incidence of congenital toxoplasmosis in Belgium is 5 to 10 per 10,000 births (W 
Foulon, personal communication). Eating insufficiently cooked meat (mostly non-frozen 
sheep and outdoor raised pork) that contains tissue cysts, is the main source of T. gondii 
infection for pregnant woman. Between 30% and 63% of the infections during pregnancy 
were attributed to consumption of undercooked or cured meat products in a European 
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multicentric case-control study (Cook et al., 2000). Contact with soil contaminated by 
oocysts, e.g. unwashed vegetables or fruits, is the second most important source. Direct 
contact with cats is not very important in terms of transferring the infection (Cook et al., 
2000). 
There is a seasonal variation in human toxoplasmosis in many areas of the world. In 
Slovenia, the incidence of acute toxoplasmosis was significantly higher (p < 0.025) during 
winter and spring than during summer and autumn, and in pregnant women significantly 
higher (p < 0.01) during winter than in summer (Logar et al., 2005). This seasonal pattern 
occurs also in Austria where a twofold increase in seroconversion was found during winter 
months compared to summer months (Sagel et al., 2010). A retrospective study in the 
Netherlands investigating the birth months of 532 patients with ocular toxoplasmosis showed 
a significantly higher incidence in individuals born in May and a significantly lower incidence 
in those born in November (Meenken et al., 1991). Other studies reported the seasonality of 
receiving samples for T. gondii testing. A UK study reported a peak from November to 
February, and a decrease in September (Bannister, 1982), but in another UK study no seasonal 
pattern was reported (Ryan et al., 1995). In Canada, reports on toxoplasmosis were relatively 
evenly distributed during the year except for September-November, when there was a decline 
(Tizard et al., 1976). In Serbia, acute infections occurred more often between October and 
March (p = 0.05) (Bobic et al., 2010). Taking all data together, it appears that human T. 
gondii infections are more common in winter and show a drop in the fall months. One of the 
hypotheses is that during colder months there is a more frequent and closer contact with cats 
that are potentially Toxoplasma-infected. Indeed cats prefer to spend more time indoors 
during the winter so that there is an increased risk that cats will be excreting oocysts in the 
house (Logar et al., 2005). 
1.5.2.2 Toxoplasma gondii infection in pigs 
T. gondii infection in pigs has a worldwide distribution (Dubey, 2009b). Normally, pigs 
used for meat consumption are raised indoors in well-managed facilities on a concrete 
bedding, and are given regular pig feed. While open production systems improve animal 
welfare, they increase food safety risks due to bacterial, viral or parasitic infections or even 
environmental contaminants (Kijlstra et al., 2009; Schoeters and Hoogenboom, 2006; Van 
Overmeire et al., 2006). There is a difference between organic and "free-range pigs" (Kijlstra 
et al., 2004). Free-range pigs have outdoor access, straw bedding and are fed with regular pig 
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feed, whereas organic pigs are reared outdoor for at least 80% of their live. Organic pig 
raising is controlled by the European Union Council Regulation (EC) No 834/2007 of 28 June 
2007 on organic production, labelling of organic products and repealing regulation (EEC) No 
2092/91. The EEC implicates outdoor access, organic pig feed, no feed of “animal” origin, 
more comfortable living space than on intensive farms, weaning at later age, restricted 
antibiotic and drugs use. Organic pig feed contains the same plant ingredients as regular pig 
feed, but is grown on farms where the use of chemical fertilisers or pesticides is forbidden. 
One treatment of synthetic drugs or antibiotics is allowed in organic slaughter pigs during 
their life. When more treatments are needed the pigs must be sold as cheaper regular pigs 
(Kijlstra et al., 2004). 
During the 90s the T. gondii seroprevalence in pigs under intensive management was 
decreasing in some European countries; however, since then there is a trend for breeding pigs 
with outdoor access, resulting again in an increasing seroprevalence (Kijlstra et al., 2004; 
Meerburg et al., 2006). Toxoplasmosis in pigs seldom has a clinical outcome, but mortality 
can occur, especially in neonatal piglets. Nevertheless, in 2001 on a small pig farm in 
Thailand, seventeen-day-old piglets had fever, convulsions, dyspnoea, diarrhoea and some 
died as a result of toxoplasmosis. The morbidity and mortality rates were 26.09 % (6/23) and 
4.35 % (1/23), respectively. Histopathology showed interstitial pneumonia and smears of the 
lungs contained tachyzoites of T. gondii. The latex agglutination test on serum samples 
confirmed the diagnosis of toxoplasmosis. Two possible routes of transmission were 
suggested: transplacental and the oral infection route via ingestion of oocyst contaminated 
feed (Thiptara et al., 2006). Another acute Toxoplasma outbreak of abortion with mortality of 
sows was reported in 2002 in Korea (Kim et al., 2009). The clinical signs in the pregnant 
sows were fever, vomiting, anorexia, depression, recumbency, prostration, abortion and death. 
The abortion rate was 44 % and the mortality rate of the sows was 19 %. On necropsy, 
cutaneous cyanosis, enlarged lymph nodes, hepatomegaly and splenomegaly, necrotizing 
pneumonia, multiple necrotic foci in the liver, spleen, and lymph nodes were found. T. gondii 
tachyzoites were seen by microscopic examination of the lesions. No significant gross 
abnormalities were noted in any of the aborted foetuses. In the aborted sows, high antibody 
titers to T. gondii were measured. One month before the disease outbreak, the source of 
commercial feed was changed, but the feed was not tested, therefore, the source of this 
outbreak remained unknown. In 2004, a severe outbreak occurred on a farm in the Gansu 
Province in China. During this outbreak, 594 out of 960 fattening pigs became ill. The clinical 
signs were fever up to 40-42°C, loss of appetite and depression. Antibiotic treatment of 
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penicillin and streptomycin was without effect. Blood samples were examined by 
hemagglutination inhibition assay for T. gondii antibody detection. Although all the ill pigs 
were treated with trimethoprim and sulfamethoxazole and their feed was changed, the 
T. gondii infection still resulted in the death of 19 pigs. Feed contaminated with cat faeces 
was found to be the source of the infection (Li et al., 2010). In none of these cases, 
genotyping of the parasite was done. 
The major risk factors for toxoplasmosis in pigs are contaminated feed, cat access and the 
presence of seropositive rodents (Kijlstra et al., 2008; Meerburg et al., 2006). Other risk 
factors are the origin of pigs (farrow-to-finish farming types compared to finishing or farrow-
to-breed farming types), age, number of pigs on a farm and carcass disposal methods (Hill, 
2010; Villari et al., 2009). 
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In 1954 for the first time perinatal mortality due to toxoplasmosis was reported in sheep (Hartley, 
1954). Meanwhile, it is known that the parasite infects sheep (Ovis aries) worldwide and is frequently 
being implicated in reproductive failure with severe economic losses as a consequence (Dubey, 2009; 
Dubey, 2010; Weissmann, 2003). In Europe, but also in most parts of the world, T. gondii is the 
second most important infectious cause of abortion in sheep and goats after Chlamydia abortus 
(Szeredi and Bacsadi, 2002). In some cases both pathogens can be detected during the same outbreak 
of abortion (Brodie et al., 1983; Steuber et al., 1995). 
2.1 Transmission and pathogenesis 
2.1.1 Oocysts in the environment 
Ovine Toxoplasmosis has been linked to feed or pasture contamination with sporulated 
oocysts. These oocysts may remain viable and infective in the environment for several months 
depending on temperature and relative humidity (Dubey, 1988; Innes et al., 2009b; Plant et 
al., 1974). Clinical toxoplasmosis starts by the ingestion of as few as 200 sporulated oocysts 
(McColgan et al., 1988). Associations have been made between infection of sheep and the 
ownership of cats and the presence of stray cats on the farms (McColgan et al., 1988). To 
prevent as much as possible contamination of sheep feed by cat faeces or infected rodents, 
sheep feed should be stored covered. 
Once ingested, excystation of the oocysts takes place in the lumen of the small intestine, 
followed by the release of the sporozoites, which subsequently invade the intestinal mucosa, 
and multiply as tachyzoites in regional lymph nodes. This can occur already by the fourth day 
after ingestion. Then the endodyogeny takes place, during which T. gondii multiplies within 
the host cells, whereafter the parasitized cells rupture releasing the tachyzoites. These can 
then invade other host cells (Ferguson, 2009). In the meantime, the sheep develop fever that 
may persist until day 10 of infection. During this period, between six to eleven days after 
inoculation, the parasite may be found in the blood (parasitemia) during one or two days 
(Dubey and Sharma, 1980; Wastling et al., 1993). The haematogenous spread of the 
tachyzoites establishes a generalised infection. Meanwhile, tachyzoites transform into 
bradyzoites under influence of the host immune response. Bradyzoites, sequestered in tissue 
cysts, maintain the infection and a lifelong immunity. 
 
Chapter 2 
 
40 
2.1.2 Congenital Transmission 
Besides oral infection with oocysts, the only other route of infection is vertical from 
mother to foetus during pregnancy. This represents a serious risk for congenital disease 
(Dubey, 2009). Disease signs are depending on the immune status of the ewe and the stage of 
gestation at the time of infection (Brodie et al., 1983). They vary from foetal resorption, 
mummification, abortion, stillbirth, to birth of weak lambs or lambs with growth retardation 
(Buxton, 1998). Abortions due to toxoplasmosis are particularly seen in temperate countries, 
where climatic conditions favour oocyst survival and sporulation (Innes et al., 2007). The 
naive and pregnant ewe is susceptible to Toxoplasma-induced reproductive losses when 
parasitaemia occurs and tachyzoites invade the uterus and placenta. In case the primary 
infection takes place before the last month of gestation; the consequences for the foetus are 
more severe like abortion, foetal death and mummification due to the absence of a foetal 
immune response (Blewett et al., 1982; Hartley and Moyle, 1974). There is no inhibition of 
parasite multiplication what causes foetal resorption and the ewes subsequently will be barren.  
A primary infection in the later stages of pregnancy (after day 120 of gestation) will result 
most of the time in the birth of a normal lamb, which may be infected and immune. At that 
stage, the immune system of the foetus is already sufficiently developed (Blewett and Watson, 
1983; Buxton et al., 2006; Rodger et al., 2006). The interval between infection and abortion is 
estimated to be about forty days, similar to enzootic abortion due to Chlamydia abortus (Bos, 
1993). Approximately five days after T. gondii infection, pregnant ewes develop pyrexia that 
lasts for four days (Owen et al., 1998). During this period, the tachyzoites spread to the 
placenta where they invade and multiply within the maternal caruncular septa in the 
placentome and from there they invade the adjoining foetal trophoblast cells (Buxton and 
Finlayson, 1986). Placental tissue from infected ewes may show characteristic gross white 
spot lesions, areas of necrosis that will limit its function in supporting the pregnancy 
(Fredriksson et al., 1990). Placentitis occurs, and abortion as well as stillbirth may be 
attributed to placental insufficiency (Owen et al., 1998). Pyrexia may also induce abortion in 
the acute phase of the infection (Owen et al., 1998). The immune balance between the ewe 
and the foetus, plays another important role in the severity of the disease (Anderson et al., 
1994; Innes and Vermeulen, 2006). In subsequent pregnancies the immune response 
developed by the infected animals, will protect them against disease (Innes et al., 2009b). 
A non-pregnant ewe, infected with T. gondii, will equally develop an immune response that 
protects against Toxoplasma-induced abortion during a following gestation (Buxton, 1998; 
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Rodger et al., 2006). However, data of Morley et al. (2005, 2008) suggest that immunity 
might be less protective against transplacental transmission than thought. In a first paper, 
abortion data of 765 ewes from 27 Charollais sheep families in one flock were investigated. 
The abortion rate for the families varied from 0 up to 100 %. Tissue samples of 155 aborted 
lambs were analysed for T. gondii DNA. The positivity varied also from 0-100 % (Morley et 
al., 2005). In a follow up study 29 ewes from the first report that gave birth to lambs during 
two successive years, were selected. Nine of the ewes produced 35 lambs over two lambings. 
From those 35, 37 % were born alive and 63 % were aborted or mummified. Thirty-three out 
of those 35 lambs were PCR-positive when tested with SAG1 nested PCR (Morley et al., 
2008). However, those studies are based only on T. gondii DNA detection. Hence there is 
neither demonstration of T. gondii-associated lesions by histopathology nor exclusion of other 
abortifacient agents (Dubey, 2009). 
2.1.3 Recrudescence of an endogenous infection 
Recrudescence of an endogenous infection is a common transmission route of congenital 
infection with Neospora caninum in cattle (Innes et al., 2005). Endogenous transplacental 
transmission of T. gondii occurs very infrequent and is not considered as a clinical risk 
(Dubey, 1988; Innes et al., 2009b). However, the endogenous transplacental transmission of 
Toxoplasma was suggested to play a more significant role than previously thought 
(Duncanson et al., 2001; Williams et al., 2005). All in all, the studies conclude that 
endogenous transplacental transmission could occur in persistently infected ewes, but that is 
very rare. Other studies have shown that the seroprevalence increases with age meaning that 
most infections occur after birth and suggest that the most significant cause of infection for 
sheep is T. gondii oocysts in the environment and not by vertical transmission (Blewett and 
Watson, 1983; Waldeland, 1977). 
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2.2 Immunological Responses 
Host protection against T. gondii is complex and takes into account innate and adaptive 
immune mechanisms and within the latter both humoral as well as cellular immunity play a 
role. During the acute infection high levels of T. gondii specific serum antibodies can appear 
(Dubey, 1988). After feeding oocysts to sheep, latex agglutination test (LAT) titers increased 
eightfold and these antibodies could be detected earlier than by an indirect 
immunofluorescence antibody test (IFA) or by an indirect hemagglutination assay (IHA) 
(Trees et al., 1989). It is well known that agglutination tests detect IgM antibodies easier than 
IgG. IgM antibodies appear 10-12 days after a primo-infection and peak at three weeks post 
infection. They precede the IgG response (Innes et al., 2009b; Trees et al., 1989). Once IgG is 
produced, it remains in the blood circulation lifelong. High IgG antibody levels can persist in 
sheep for months or years (Dubey, 1988). Re-infection does not increase the antibody titer 
(McColgan et al., 1988) 
The cell-mediated immunity is seen as the mediator for protection. In several studies in 
mice the role of cytokines, antibodies and immune cells, especially CD4
+
 and CD8
+
 T cells 
has been investigated (Denkers and Gazzinelli, 1998; Frenkel, 1967; Gazzinelli et al., 1991; 
Suzuki et al., 1988; Yap and Sher, 1999). Mainly interferon-gamma (IFN-gamma) seems the 
pre-eminent cytokine for protection (Ely et al., 1999; Gazzinelli et al., 1993a; Gazzinelli et al., 
1993b; Khan et al., 1994; Suzuki et al., 1988). CD4
+
 as well as CD8
+
 T cells are the main 
producers of IFN-gamma, but CD8
+
 T cells play a more crucial role in protective immunity in 
vivo (Gazzinelli et al., 1991; Suzuki et al., 1989). Depletion of IFN-gamma in chronically 
infected mice led to reactivation of T. gondii tissue cysts (Suzuki et al., 1989). 
As mentioned above, most of the research has been done in mouse models. There are only 
a few studies done in sheep. Three days after experimental T. gondii infection of sheep, 
parasites were detected in the efferent lymph, IFN-gamma comes up one day later, preceding 
the detection of lymphoblasts (Innes et al., 1995a; Innes et al., 1995b). Subsequently, there is 
a switch from CD4
+
 T cells, initially the largest population, to CD8
+
 cells (Innes et al., 
1995a). This switch is accompanied with the disappearance of parasites from the lymph. 
Other evidence demonstrating the importance of IFN-gamma, is that ovine recombinant 
IFN-gamma inhibits Toxoplasma replication in ovine fibroblasts and macrophages (Oura et 
al., 1993). Activated CD8
+ 
T cells are also able to inhibit T. gondii multiplication within 
autologous target cells (Innes et al., 1995a). In general, CD4
+
 as well as CD8
+
 T cells are 
necessary for the development of protective immunity to T. gondii. 
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2.3. Diagnostic detection methods 
Many detection techniques are available for the diagnosis of T. gondii, however with 
different sensitivities and specificities. Therefore, in some cases a combination of different 
techniques is preferable. 
2.3.1 Serological methods 
There is still no serological test validated for the detection of T. gondii in sheep when 
compared to the gold standard "isolation of the parasite" (Dubey, 2009). Nonetheless, 
serological analysis using tests such as indirect immunofluorescent antibody test (IFA), an 
enzyme-linked immunosorbent assay (ELISA) and/or a modified agglutination test (MAT) 
has been widely and commonly employed in order to demonstrate infection of T. gondii in 
sheep flocks in several countries (van der Puije, 2000). Both IgG and IgM are demonstrated 
for diagnosing ovine toxoplasmosis. 
2.3.1.1 Sabin-Feldman dye test 
The Sabin Feldman test (SFDT), also known as T. gondii lysis test or dye test, was first 
described sixty years ago by Sabin and Feldman (Sabin and Feldman, 1948). A first step 
towards the standardization was taken in 1968 when the WHO recommended the expression 
of dye test titres in international units per millilitre. A first international human standard 
serum for total anti-Toxoplasma antibodies was then produced, followed by a second one in 
1980. The estimation of IU in both preparations is based on dye test results for the detection 
of all immunoglobuline classes using membrane antigens on the surface of live T. gondii 
(Reiter-Owona et al., 1999; Standardization, 1968, 1981). The SFDT – still regarded as the 
gold standard - and thus the reference test for human toxoplasmosis. It has the highest 
sensitivity and specificity (Reiter-Owona et al., 1999), thus detect early and late Toxoplasma 
infections. 
The SFDT is based on complement-mediated cytolysis of antibody-coated live T. gondii 
tachyzoites and uptake of methylene blue dye by living tachyzoites. Seronegative human 
serum used as an accessory complement factor and live T. gondii tachyzoites are added to 
samples of diluted patients’ serum. After an incubation for 1 hour at 37°C, methylene blue is 
added and each reaction is read using a polarised light microscope. If Toxoplasma tachyzoites 
are not stained, cytolysis due to the presence of anti-Toxoplasma antibodies in the patients’ 
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serum has occurred and the test is positive. If tachyzoites appear blue under the microscope, 
they have an intact membrane and therefore no specific antibodies were present in the serum. 
Nowadays the use of methylene blue is used as a confirmation. The test is mostly read by 
phase contrast microscopy, allowing the observation of cells and organelles on unstained, 
living parasites (McGovern and Wilson, 2013).Although this test is the most specific test for 
T. gondii, it has several disadvantages such as: the necessity of live virulent tachyzoites, the 
requirement of human serum from seronegative individuals as complement, the impossibility 
to automate the test, the time needed to read each dilution and thus the high cost. This 
technique has therefore been replaced by other tests in most laboratories (Dubey, 1988; 
Shaapan et al., 2008). 
2.3.1.2 Indirect immunofluorescent antibody test (IFA)  
The indirect immunofluorescent antibody test (or assay; IFA) uses intact formalin-fixed 
tachyzoites. The tachyzoites are coated on a microscope slide and incubated with dilutions of 
the serum to be tested. If specific antibodies are present, they will bind to the parasite. The 
slides are then incubated with, a fluorescent molecule labelled, secondary antibody which is 
species and immunoglobulin specific. Fluorescein isothiocyanate (FITC) is commonly used. 
Evans blue is added to the FITC labelled conjugate for counterstaining (Ambroise-Thomas et 
al., 1966). 
After washing and drying, the slides are examined by fluorescence microscopy. A positive 
reaction colours green, a negative reaction will be red when counterstained with Evans Blue.  
The limitation of this technique, as with most fluorescence techniques, is the loss of 
fluorescent activity and thus resolution caused by photo bleaching. The major disadvantage of 
this test is the complexity of reading and therefore the need for well-trained personnel. The 
subjectivity of the visual assessment of fluorescence of the whole-cell antigen can be 
controlled by reducing light exposure or by employing more robust fluorophores such as 
Alexa fluors (Ambroise-Thomas et al., 1980; Gordon et al., 1981).  
This method is highly specific, but a lower sensitivity in sheep has been demonstrated 
(Shaapan et al., 2008). Nevertheless, the IFA is still more sensitive and specific than the other 
widely used methods such as IHA, LA and ELISA. The technique is reproducible, with 
antibody titers related to clinical events (Gordon et al., 1981). 
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2.3.1.3 Enzyme-Linked Immunosorbent Assay (ELISA) 
The enzyme-linked immunosorbent assay is used to detect specific antibodies against 
T. gondii in sera. Crude, fractionated and recombinant antigens are widely used in various 
ELISA methods.  
Anti-Toxoplasma IgM antibodies are considered as a main marker of acute toxoplasmosis 
(Naot and Remington, 1980). However, when testing for IgM, major difficulties are 
encountered such as the persistence of positive values (Fuccillo et al., 1987), the lack of 
specificity associated with immunopathological responses (Fuccillo et al., 1987; Konishi, 
1987; Liesenfeld et al., 1997; Palosuo and Aho, 1983). As a consequence, IgM is often not a 
good marker to have an idea regarding the time of the infection and additional methods for 
determining acute toxoplasmosis, such as IgG avidity assays are necessary. Avidity is the 
affinity with which IgG attaches to the antigen and this matches with the time following a 
primary infection. In other words, IgG produced within the first months following primary 
infection exhibits low avidity, whereas IgG produced months or years later exhibits high 
avidity levels (Hedman et al., 1989; Joynson et al., 1990). Studies of the kinetics of the IgG 
avidity in sheep, showed that sheep with high avidity IgG were infected at least 10 weeks 
earlier (time to conversion from low to high avidity antibodies varies with the method used) 
(Sager et al., 2003b). Similar results are found in humans (Auer et al., 2000). Most of the 
avidity tests use urea, or other denaturing agents that disrupt van der Waals' interactions. Low 
avidity IgG readily dissociates from the antigen in the presence of urea whereas high avidity 
IgG does not (Rossi, 1998). Especially in case of a possible human congenital infection, 
avidity testing may be important for identifying pregnancies that are at risk for congenital 
toxoplasmosis (Clementino et al., 2007; Sager et al., 2003a; Sager et al., 2003b). However, a 
study of Jenum et al. (1997) showed that, in some cases, a low avidity could persist for more 
than 20 weeks. So in these cases a low IgG avidity could not identify a recent acquired 
infection in the first 13 to 20 weeks of the pregnancy (Auer et al., 2000; Hedman et al., 1989; 
Jenum et al., 1997). Because ELISA is quantitative, highly sensitive and has a low cost it is a 
commonly used test for diagnosing infection in sheep. Nonetheless, the lack of 
standardization of this technique and of the coated antigens is a major problem (Dubey et al., 
1995). 
  
Chapter 2 
 
46 
2.3.1.4 Agglutination 
A direct agglutination test (DT) was first described 50 years ago by Fulton and Turk 
(1959). The original method entails the reaction of specific antibodies, present in the sample 
to be tested, with whole formalin-fixed Toxoplasma tachyzoites. Important disadvantages of 
this test are the lack of sensitivity and specificity. In general, the titer in the agglutination test 
is in general higher than tin the Sabin-Feldman dye test (SFDT) or the IFA. Some sheep sera 
are seen as positive in agglutination while they are negative in SFDT and IFA (Shaapan et al., 
2008). The reason is the binding of IgM to the surface of the parasite (Desmonts and 
Remington, 1980). Subsequent modifications were developed to increase the sensitivity and 
specificity. One method is to use 2-mercaptoethanol in the incubation buffer. This will reduce 
the disulphide bridges in the IgM, making it fall apart into its monomers. Destroying the IgM 
decreases non-specific reactions (Dubey et al., 1987). Other alternatives for the DT are the 
latex agglutination test (LAT) and the indirect hemagglutination test (IHA) (Lunde and 
Jacobs, 1959). In the IHA, sheep red blood cells were used as antigen carrier and in the LAT 
latex particles (Balfour et al., 1982; Jacobs and Lunde, 1957). An agglutination test is simple 
to perform, but due to the use of 2-mercaptoethanol in the incubation buffer, only IgG 
antibodies can be demonstrated, making this method not useful for diagnosing early 
infections. 
2.3.2 Detection of T. gondii 
Direct detection of the parasite is conducted in most of the cases to confirm dubious or 
uncertain serological results. However, in veterinary diagnosis, those tests are mainly used to 
confirm infection in aborted foeti or dead animals. 
2.3.2.1 Bio-assay 
2.3.2.1.1 Bio-assay in mice 
Clinical samples are intraperitoneally inoculated into female T. gondii-free Swiss mice. 
Blood samples are taken from these mice after an observation period of 45 days and 
individually examined for the presence of anti-Toxoplasma-specific IgG antibodies by IFA. 
Mice having received positive and thus infectious sample will seroconvert, while those 
inoculated with negative material will remain negative. A confirmation of the parasite 
infection is than performed on the brains by PCR or by light microscopy to demonstrate the 
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presence of cysts. Due to the low concentration of the cysts is the use of microscopy often 
difficult. Three smears have to be examined, at least in case of low mouse virulent parasite 
strains (Jacobs and Melton, 1954). Indeed, during acute infection tachyzoites can be found in 
peritoneal exudate of mice, but tachyzoites may be rare when infected with a low virulent 
strain (Derouin et al., 1987).  
The susceptibility of mice to T. gondii depends on the infection route, the challenge dose 
(Eyles and Coleman, 1956) and the parasite stage (Derouin et al., 1987). Chronic infection is 
seen after inoculation with bradyzoites of a low virulent strain. Inoculation with tachyzoites of 
type I strains causes death. However, the strain is equally important (Johnson, 1984). Some 
strains infect mice poorly, others strongly (Jacobs and Melton, 1954). Tachyzoites of the RH 
strain kill mice from acute infection within 9 days. 
Bioassay is still regarded as the reference method to detect viable T. gondii in tissues or 
fluids, Many authors consider it as the most sensitive method even though this method has the 
disadvantages of being labour-intensive, using animals and it can take 30 to 45 days 
incubation to obtain the result (Derouin et al., 1987; Hitt and Filice, 1992). The sensitivity is 1 
cyst per 100 gram tissue (Rothe et al., 1985). However, more rapid and highly reliable 
diagnostic methods have to be used in clinical cases where early therapeutic treatment is 
necessary. 
2.3.2.1.2 Bio-assay in cats 
The number of tissue cysts in sheep or other food producing animals is sometimes too 
small to be detectable by the bioassay in mice. Larger volumes of minced sheep tissue can be 
fed to cats. The administration of 500 g meat or more (per cat) makes this technique more 
sensitive than the bioassay in mice (Dubey, 2010). The major drawback of this test is the 
shedding of very resistant oocysts by the inoculated cats, which can lead to environmental 
contamination and are a serious risk for laboratory personnel; a lot of safety measures have to 
be taken into account using this test. Purification and concentration of oocysts from faeces is 
done by centrifugation (Kourenti et al., 2003), flocculation (Dubey et al., 1970; Kourenti et 
al., 2003) and flotation techniques (Dubey et al., 1970). Hereto, faeces are first mixed with 
distilled water and poured through a strainer, followed by centrifugation. After several 
washing steps, the oocysts eventually present in the pellet can be isolated by a standard 
flotation technique using a sucrose (Dubey et al., 1970) or cesium chloride solution (Dumetre 
and Darde, 2004). Detection of the purified oocysts can be achieved by light or fluorescence 
microscopy, bioassay in mice or PCR (coproPCR).  
Chapter 2 
 
48 
Confusion between T. gondii oocysts and those from related coccidians hampers the 
detection by light microscopy as well as the insufficient concentrating of the oocysts. 
Unsporulated oocysts are 10 x 12 µm, smaller than Isospora felis oocysts and Toxocara cati 
eggs, but bigger than red blood cells (Dubey, 2010). Extra attention has to be paid to 
distinguish the T. gondii oocysts from those from Hammondia hammondi. The only 
differentiating method between T. gondii and Hammondia sp. is by PCR or by mouse 
inoculation after sporulation of those oocysts (Dubey, 2010). 
Fluorescence microscopy is based on a blue autofluorescence of the oocysts (Lindquist et 
al., 2003). The intensity and the time of being auto fluorescent are sufficient enough to see 
oocysts. However, due to the autofluorescence of related coccidia, additional methods are 
needed to clearly identify the T. gondii oocysts (Lindquist et al., 2003). Further information is 
given in 2.6.2.4.3. 
PCR is very sensitive but before the DNA extraction can be performed, the oocysts have 
to be purified and concentrated from the fecal matter. Furthermore, the presence of some 
substances like clay, blood and polysaccharides can inhibit the detection.  
2.3.2.2 Cell Culture 
This technique provides also information about the parasite’s growth, replication and 
structure with no interference of immune effector mechanisms (Azab and Beverley, 1974; 
Hughes et al., 1986). In vitro easily growing cell lines can be used to culture T. gondii, but 
usually fibroblast cell lines such as the human embryonic fibroblast cell line, MRC5, are used. 
Toxoplasma can already be detected in the cells using an immunofluorescence technique 
(described in 2.6.2.4.3) from 2 days after inoculation. However, later examination of the cell 
cultures, on days 4 to 5 after inoculation, is preferable for easier identification of the parasite. 
Indeed, clusters of T. gondii can be observed after four days incubation (Hitt and Filice, 1992; 
Hughes et al., 1986). 
Although much less sensitive than bioassay, the cell culture was the most practical and 
readily available technique for T. gondii detection, until PCR was developed. Nowadays this 
method is abandoned by the laboratories (Hitt and Filice, 1992). 
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2.3.2.3 Polymerase Chain Reaction (PCR) 
Molecular detection methods such as PCR are increasingly used in veterinary and human 
medicine to diagnose toxoplasmosis (Fuentes et al., 1996; Montoya et al., 2009). After all, 
isolation of T. gondii DNA from placental and foeti tissues confirms the diagnosis and is very 
useful in recovering the parasite from autolysed tissues as those may be useless for 
histological examination or bioassay (Dubey, 2010). Many PCR based assays have been 
developed for the detection of T. gondii DNA in blood, fluids and tissue samples. The most 
common PCR T. gondii target is the B1 repetitive sequence, which is a 35-copy repeated 
DNA sequence (Burg et al., 1989; Burg et al., 1988). This protocol was developed in 1989 
and has since then been modified and optimized by many laboratories (Fuentes et al., 1996; 
Liesenfeld et al., 1994). Other targets are the p30 or Sag1 gene, with only one copy and a 
more and more used 529 bp fragment that is repeated 200- to 300-fold in the T. gondii 
genome (Chabbert et al., 2004; Ellis, 1998; Homan et al., 2000). 
PCR can be applied on various types of samples and is specific, sensitive as well as fast in 
comparison with the other methods (MacPherson and Gajadhar, 1993; van de Ven et al., 
1991). Even if the samples are in a decomposed state, detection of DNA from the parasites is 
possible whilst a bioassay only detects viable parasites (Yai et al., 2003). Despite these 
advantages, diagnosis by PCR remains limited due to the still expensive equipment (Kong et 
al., 2012). Additionally, false positive results have been reported due to cross-reactivity e.g. 
with species of Nocardia, Mycobacterium and Actinomyces (Bhalla et al., 1999). Furthermore, 
false negatives can occur due to the presence of inhibitory factors e.g. porphyrin (Dupon et 
al., 1995; van de Ven et al., 1991).  
A modification of the polymerase chain reaction is the nested-PCR. This method is used 
to increase the sensitivity and specificity of amplification (Fallahi et al., 2014). The technique 
uses two pairs of primers, the external ones and the internal ones. The external primer pair has 
a higher melting temperature and is used in lower concentration than the internal ones, to 
prevent the first amplification round interfering with the second one (Ellis, 1998). The PCR 
product generated with the external primer pair, is used as a template for the second PCR. The 
binding sites of the second primer set are nested within the first set, which enhances the 
specificity (Pujol-Rique et al., 1999). Even though PCR is often used for diagnosing the cause 
of an abortion and as screening method in flocks, unfortunately until now no standardised 
method or commercial kit is available; different sets of primers and different PCR products 
are used by different laboratories. 
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Competitive PCR is a commonly used method to transform PCR from a qualitative 
method into a quantitative assay (Orlando et al., 1998). The technique includes a known 
quantity of an exogenous competitor molecule (also known as a PCR mimic) which competes 
with the target for the components of the PCR since it is amplified by the same primers as the 
target sequence. The known quantity of PCR mimics are spiked into the PCR amplification 
reactions containing the target DNA. During the reaction, the amount of products amplified 
relates directly to the amount of template molecules (both genomic and competitor targets) in 
the original reaction. Quantitation is then performed by comparing the amount of target PCR 
product with the amount of product amplified from a defined quantity of competitor (Orlando 
et al., 1998; Siebert and Larrick, 1993). Competitive PCR was initially followed by agarose 
gel image analysis for quantification of the parasite load in the sample, which was a time 
consuming procedure (Homan et al., 2000; Kirisits et al., 2000; Luo et al., 1997).  
Nowadays real-time PCR is commonly used for quantification of the parasitic load 
(Jauregui et al., 2001). This technique follows the general principle of a PCR with the extra 
ability to monitor the progress of the PCR as it occurs, i.e. in “real-time”. The reactions are 
characterized by the time-point when the amplification of a target is first detected, rather than 
the amount of accumulated product after the number of cycles. The higher the starting 
quantity of the DNA target, the sooner a significant increase in fluorescence is observed. In 
contrast, the amplified DNA in a standard PCR is detected at the end of the reaction (Fraga et 
al., 2014). The sensitivity of real-time PCR can be greatly enhanced using a magnetic capture 
technique: a crude DNA extract is prepared from a 100 g meat sample and subjected to a 
T. gondii DNA concentration step using magnetic beads coated with probes that target a 
specific region on the T. gondii genome. After this capture step, real-time PCR can be 
performed (Opsteegh et al., 2010a). 
2.3.2.4 Microscopy 
2.3.2.4.1 Light microscopy 
Light microscopy, and later on fluorescence and electron microscopy have been intensely 
used for studying the parasite since Nicolle and Manceau described T. gondii in 1908. Jankû 
has published the first images of T. gondii in 1923. The photograph was taken from the retina 
of an infant. The tachyzoites were described by Jankû (1923) as “small, cylindrical bat-like 
cells in rosette form”. Tachyzoites were first observed by Splendore as structures with 
“yellow cytoplasm and granular nucleus” (Splendore, 1908), he noted that they are better 
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visualised after Giemsa staining, by colouring the negatively charged phosphate groups on 
DNA. Hematoxylin and eosin (H&E) staining is also frequently used for visualising 
tachyzoites. Hematoxylin stains nuclear proteins, violet coloured complexes are formed with 
metal ions, while eosin, a red acidic dye, colours the proteins (Jankû, 1923). A periodic acid 
Schiff (PAS) staining visualises the tachyzoites poorly. The bradyzoites contain several 
amylopectin granules which stain red with PAS reagent. Those granules are in discrete 
particles or even absent in tachyzoites. The periodic acid oxidizes the polysaccharides 
whereafter they react with the Schiff component resulting in a pink-purple colour (Dubey et 
al., 1998). 
T. gondii tissue cysts are strongly stained with H&E. Also Giemsa, Mallory and Biondi 
staining of cysts result in clear images. Mallory is a mix of acid fuchsin, aniline blue and 
orange G, three dyes which the nuclei red, cytoplasm pink and the extracellular matrix blue. 
Biondi consists of aurantia, acid fuchsin and methyl-green which colours the chromatin green 
and cytoplasm pale yellow (Jankû, 1923).  
With a Silver and PAS colouring it is easier to visualise the cysts. However, confusion 
with cysts of other parasites is possible (Sims et al., 1988). Therefore and due to the limited 
resolution, light microscopy is an inferior method for identifying tissue cysts (McGovern and 
Wilson, 2013). But, it allows to determine the complete cycle of T. gondii (Dubey and 
Frenkel, 1972). 
Histologic and cytologic examinations are still used to diagnose T. gondii-induced 
abortion in ewes. T. gondii causes no macroscopic lesions in the foetus but produces 
microscopic to macroscopic necrosis of the placental cotyledons. Recognizing lesions is more 
important than to find the parasite, because degenerating host cells are often confused with 
T. gondii tachyzoites (Dubey, 2010). 
2.3.2.4.2 Fluorescence and bioluminescence 
As mentioned above, oocysts exhibit a blue autofluorescence, which makes them visible 
under UV-light (Lindquist et al., 2003). In addition, most proteins of interest can be visualised 
by staining them with fluorescently labelled protein-specific antibodies (Nery-Guimaraes et 
al., 1968). 
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2.3.2.4.3 Confocal microscopy 
The basis of the confocal microscopy was patented in 1957 by Marvin Minsky of the 
Harvard University. The first confocal microscope dates from 1979. The technique of laser 
scanning confocal fluorescence microscopy is especially used to study the subcellular 
structures of T. gondii (Melzer et al., 2010). The main advantages in comparison with the 
conventional optical microscope are the inclusion of shallow depth of field, the elimination of 
out-of-focus glare and the ability to make a series of optical sections from thick specimens. In 
the case of T. gondii the microscope is used to make ultra-structural images of fixed or living 
parasites that have been labelled with one or more fluorescent probes. The main disadvantage 
of this type of microscopy is the high cost of the equipment (Kervrann et al., 2000). 
2.4 Seroprevalence 
The seroprevalence of T. gondii in sheep has been investigated worldwide and found to 
vary greatly (Dubey, 2009). Caballero-Ortega et al. (2008) suggested a relation between 
seropositivity and altitude, being higher at sea level than at 1200 meters above sea. 
Furthermore the farm size was important and seropositivity was higher in larger than in small 
flocks (Caballero-Ortega et al., 2008). Table 1 presents seroprevalence data per country from 
1991-2013. 
Toxoplasma gondii in sheep 
 
53 
Table 1: Seroprevalence data from 1991-2013 of T. gondii per country and the serological assays used. 
Country # animals test Commercial/method 
Cut-off 
titer 
% Pos Reference 
Argentina 704 IFA ns 50 17,3 Hecker et al. (2013) 
Austria 4079 IFA ns 40 66,4 Edelhofer and Aspöck (1996) 
Bangladesh 25 LAT Toxotest-MT® (Eiken Kagaku, Tokyo, Japan) 8 40 Shahiduzzaman et al. (2011) 
Brazil 
382 MAT In house test according to the method of Desmonts and Remmington (1980) 16 18,6 Langoni et al. (2011) 
360 IFA In house test according to the method of Camargo (1964) 64 56,9 Sakata et al. (2012) 
795 IFA In house test 64 30,2 Guimaraes et al. (2013) 
932 IFA In house test 64 28,22 Mendonca et al. (2013) 
930 ELISA In house test according to the method of Clementino et al., (2007) ns 22,1 Andrade et al. (2013) 
Bulgaria 380 IHA In house test 1280 48,2 Prelezov (2008) 
Burkina 
Faso 
65 IHA ns 64 23 Deconinck (1996) 
Canada 3872 ELISA TLA RH (IgG) ns 57,6 Waltner-Toews et al. (1991) 
China 
580 IHA Kit Lanzhou® ( Vet. Res. Inst. Chinese academy of agriculture) 64 4,4 Liu et al. (2010) 
455 IHA Kit Lanzhou® (Vet. Res. Inst. Chinese academy of agriculture) 64 5,7 Wu et al. (2011) 
566 IHA Kit Lanzhou® (Vet. Res. Inst. Chinese academy of agriculture) 64 29,8 Yang et al. (2013) 
Czech 
Republic 
24 IFA ns 40 4 Sedlák and Bártová (2007) 
547 ELISA Commercial kit (Institut Pourquier, Montpellier, France) ns 59 Bartova et al. (2009) 
Cjile 408 IFA In house test  16 28 Gorman et al. (1999) 
Côte 
d’Ivoire 
62 IHA ns 64 68 Deconinck (1996) 
Djibouti 183 IHA ns 64 13 Deconinck (1996) 
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Egypt 
300 MAT In house test according to method of Dubey and Desmonts (1987) 25 43,7 Shaapan (2008) 
320 IHA ns 80 47,5 Barakat et al. (2009) 
62 ELISA In house test according to the method of Voller et al. (1976) ns 98,4 Ghoneim et al. (2010) 
Ethiopia 
116 MAT Toxosreen DA test (®Behring, Germany) ns 52,6 Negash et al. (2004) 
787 
P-30 
ELISA 
Kit ID Screen® (ID. Vet Montpellier France) ns 37 Gebremedhin et al. (2013b) 
357 
P-30 
ELISA 
Kit ID Screen® (ID. Vet Montpellier France) ns 31,59 Gebremedhin et al. (2013a) 
France 
141 lambs 
MAT In house test according to method of Desmonts and Remmington (1980) 20 
20,5 
Rozette (2005) 
65 ewes 59,1 
164 lambs 
MAT In house test according to method of Desmonts and Remmington (1980) 20 
22 
Dumetre et al. (2006) 
93 ewes 65,6 
Finland 1940 MAT Toxosreen DA test® (BioMérieux, Marcy-l'Etoile, France) 40 24,6 Jokelainen et al. (2010) 
Germany 1122 ELISA ns ns 33 Seineke (1996) 
Great 
Britain 
411 
MAT In house test according to method of Dubey and Desmonts (1987) 25 
12,2 
Mason et al. (2010) 
329 3 
3539 LAT 
accredited test used by Animal Health and Veterinary Laboratories Agency 
UK 
64 74 Hutchinson et al. (2011) 
Greece 
1501 
tg 
SAG1-
ELISA 
In house test ns 48,6 Tzanidakis et al. (2012) 
458 ELISA In house test according to the method of Osawa et al. (1998) ns 53.71 Anastasia et al. (2013) 
360 
TLA-
ELISA 
In house test ns 28,3 Kantzoura et al. (2013) 
Ghana 732 
TLA-
ELISA 
In house test according to the method of Voller et al. (1976) ns 33 van der Puije (2000) 
India 
186 ELISA Commercial kit (Institut Pourquier, Montpellier, France) ns 3,8 Sharma (2008) 
204 MAT In house test according to method of Dubey and Desmonts (1987) 25 44,1 Chikweto et al. (2011) 
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Iran 
588 IFA In house test according to method of Voller and O’Neill (1971) 16 35 Sharif et al. (2007) 
105 LAT 
Commercial kit (®LA, SGM Italia, Roma Italy) according to method of 
Mazumder et al. (1988) 
8 20,9 Zia-Ali et al. (2007) 
150 ELISA Commercial kit (Institut Pourquier, Montpellier, France) ns 72,6 Hamidinejat et al. (2008) 
156 MAT In house test according to method of Desmonts and Remmington (1980) 20 21,1 Raeghi et al. (2011) 
Ireland 292 LAT 
Toxoplasma LAT test® (Toxoreagent RST701, Mastgroup Ltd., Merseyside, 
UK) 
64 36 Halova et al. (2013) 
Italy 
7194 IFA Toxo-spot IF® (BioMérieux Marcy-l'Etoile, France) 200 28,4 Masala et al. (2003) 
1056 LAT Toxotest-MT® (Eiken Kagaku, Tokyo, Japan) 32 78 Gaffuri et al. (2006) 
1876 ELISA Commercial kit (Institut Pourquier, Montpellier, France) ns 49,9 Vesco (2007) 
1170 IFA Toxo-spot IF® (BioMérieux Marcy-l'Etoile, France) 100 28,5 Fusco et al. (2007) 
630 IFA IFA slides® (Mega-Cor diagnostic, Austria) 64 34 Cenci-Goga et al. (2013) 
Japan 267 IFA Toxo-spot IF® (Biomérieux, Marcy-étoile, France) 40 28,78 Giangaspero et al. (2013) 
Lithuania 354 ELISA 
Chekit Toxotest Enzyme Immunoassay® (IDDEXX laboratories, Intervet, 
The Netherlands) 
ns 42,1 Stimbirys et al. (2007) 
Mexico 
511 MAT In house test according to the method of Dubey and Desmonts (1987) 25 15,1 
Alvarado-Esquivel et al. 
(2012) 
429 MAT In house test according to the method of Dubey and Desmonts (1987) 25 23,1 
Alvarado-Esquivel et al. 
(2013a) 
405 MAT In house test according to the method of Dubey and Desmonts (1987) 25 29,9 
Alvarado-Esquivel et al. 
(2013b) 
Mongolia 175 LAT Toxotest-MT® (Eiken Kagaku, Tokyo, Japan) 32 16,57 Tumurjav et al. (2010) 
Netherlands 1179 ELISA In house test ns 30 Opsteegh et al. (2010b) 
New 
Zealand 
2254  LAT Toxotest-MT® (Eiken Kagaku, Tokyo, Japan) 16 85 Dempster et al. (2011) 
Niger 77 IHA ns 64 19,5 Deconinck (1996) 
Nigeria 372 ELISA Commercial kit (Institut Pourquier, Montpellier, France) ns 6,7 Kamani et al. (2010) 
Norway 1940 ELISA In house test ns 16,2 Skjerve et al. (1998) 
Pakistan 90 LAT Toxotest-MT® (Eiken Kagaku, Tokyo, Japan) 8 11,2 Ramzan et al. (2009) 
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Peru 211 IHA Commercial antigen (TPM-TEST Wampole laboratories, Cranbury, NJ) 64 27 Reif et al. (1989) 
Poland 41 IFA ns 8 53,6 Gorecki et al. (2008) 
Portugal 119 MAT Toxosreen DA test® (BioMérieux, Marcy-l'Etoile, France) 20 33,6 Lopes et al. (2013) 
Scotland 3333 ELISA In house test according to the method of Buxton et al. (1988) 25% 56,6 Katzer et al. (2011) 
Senegal 52 IHA ns 64 11,5 Deconinck (1996) 
Serbia 511 MAT In house test according to the method of Desmonts and Remmington (1980) 25 84,5 Klun et al. (2006) 
Slovakia 1939 SFDT In house test according to the method of Sabin and Feldmand (1948) 4 10 Kovâcovâ (1993) 
Spain 
203 MAT Toxosreen DA test® (BioMérieux, Marcy-l'Etoile, France) 40 40,4 
Mainar-Jaime and Barberan 
(2007) 
177 MAT Toxosreen DA test® (BioMérieux, Marcy-l'Etoile, France) 40 57 Panadero et al. (2010) 
503 ELISA Commercial ns ns 49,3 
Garcia-Bocanegra et al. 
(2013) 
Sweden 704 ELISA In house test according to the method of Voller et al. (1976) ns 19 Lunden et al. (1992) 
Switzerland 
150 adults 
ELISA ELISA according to the method of Wyss et al. (2000) ns 
80,7 
Berger-Schoch et al. (2011) 
100 lambs 33 
Tunis 350 ELISA Kit ID Screen® (ID. Vet Montpellier France) ns 10,8 Gharbi et al. (2013) 
Turkey 
181 ELISA 
Modification of human ELISA according to the method of Mondesire et al. 
(1981) 
ns 31 Oncel and Vural (2006) 
95 SFDT ns 16 49,5 Acici et al. (2008) 
152 SFDT In house test according to method of Sabin and Feldmand (1948) 16 45,4 Babur et al. (2001) 
186 SFDT ns 16 98,92 Cicek et al. (2011) 
Uruguay 1613 MAT Toxosreen DA test® (BioMérieux, Marcy-l'Etoile, France) 64 28,7 Freyre et al. (1999) 
USA lambs 383 MAT In house test according to the method of Dubey and Desmonts (1987) 25 27,1 Dubey et al. (2008) 
Zimbabwe 23 IFA In house IFA 50 47,8 Hove et al. (2005) 
SFDT = Sabin Feldman Dye Test. ELISA = enzyme-linked immunosorbent assay. IFA = Indirect immunoﬂuorescent antibody test. IHA = Indirect 
hemagglutination assay. LAT = Latex agglutination test. MAT = Modiﬁed agglutination test. PCR = Polymerase chain reaction. WB = Western blot. ns = Not 
specified. 
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The prevalence of antibodies in ewes is more than twice the prevalence in lambs, 
demonstrating that the seroprevalence increases with age and suggesting that lambs become 
infected postnatally. Seroconversion occurs in most cases before the age of four, but Dubey 
and Kirkbride (1989) noted that 25% of 5-year-old ewes were still seronegative in highly 
endemic flocks. The contamination of the environment with oocysts, the presence of cats and 
rodents on the pastures but also the disposal of aborted foetuses may be a risk for seronegative 
sheep. The risk of seroconverting was about fourfold higher on farms that left foetuses on the 
ground in comparison with farms that fed the aborted foetuses to dogs. Riyadh (2005) showed 
that burying or incineration of foetuses led to a decrease in seropositivity of sheep and goats 
by 8%. The seroprevalence also increased with the use of surface water as drinking water and 
with farm size (Vesco, 2007). 
2.5 Economic Importance 
Toxoplasmosis has a considerable economic relevance, provided that T. gondii has been 
recognised as one of the main causes of abortion in sheep in New Zealand, Australia, The 
United Kingdom, Norway and the United States (Beverley et al., 1971; Buxton et al., 1991; 
Dubey and Welcome, 1988). Significant losses occur due to abortion if the animals become 
infected during pregnancy. It is difficult to accurately estimate the losses: only a small 
proportion of aborted lambs are handed over for diagnosis. Furthermore, samples are often 
examined inadequately and/or the submitted material is not even suitable for diagnosis. 
Moreover, existing serological tests lack specificity. In general, Toxoplasmosis does not 
induce clinical symptoms in ewes and since disease occurs sporadically, the farmer is not 
alarmed as quickly as in case of some other abortion-causing bacterial or viral infections such 
as foot and mouth disease or bluetongue (Dubey, 2010). In the UK it has been estimated that 
over 0.5 million lambs may be lost each year due to toxoplasmosis. The UK Department for 
Environment, Food and Rural Affairs correlated this loss with a yearly cost of €15.3 to 30.6 
million to the sheep industry (Cruz-Vazquez et al., 1992; Defra, 2009). 
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2.6 Prevention of infection 
Prevention of infection relies primarily on hygienic measures to avoid infection such as 
absence of felids in the direct environment, direct removal of aborted foetuses, no surface 
water as drinking water (2.6.1). Also the use of vaccines can prevent abortion (2.6.2). 
Furthermore, chemotherapy or chemoprophylaxis can reduce the impact of infection (2.6.3) 
(Buxton et al., 1996). 
2.6.1 Control by protecting pregnant ewes from exposure to infection 
Outbreaks of clinical toxoplasmosis are mostly caused by exposure to oocysts (Blewett 
and Watson, 1983; Caballero-Ortega et al., 2008). Feed contaminated with cat faeces 
introduces the infection in breeding flocks. Actions should be taken to prevent the possibility 
of cats defecating in feedstuff such as excluding them from the farm, or at least by shielding 
feed storages for instance by storing it in closed bins or silos. Baling hay makes it less 
attractive to cats. Contamination of commercial feed cannot be excluded, but oocysts are 
killed between 50 and 55°C, hence bagged and pelleted feed is unlikely to be infected. 
Drinking water was recently discovered as a new risk factor in some countries like Brazil. 
Sheep drinking from running water systems had a higher risk to become infected than those 
drinking from still water (Andrade et al., 2013; Pinheiro et al., 2009). Another study in 
Ethiopia demonstrated that sheep drinking from rivers and stagnant water were more likely to 
become infected than animals that drank tap water (Gebremedhin et al., 2013b). Due to the 
higher chance of contamination with cat faeces, and thus oocysts, still water is more expected 
to be contaminated than running water. Anyway, water has to be taken into account as a 
source of infection. 
2.6.2 Control by vaccination 
Vaccines play an important role in the control of animal diseases, particularly in livestock. 
The use of a vaccine to prevent the infection of meat animals with Toxoplasma is desirable; in 
order to reduce the rate of human infection from the ingestion of undercooked infected meat. 
A vaccine is also required to control the adverse effects on pregnant animals. 
  
Toxoplasma gondii in sheep 
 
59 
There are three targets for a vaccination strategy: 
1) Limitation of the acute parasitaemia and protection against congenital  
  toxoplasmosis 
2) Reduction of the presence of tissue cysts 
3) Reduction of oocyst shedding by cats to limit environmental contamination 
Here we restrict the discussion to a commercial vaccine used in sheep and new 
vaccination strategies with potential for sheep. 
There is a commercial attenuated live vaccine available to protect against Toxoplasma 
abortion in sheep and goats: Ovilis
®
 Toxovax (MSD Animal Health, New Zealand) which is 
allowed in the United Kingdom, Ireland, France, Spain, Portugal and New Zealand since two 
decades (Buxton et al., 2007). The vaccine, developed in New Zealand, consists of 
tachyzoites of the T. gondii modified strain S48 and mimics a natural infection (O'Connell et 
al., 1988; Wilkins et al., 1988). The S48 strain was isolated from an aborted lamb and has lost 
the ability to produce tissue cysts by repeated passages in mice for many years. Therefore, 
vaccination cannot establish a persistent infection in sheep. The vaccine has to be 
administered subcutaneously at least three weeks before the start of the mating period. Soon 
after vaccination the tachyzoites can be isolated from the blood, but no cysts are apparent in 
the muscles one month later. The inoculation of the S48 vaccine strain causes a short infection 
of 14 days, after which the parasites are cleared from the animal’s system. During this period, 
a humoral and cellular immune response is induced, involving CD4
+
, CD8
+
 T cells and 
IFN gamma (Buxton et al., 2007; Wastling et al., 1994; Wastling et al., 1995; Wastling et al., 
1993), which protects the ewe against natural infection and against abortion for at least 
18 months (Menzies, 2012). When pregnant vaccinated sheep ingest oocysts, there is a normal 
release of sporozoites into the gut lumen. However, the ability of the parasite to invade the gut 
wall followed by multiplication in mesenteric lymph nodes is inhibited and the spread via 
lymph and blood is prevented. Thus the pregnant uterus and the foetus are protected against 
the infection. In conclusion, the vaccine not only causes reduction of foetal mortality but also 
a reduction of tissue cysts in the dam’s meat (Buxton et al., 2007; Katzer et al., 2014). So, this 
attenuated vaccine has the advantage that it avoids zoonotic infections as a result of 
consuming undercooked meat. Disadvantages of the vaccine are: (1) the possible reversion of 
the S48 strain to the wild type, (2) the risk for humans to become infected by handling the 
vaccine, (3) its short shelf-life of two to three weeks after reconstitution, and (4) the need of a 
cold chain during transport of the vaccine (Menzies, 2012). 
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The attenuated T. gondii strain M49 has been evaluated by Falcón and Freyre (2009) 
without convincing results. This illustrates that the need for a non-infectious vaccine is still 
relevant. 
In recent years, different non-infectious vaccine candidates have been tested for inducing 
a protective immunity including DNA vaccines. DNA vaccination is an interesting method for 
the induction of specific humoral and cellular immune responses since the vaccine is very 
stable and once taken up by host cells can lead to major histocompatibility complex (MHC) 
type II presentation with activation of CD4
+
 cells and MHC type I presentation with 
activation of CD8
+
 cells, similar to live parasites. Activation of CD8
+
 cells normally does not 
occur when vaccinating with protein vaccines. However, whereas DNA vaccines are very 
successful in mice, there is still work to improve the immune response in larger mammals 
such as humans and farm animals. Therefore many adjuvants have been explored in 
combination with DNA vaccines such as Toll-like receptor ligands and immunostimulating 
complexes (ISCOMs). 
Research on T. gondii subunit vaccines consisting of one or a cocktail of antigens, has 
focused on the surface antigens of tachyzoites (Bhopale, 2003). The major surface antigens 
(SAG) are SAG1, SAG2 and SAG3. In goats, the most antigenic surface antigen is 
SAG1 (P30) (Conde et al., 2001). SAG1 combined to liposomes as adjuvant has been tested 
to immunise mice. This combination elicited a good cellular immune response in mice, 
resulting in a partial protection (Bulow and Boothroyd, 1991). When SAG1 was combined 
with adjuvants like Quil A and cholera toxin, an induction of mucosal and systemic immune 
responses was seen (Debard et al., 1996; Velge-Roussel et al., 2000). 
Other vaccine candidates are some of the excretory/secretory antigens, which are 
expressed by both tachyzoites and bradyzoites (Capron and Dessaint, 1988; Cesbron-Delauw 
and Capron, 1993). Dense granule (GRA) molecules like GRA1 (23kDa), GRA4 (40kDA) 
and GRA7 (29kDa) are the leading vaccine candidates. Vaccination studies have been 
conducted using GRA7 formulated with different adjuvant formulations. Also, the rhoptry 
protein ROP2 (56kDa), expressed by tachyzoites, bradyzoites and sporozoites has been 
proposed as a vaccine candidate since the T-cell epitopes for the ROP2 antigen are recognised 
by a high percentage of immune humans (Saavedra et al., 1996). 
Although many candidate vaccines have been investigated, none of them have been brought 
to commercial production. There is an urgent need to verify the potential of these vaccines in 
the target species by further experimental work and field studies. 
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2.6.3 Control by use of drugs 
Prophylactic treatment of ewes during pregnancy by monensin and 
sulfamezatin-pyrimethamine reduces the abortion rate significantly (Buxton et al., 1988). For 
monensin, the dose varies between 15 to 30 mg/animal daily. The treatment is effective but 
expensive (Buxton et al., 1988).  
Also chemoprophylaxis with decoquinate in the diet will reduce the impact of infection. 
Decoquinate causes a reduction in the febrile response and in the placental damage and 
increases the number of lambs born and the birth weight of live lambs, in comparison with 
ewes not fed with decoquinate (Buxton et al., 1996). 
In the cat intestine toltrazuril, a triazinetrione derivative, is very effective during the 
sexual replication cycle in reducing the schizogony and gametogony. This drug leads to a 
reduction in the multiplication rate of the parasite by e.g. killing of the tachyzoites. Swelling 
of the endoplasmic reticulum and visible damage to the parasite’s DNA has been seen by 
electron microscopy. Toltrazuril causes also a reduction of the extra-intestinal developmental 
stages of T. gondii (Haberkorn, 1996). This molecule is used as treatment against avian 
coccidiosis and more recently against coccidiosis in calves, piglets, lambs and kids 
(Haberkorn, 1996; Jonsson et al., 2011; Kreiner et al., 2011; Le Sueur et al., 2009). Treatment 
of experimentally infected lambs with toltrazuril resulted in degenerative changes in the tissue 
cyst wall, resulting in an invasion of macrophages and thus reduction of the number of tissue 
cysts (Kul et al., 2013). 
Ponazuril, another triazinetrione derivative, induces rupture of the membrane of the 
parasitophorous vacuole, causes mitochondrial damage in the parasites and prevents cell 
division, inhibiting the replication of T. gondii tachyzoites (Darius et al., 2004; Mitchell et al., 
2004). An oral dose of 10 or 20 mg/kg ponazuril, given during 10 days, protected mice from 
death in experimental toxoplasmosis with RH strain (Mitchell et al., 2004). 
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In 2008, toxoplasmosis was identified as the fifth most important food-borne zoonotic 
pathogen in Belgium after Salmonella spp., Campylobacter spp., Listeria monocytogenes and 
verocytotoxigenic Escherichia coli (FAVV, 2008). Epidemiological data and case-control 
reports identify sheep as an important source of human toxoplasmosis. The literature review 
highlighted a gap in quantitative data on T. gondii prevalence in sheep in Belgium. The 
European Food Safety Authority has recommended the EU member states to implement 
control strategies for toxoplasmosis in animals and food products for human consumption, to 
reduce better the disease risk of T. gondii.  
Aside from the gap in seroprevalence, significant gaps still exist in the pathogenesis and 
immune response during acute toxoplasmosis. Several experimental infections have been 
carried out, especially in mice, to investigate the host-immune responses during T. gondii 
infection. However, to our knowledge the distribution of the parasite and the correlated 
antibody and interferon (IFN)-gamma responses during the acute stage have not been 
investigated yet in larger animals. We studied the progress of a T. gondii infection in sheep 
with a special focus on the antibody and IFN-gamma responses as well as on the distribution 
of the parasite during the first three weeks after infection. Furthermore, the evolution of the 
immune response until two months after infection was studied. Since we observed strong 
antibody responses against several parasite antigens and clear T helper 1 cytokine responses 
in sheep, we were interested to see if a comparable immune response occurs in pigs.  
 
The specific aims of this work are as follows: 
1) To generate baseline data on the prevalence of ovine toxoplasmosis in Belgium 
2) To study the acute T. gondii infection in sheep.  
Following questions were addressed in this study: 
2.1 Which small intestinal tissues are infected by the parasite in this acute phase and 
how long does the parasite reside in the gut?  
2.2 Which immune response is evolving during this early phase? Here we specially 
focused on the IFN-gamma response, which is important for controlling the infection. 
3) To study on a longer term - the first two months after infection - the humoral and cellular 
immune responses (Th1 versus Th2) in sheep against the parasite and to observe whether 
there is a relation between immune response and parasite distribution.  
4) To compare the immune response and parasite distribution following a T. gondii infection 
in pigs with the results we obtained in sheep. Here, the pig model was chosen because pork is 
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the most commonly consumed meat in Belgium (and worldwide) (Worldwatch Institute) and 
because it was shown to be a risk factor for human toxoplasmosis in previous studies (Kijlstra 
and Jongert, 2009; Tenter et al., 2000) 
 
.
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3.1 Abstract 
Although infected sheep are a potential source of T. gondii infection in humans, 
information is not available regarding the seroprevalence of Toxoplasma gondii in sheep in 
Belgium. We examined 3170 serum samples for anti-Toxoplasma IgG in sheep by a total 
lysate antigen (TLA) enzyme-linked immunosorbent assay (ELISA). The presence of IgG in 
sheep sera directed towards T. gondii could be demonstrated in 87.4 % of the tested sheep and 
in 96.2 % of the 209 tested flocks. The seroprevalences in Antwerp (65.2 %) and Wallonia 
(68.6 %) were significantly lower compared to the other regions in Belgium (96.7 % -97.8 %) 
(P < 0.05). The present study is the first report that analyzed the prevalence of T. gondii 
infection in sheep in Belgium and confirms the high prevalence of Toxoplasma-specific IgG 
antibodies in the Belgian sheep population. 
3.2 Introduction 
Toxoplasmosis is a worldwide zoonosis caused by the obligatory protozoan 
Toxoplasma gondii. Almost all warm-blooded animals and humans can be infected (Yuan et 
al., 2013). Infections with T. gondii in sheep may lead to abortion and causes huge economic 
losses to the livestock industry (Tenter et al., 2000). In addition, consumption of non-frozen 
and undercooked sheep meat products are considered a source for human toxoplasmosis 
(Cook et al., 2000). The prevalence of T. gondii infection in sheep has been reported for many 
countries and ranged from 10 % in Slovakia (Kovâcovâ, 1993) to 27.8 % in the Netherlands 
(Opsteegh et al., 2010), 65.6 % in France (Dumetre et al., 2006) and even 98% in Egypt 
(Ghoneim et al., 2010). The Belgian sheep population consists of 216,018 sheep divided over 
27,253 flocks; 64.33 % of the sheep and 70.11% of the flocks are located in Flanders. Only 
8,145 flocks are located in Wallonia, the French-speaking southern region of Belgium, 
corresponding to 55 % of the Belgian territory. The Flemish provinces East- and West-
Flanders are the largest domestic sheep producers.  
Considering the possible impact of T. gondii on human and veterinary health as well as 
the lack of knowledge regarding the prevalence in Belgium, the aim of this study is to 
determine the prevalence of T. gondii infection in Belgian sheep and sheep flocks. 
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Province Total N tested N pos Total N tested N pos (%)
True Prevalence 
(95%CI)
Antwerp 2105 23 23 18326 402 240 (59.7%) 65.2% ( 58.5% - 62.6%)
East-Flanders 7127 48 48 40508 563 479 (85.1%) 96.6% (92.1% - 99.6%)
Flemish Brabant 2973 31 31 23144 370 323 (87.3%) 97.8% (93.8% - 99.8%)
Limburg 1783 20 19 18459 256 222 (86.7%) 97.3% (92.5% - 99.7%)
West Flandres 5120 36 36 38537 667 569 (85.3%) 96.8% (92.8% - 99.7%)
Wallonia 8145 51 44 77044 912 567 (62.2%) 68.6% (63.0% - 74.8%)
Total 27253 209 201 216018 3170 2400 (75.7%) 87.4% (82.0% - 93.4%)
Flandres
Flocks Sheep
3.3 Material and Methods 
3.3.1 Sample selection 
Blood samples were collected from domestic sheep participating in the Visna-Maedi/ 
CAE screening program of the Federal Agency for Safety of Food Chain (FASFC). These 
samples were from animals older than one year and from flocks from East-Flanders, West-
Flanders, Antwerp, Limburg, Flemish Brabant and Wallonia. The distribution of samples over 
the sheep flocks of the different provinces and the number of sheep per provinces is presented 
in Table 3.1. After testing for Visna-Maedi/ Caprine Arthritis Encephalitis the 3170 serum 
samples were kept at -20°C until analysis for T. gondii antibodies. 
 
Table 3.1: Seroprevalence of T. gondii in sheep and sheep flocks in different Flemish provinces and in 
Wallonia as determined by a TLA-specific antibody ELISA. 
 
 
 
 
 
The blood samples were marked per flock but were not marked for specific characteristics 
such as age, breed, gender and farm management. The blood samples were tested for IgG 
antibodies to T. gondii, based on a T. gondii-specific antibody enzyme-linked immunosorbent 
assay (ELISA) following a protocol described further. One hundred samples were tested in 
indirect immunofluorescence assay (IFA) to confirm the results of the total lysate antigen 
(TLA) ELISA. The agreement between the results of the TLA ELISA and the IFA was 
assessed by calculating positive and negative agreement indices with credibility intervals 
according to the method described by Graham and Bull (1998) (Table 3.2). Considering the 
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results of those two tests, a, b, c and d are the observed results for each possible combination 
of ratings by the tests. a, being the number of positives with both tests, b, the number of 
samples testing negative in ELISA but positive in IFA, c, the number of samples testing 
positive in ELISA but negative in IFA, d, the number of negative samples in both tests. The 
proportion of specific agreement, positive agreement index (pr+) and negative agreement 
index (pr-), were calculated as follows: pr+ = 2a/(2a+b+c) and pr- = 2d/(2d+b+c). The 
positive rating is an estimation of the conditional probability, given that one of the test results 
is positive, the other is also positive.  
The true prevalences were estimated in a Bayesian analysis based on the model used by 
Speybroeck et al. (2013). The apparent antibody status of a sheep was linked to the true 
antibody status in terms of sensitivity (Se) and specificity (Sp) of the diagnostic test. 
Although we found a 100% agreement between the IFA and the TLA ELISA, these results 
were not retained as we could not validate the tests due to the lack of negative control 
samples. Therefore, we used the Se and Sp estimations from the previous study of Shaapan et 
al. (2008). The ELISA and the IFA had sensitivities of 90.1 % and 80.4%, respectively; and 
specificities of 85.9% and 91.4%, respectively. According to that study a Se range between 
0.80 and 0.90 and a Sp range between 0.85 and 0.90 was used for the TLA ELISA. Credibility 
intervals (95%) of the true prevalences were calculated using the Bayesian model in 
Prevalence Package for R version 0.2.0 (Devleesschauwer et al., 2013; Speybroeck et al., 
2013) 
Statistical analysis of T. gondii prevalence between the different regions was performed 
using a Chi-square test using Prism (GraphPad). A P-value < 0.05 was considered statistically 
significant. Assuming a family-wise significance level of 0.05, individual P-values were 
considered significant if lower than Bonferroni corrected significance level of 0.05/15=0.003. 
3.3.2 T. gondii-specific antibody enzyme-linked immunosorbent assay (ELISA) 
Serum samples were tested for antibodies against total lysate of T. gondii using a 
T. gondii-specific antibody enzyme-linked immunosorbent assay (ELISA). TLA was prepared 
as described by Scorza et al. (2003). Briefly, tachyzoites of the T. gondii RH strain, isolated 
from the peritoneal cavity of Swiss mice 4 days after intraperitoneal infection, were squeezed 
twice through a 26-Gauge needle and pelleted by centrifugation at 1000 x g. Next, the pellet 
was washed twice in PBS, followed by freezing, thawing and sonication on ice for 5 minutes 
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in an Ultrasonic disintegrator (MSE, Leicester, United Kingdom) to solubilize the T. gondii 
tachyzoite antigens. The ELISA was performed as described by Verhelst et al. (2011). 
Briefly, 96-well Nunc Maxisorp™ plates were coated overnight with TLA at a concentration 
of 10µg ml
-1 
bicarbonate coating buffer (pH 9.4) at 4°C. Afterwards the plate was blocked 
with PBS 5% non fat milk powder for 2 hours at 37°C, and incubated with the serum samples, 
being diluted 100 fold into PBS 0.2% Tween
®
 20,
 
for 1 hour at 37°C. An anti-sheep IgG 
horseradish peroxidase conjugated rabbit antiserum (AbD Serotec, Belgium), appropriately 
diluted in PBS 0.2% Tween 20
®
 was added for 60 min. at 37°C. In between each step, plates 
were washed 5 times with PBS 0.01% Tween20
®
. As a last step, a 
3,3,5,5-tetramethylbenzidine buffer was added for 30 min. at room temperature, whereafter 
the OD at 450 nm was determined with an ELISA reader. Positive and negative control serum 
samples at the same dilution of the serum samples were included on each plate. A corrected 
optical density (OD) was calculated as the OD of a sample – OD of the negative control 
samples. 
3.3.3 Indirect immunofluorescence antibody test (IFA) 
One hundred samples were tested in IFA to confirm the results of the ELISA. Fifty 
microliters of the 1/50 diluted serum in PBS was applied for 30 min. at 37°C on a slide coated 
with formalin fixed tachyzoites from the RH strain (Toxo-Spot IF, Biomérieux, Marcy-
l’Etoile, France). In subsequent steps, the slides were washed with PBS, incubated for 30 min. 
at 37°C with 30 µl of a 1/25 in PBS-Evans Blue diluted fluorescein isothio-cyanate (FITC) 
conjugated rabbit anti-sheep IgG (KPL, Maryland, USA), washed again, dried and examined 
by fluorescence microscopy.  
3.4 Results and Discussion 
A total of 3170 ovine serum samples were tested by TLA-ELISA for the presence of anti-
T. gondii IgG. When comparing the one hundred samples tested in IFA and TLA ELISA, 
positive and negative agreement indices with their 95 % credibility intervals (between 
brackets) were used to assess the agreement between both tests (Table 3.2). A positive 
agreement of 1 (0.94-1.00) and a negative agreement of 1 (0.91-1.00) were determined. The 
literature mentioned estimates of sensitivity between 90.1 % and 97.8 % and of specificity 
between 85.9 % and 96.4 % for the TLA ELISA (Opsteegh et al., 2010; Shaapan et al., 2008).  
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+ -
TLA ELISA
+ 63 (a) 0 (c)
- 0 (b) 37 (d)
IIFA
 
Table 3.2: Results of the serological tests on sheep sera. Comparison between the TLA-specific 
antibody ELISA and the IFA.  
Positive agreement index:pr+ = 2a/(2a+b+c) =2*63/(2*63+0+0) 
Negative agreement index pr- = 2d/(2d+b+c) = 2*37/(2*37+0+0) 
 
 
 
 
 
 
The 3170 ovine serum samples, obtained from “Animal Health Care Flanders and 
Wallonia (DGZ and ARSIA), were sampled as part of the Visna-Maedi/ CAE screening 
program of the Federal Agency for Safety of Food Chain (FASFC). As mentioned above, no 
information was available about the farms, flock size, age, gender or breed. Table 3.1 gives an 
overview of the sheep population in Belgium, and shows the results of the tested sheep flocks 
and the seroprevalence per province. We found a very high seroprevalence of 87.4 % 
(CI 0.81-0.93) in the Belgian sheep population. This is much higher than in the 
Netherlands (27.8 %) (Opsteegh et al., 2010) and higher than in other European countries 
such as France, with a seroprevalence of 65.6 % (Dumetre et al., 2006) or Great-Britain with 
74 % (Hutchinson et al., 2011).  
To evaluate whether the seroprevalence in Belgian sheep matches a geographical 
distribution, the results of our study were grouped per region. Small regional differences were 
observed and are shown in Table 3.1. The province of Antwerp showed the lowest 
seroprevalence (65.2 %), followed by the Walloon region (68.6 %), East Flanders (96.7 %), 
West Flanders (96.8 %) and Limburg (97.3 %). Flemish Brabant noted the highest 
seroprevalence namely, 97.8%. The T. gondii seroprevalence in Antwerp and Wallonia were 
significantly lower than those in the other regions (P < 0.0001) (Table 3.3). Only 8 of the 209 
tested flocks were seronegative; among these, one flock was located in Flanders, more 
specifically in Limburg, the other 7 seronegative flocks were located in Wallonia.  
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P-value Antwerp
East-
Flanders
Flemish 
Brabant
Limburg
West 
Flandres
Wallonia
Antwerp - <0.0001 <0.0001 <0.0001 <0.0001 0.698
East-
Flanders
- - 0.635 0.826 0.993 <0.0001
Flemish 
Brabant
- - - 0.978 0.676 <0.0001
Limburg - - - - 0.86 <0.0001
West 
Flandres
- - - - - <0.0001
Wallonia - - - - - -
Table 3.3: P-value between the provinces 
 
 
 
 
 
 
 
 
 
 
These results show the widespread distribution of T. gondii infection in sheep flocks in 
Belgium. 
Innes et al. (2009a) mentioned that regional differences in the level of soil contamination 
may lead to variation in the seroprevalence as sheep get T. gondii infections mainly from 
ingesting oocysts from the environment. In that respect, it is important to note that sporulated 
oocysts can remain viable and infective in the environment for several months, depending on 
temperature and relative humidity (Dubey, 1988; Innes et al., 2009a; Owen and Trees, 1999; 
Plant et al., 1974). Toxoplasmosis in sheep starts mostly by the ingestion of as few as 200 
sporulated oocysts (McColgan et al., 1988). As sheep are not carnivores, the only two 
possible infection routes are: 1) the vertical from mother to foetus during pregnancy, that 
represents a serious risk for congenital disease (Dubey, 2009b), 2) the ingestion of oocysts 
during grazing. Congenital transmission of T. gondii is reported in several studies (Buxton et 
al., 2007; Innes et al., 2009b). An infection in the early gestation is mostly fatal due to the 
absence of a foetal immune response, whereas infection in the late pregnancy, after day 120 of 
gestation, most of the time results in the birth of normal lambs, which may be infected and 
immune (Blewett and Watson, 1983). In subsequent pregnancies the effective immune 
response developed by the infected animals, will protect them against disease (Innes et al., 
2009b). Nevertheless, it has been shown that in sheep repeated transplacental transmission of 
T. gondii can occur (Morley et al., 2005; Morley et al., 2008). In Belgium, the obtained 
seroprevalence cannot be linked with abortion, since there are no official data. 
Associations have been made between exposure of sheep to T. gondii and the presence of 
cats in farms or the circulation of stray cats (Plant et al., 1974). It has been noted that 
environmental oocyst contamination is concentrated in and around cat defecation sites 
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(Afonso et al., 2008). After a primary infection, cats continuously shed oocysts in their faeces 
for 4 to 14 days with a peak of tens of millions at 6-8 days (Dubey, 2009a; Dubey and 
Frenkel, 1972; Skjerve et al., 1998). There are only two reports on the seroprevalence of 
toxoplasmosis in Belgian cats, one in the stray cat population of Ghent (Dorny et al., 2002) 
and one in Belgian pet cats (De Craeye et al., 2008). In the stray cat population, a very high 
T. gondii seroprevalence of 70.2 % was found (243/346) (Dorny et al., 2002), but this was not 
the case when testing serum samples of pet cats throughout Belgium (De Craeye et al., 2008). 
The geographical differences in cat seroprevalence observed in the study of De Craeye et al 
(2008) do not correspond with those in sheep seroprevalence observed in our study. A 
possible reason is that the pet cat population studied by De Craeye et al (2008) does not 
contribute much to infection of pastures on which sheep graze. 
Flock location has been reported as another reason for variation in seroprevalence in sheep 
(Caballero-Ortega et al., 2008; Halos et al., 2010; Skjerve et al., 1998). However, due to 
privacy regulations, the exact location of the flocks cannot be released. We assume that the 
difference is not due to housing conditions since Belgian sheep are kept either totally outdoor 
or indoor with outdoor access. The differences we found among the provinces should most 
likely be seen as a result from differences in environmental contamination, nevertheless we 
could not identify etiological factors.  
In conclusion, this is the first report of T. gondii seroprevalence in sheep in Belgium, 
demonstrating a very high seroprevalence in sheep and flocks. As a consequence, this study 
supports the hypothesis that mutton is a major source of human toxoplasmosis. 
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CHAPTER 4 
PARASITE DISTRIBUTION AND ASSOCIATED IMMUNE RESPONSE DURING 
THE ACUTE PHASE OF TOXOPLASMA GONDII INFECTION IN SHEEP 
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distribution and associated immune response during the acute phase of a Toxoplasma gondii 
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4.1 Abstract 
In many countries, Toxoplasma gondii (T. gondii) is a major cause of reproductive 
disorders and abortions in the sheep industry, and therefore responsible for important 
financial and economic losses. In addition, consumption of undercooked infected lamb is an 
important risk factor for human toxoplasmosis. 
In the present study, sheep were orally infected with T. gondii tissue cysts to investigate 
the initial phase of the infection: the parasites’ entry site, the subsequent distribution of the 
parasite and the host-immune response. The presence of parasite DNA, the interferon-gamma 
(IFN-gamma) and interleukine-12 (IL-12) responses were determined at 4, 8, 10, 14 and 21 
days post infection (dpi) in the small intestinal mucosa, the draining mesenteric lymph nodes 
(MLN), the popliteal LN, the spleen and blood leukocytes (PBMC). Furthermore, appearance 
of Toxoplasma-specific IgM and IgG in serum was tested daily by an indirect 
immunofluorescence assay and total IgG, IgG1, IgG2 and IgA by a total parasitic lysate-
specific enzyme-linked immunosorbent assay. Parasite DNA already appeared in the cranial 
small intestinal mucosa the first days after infection. Simultaneously, high IFN-gamma and 
IL-12 responses were induced, mainly in the mesenteric LN. The emergence of IgG1 
(at 8 dpi), and IgG2 (at 11 dpi) was accompanied by a decrease or even disappearance of the 
IFN-gamma and IL-12 response in the Peyer’s patches (PP), PBMC and popliteal LN. 
Meanwhile, the parasite DNA could be recovered from most mucosal and systemic tissues 
while it became undetectable in the small intestine, popliteal LN, PBMC and spleen 21 dpi, 
suggesting that the parasite is leaving these tissues. 
Our results indicate that parasites enter the cranial small intestine the first days after 
infection and that after an increase the first two weeks after infection, the parasite DNA levels 
in the intestine drop below the detection limit three weeks after infection. This coincides with 
an increase in parasitic-specific serum IgG1 and IgG2 responses and a decrease of the 
antigen-specific IFN-gamma response in PP, PBMC and popliteal LN. We suggest a role for 
IFN-gamma and IL-12 during acute infection. 
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4.2 Introduction 
Toxoplasma gondii is an obligate intracellular parasite with a worldwide prevalence in a 
wide variety of hosts (Cenci-Goga et al., 2011). In many countries, the parasite is a major 
cause of reproductive disorders, miscarriages and abortions in the sheep industry, and 
therefore responsible for important financial and economic losses (Buxton et al., 2007b; 
EFSA, 2007). Based on data collected by the Veterinary Investigation Diagnosis Analysis in 
2009 (VIDA, 2009), toxoplasmosis is the second diagnosed cause of abortion in sheep in the 
UK (25.4 %), after Chlamydia abortus (45.6 %). 
Undercooked infected lamb is considered an important risk factor for human 
toxoplasmosis (Cook et al., 2000). Infection in herbivorous animals occurs through ingestion 
of T. gondii oocysts excreted by cats. One week after a first infection, cats can shed over 
100 million oocysts in their faeces during a period of 7-14 days depending on the infection 
stage and the immune status of the cat. Sporulated oocysts can stay infectious in the 
environment during several months and contaminate pastures, feeds and also drinking water 
(Dubey, 1988; Innes et al., 2009b). 
An acute primary infection during gestation in the ewe will result in the transmission of 
the parasite to the foetus. As in humans, the consequences for the foetus depend on the stage 
of the gestation: an early infection (during the first or second trimester of gestation) will result 
in fetal death and resorption or abortion, whereas a later infection will lead to the birth of 
clinically normal but latently infected lambs or lambs with symptoms of congenital 
toxoplasmosis (fever, growth retardation, weakness) (Esteban-Redondo and Innes, 1997; 
Pappas et al., 2009; Rodger et al., 2006).  
The immunity developed by the pregnant ewe will protect it against infection of the foeti 
during subsequent gestations (Innes et al., 2009b). The same protection develops when a non-
pregnant ewe becomes infected with T. gondii (Buxton, 1998; Rodger et al., 2006). 
Nevertheless, data of Morley et al. (2005, 2008) suggested that immunity might protect less 
well against transplacental transmission than thought. These findings were contested by 
several authors, as these were based on T. gondii DNA detection only and not on the 
demonstration of T. gondii-associated lesions by histopathology. In addition, the authors 
didn’t exclude other abortifacient agents (Dubey, 2009b). Williams et al. (2005) suggested 
that the observations of Morley et al. (2005, 2008) were due to breed differences.  
Whereas several experimental infections have been carried out in sheep to study host-
immune responses, to our knowledge, the distribution of the parasite and the correlated 
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antibody and interferon (IFN)-gamma responses during acute ovine toxoplasmosis after oral 
infection have not been studied yet (Blewett et al., 1982; Blewett and Watson, 1983; Buxton 
et al., 2007a, b; Dubey, 2009b; Innes et al., 2009b) 
In the present study, oral infections of sheep, with T. gondii tissue cysts, were performed 
to determine the entry site and subsequent distribution of the parasite following the oral 
infection route. Furthermore, we monitored the local IFN-gamma response during the acute 
phase of the infection, because of its important role as a mediator of host resistance against 
Toxoplasma as demonstrated in mice, sheep and humans (Hunter et al., 1994; Innes et al., 
1995b; Torres-Morales et al., 2014). 
4.3 Material and Methods 
4.3.1 Animals and experimental procedure 
Thirteen 7-week-old conventionally reared lambs were selected (Belgian cross-breed, 
Zootechnical Centre, Leuven, Belgium), based on their T. gondii and Neospora caninum 
seronegative status. The absence of antibodies against T. gondii was assessed by an indirect 
immunofluorescence assay (IFA, Toxo-Spot IF, Biomérieux, Marcy-l’Etoile, France), the 
absence of antibodies against Neospora with the Neospora caninum Antibody Test Kit 
(CHEKIT* Neospora, Idexx, Hoofdorp, The Netherlands). The latter were tested since 
Neospora antibodies can cross-react with T. gondii. 
After an acclimation period of one week at the experimental animal facilities of Ghent 
University, eleven animals were orally infected with 3000 tissue cysts of the T. gondii 
Prugniaud strain (PRU). PRU is a type II genotype isolated from a case of human lethal 
congenital toxoplasmosis (Bivas-Benita et al., 2003; Martrou et al., 1965). Sheep were killed 
by captive bolt and exsanguination on day 4 (4 dpi; N=3), 8 (8 dpi; N=2), 10 (10 dpi; N=2), 
14 (14 dpi; N=1) and 21 (21 dpi; N=3) after infection. Two animals were kept as negative 
controls (C) and euthanized at 21 days. Blood samples were taken daily from the jugular vein 
of each animal, until euthanasia, for monitoring the T. gondii-specific serum antibody 
response. At euthanasia, portions of duodenal (D), jejunal (J) and ileal (I) tissue with and 
without Peyer’s patches, the draining mesenteric lymph nodes (MLN), popliteal LN, spleen 
and blood on heparin were sampled. Samples were processed as described further, to 
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determine the spread of the parasite as well as the appearance of a specific IFN-gamma 
response in the different tissues at the early phase of the infection. 
All experimental and animal management procedures were approved by the Animal Care 
and Ethics Committee of the faculties of Bioscience Engineering and Veterinary Medicine, 
Ghent University (2007/103). 
4.3.2 Inoculum 
Tissue cysts of the T. gondii PRU strain were harvested from the brains of chronically 
infected C57BL6 mice and the number of brain cysts was calculated as described by Verhelst 
et al. (2011). Briefly, infected mice were euthanized five weeks after infection and their brains 
were homogenized in phosphate buffered saline (PBS) using a Potter Homogenizer. The 
concentration of brain cysts in the suspension was determined by phase contrast microscopy 
whereafter the brain homogenate was diluted in PBS to obtain a final concentration of 300 
cysts per ml. The sham inoculate given to the control animals was prepared similarly from 
non-infected mouse brains. 
4.3.3 Purification of recombinant antigens 
The recombinant antigens rGRA7, rEC2, rMIC3 were used to stimulate cell suspensions 
for IFN-gamma and IL-12 production. Recombinant GRA7 has already been demonstrated to 
be useful as a sero-diagnostic marker of acute and chronic toxoplasmosis (Aubert et al., 2000; 
Bonhomme et al., 1998; Jacobs et al., 1999). Furthermore GRA7 is expressed by all infectious 
stages of T. gondii and appears plentiful on the surface of the host cells, the host cell cytosol, 
the parasitophorous vacuolar membrane and lumen (Holec-Gasior, 2013). After rupture of the 
host cells, high amounts of GRA7 come in contact with the host immune system, triggering 
strong antibody responses (Fischer et al., 1998). The recombinant rEC2 antigen is a chimer of 
the antigenic regions of the microneme proteins MIC2 and MIC3 and of the surface antigen 
SAG1.  
Briefly, the HIS-tagged recombinant antigens were purified from an E. coli culture using 
metal chelate affinity chromatography (Ni-NTA Superflow, Qiagen, GmbH, Hilden, 
Germany), according to the manufacturer’s instructions. The recombinant antigens were 
eluted from the Ni-NTA columns by incubating in 500 mM imidazol buffer followed by 
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dialysis through a CelluSep H1 membrane (Membrane Filtration Products, Texas, USA) in 
urea buffer for rEC2, rGRA7 and rROP2 or PBS for rMIC3. 
Toxoplasma total lysate antigen (TLA) was produced as described before (Vercammen et 
al., 2000). Briefly, T. gondii RH tachyzoites (type I strain) were harvested from the peritoneal 
cavity of Swiss mice that were intraperitoneally infected 4 days earlier. The ascites fluid was 
passed twice through a 26-gauge needle. After centrifugation for 15 min at 950 x g, the pellet, 
containing the tachyzoites, was washed twice in PBS, followed by sonication in an Ultrasonic 
disintegrator (MSE, Leicester, United Kingdom) to solubilize the T. gondii tachyzoite 
antigens. The total protein concentration was measured by the bicinchoninic acid (BCA) 
reaction (Thermo Scientific Pierce BCA Protein Assay Kit, Erembodegem, Belgium), 
whereafter the purified antigens were aliquoted and stored at -20 °C until use. 
4.3.4 Indirect Immunofluorescence Antibody Test (IFA) 
To test the presence of specific IgG and IgM antibodies against T. gondii; the sheep sera 
were diluted 1:50 in PBS and tested as follows: fifty microliter of this dilution was applied on 
a slide coated with formalin-treated T. gondii RH tachyzoites (Toxo-Spot IF, Biomérieux, 
Marcy-l’Etoile, France) for 30 min at 37 °C. On each slide, seronegative and seropositive 
sheep reference serum samples were used as controls. After washing with PBS, 30 µl of a 
1:25 in PBS-Evans blue diluted fluorescein isothiocyanate conjugated rabbit anti-sheep IgM 
or rabbit anti-sheep IgG (KPL, Maryland, USA) was applied for 30 min at 37°C. The slides 
were then washed again; air dried and examined using fluorescence microscopy. 
4.3.5 T. gondii -specific antibody ELISA 
The presence of T. gondii antigen-specific IgG, IgG1, IgG2 and IgA in the collected sera 
was tested by ELISA. Nunc maxisorp immunoplates (Life Technologies, Merelbeke, 
Belgium) were coated overnight at 4°C with TLA, recombinant GRA7 or rROP2 at a 
concentration of 10 µg/ml in bicarbonate coating buffer (pH 9.7). In subsequent steps, the 
plates were blocked, during 2 h at 37°C, in 1% non-fat milk powder in PBS; incubated for 1 h 
at 37°C with 100-fold diluted sera in PBS with 0.05% Tween
®
 20 and 1% non-fat milk 
powder. This was followed by an incubation step, for 1 h at 37°C, with rabbit anti-sheep IgG- 
or IgA-labeled with horseradish peroxidase (AbD Serotec (Gentaur), Brussels, Belgium) or 
with a mouse anti-bovine IgG1 or IgG2 secondary antibody followed by an incubation with 
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an anti-mouse immunoglobulin-horseradish peroxidase conjugate. Subsequently a 3,3’,5,5’-
tetramethylbenzidine solution (TMB)(Sigma-Aldrich, Diegem, Belgium) was added. In 
between each step, the plates were manually washed 5 times with PBS 0.05% Tween
®
 20.
 
The 
reaction
 
was stopped by adding 50 µl 2 M H2SO4 (stop solution). Absorbance was read at 450
 
nm. Positive and negative control sera were included on each plate. The corrected optical 
density (OD) was calculated as: OD of sample - OD of negative control sample. The serum 
samples were considered positive when the corrected optical density (OD450) of the dilutions 
exceeded the cut-off value (= mean OD450 (negative controls) + 3 x its standard deviation). 
The negative control sera in the IFA and ELISA were from T. gondii negative sheep. They 
tested negative in the Modified agglutination test, the IFA and the Sabin Feldman Dye Test. 
4.3.6 Isolation of mononuclear cells (MC) from blood, spleen, lymph nodes and  
intestine 
The MC from blood and spleen were isolated as described by Verhelst et al. (2001). The 
peripheral blood MCs (PBMCs) were isolated by density gradient centrifugation using 
Lymphoprep™ (Nycomed, Brussels, Belgium). Briefly, heparinized blood was centrifuged 
during 25 min at 1000 x g and 18°C. After removing the plasma layer, the buffy coat and 
erythrocyte pellet were suspended in an equal volume of PBS with 1mM 
ethylenediaminetetraacetic acid (PBS-EDTA) and layered onto the gradient. Tubes were 
centrifuged for 45 min at 800 x g and 18°C. The interface layer, containing the MCs, was 
collected and the cells were washed in PBS-EDTA. 
Splenocytes were isolated from the spleen after removing the surrounding fat. The 
obtained cell suspension was further purified by lysing the erythrocytes in the presence of 
ammonium chloride. After centrifugation (380 x g at 18°C for 10 min), the pelleted cells were 
washed and resuspended in PBS-EDTA (1mM). 
The MCs from MLN, popliteal LN, duodenal, jejunal and ilial Peyer’s patches (PP) were 
isolated as described by Van den Broeck et al. (1998) and the MCs from the duodenal, jejunal 
and ileal lamina propria as described by Vande Walle et al. (2011). All isolated cells were 
resuspended at a final concentration of 1 x 10
7
 cells/ml in complete leucocyte medium (RPMI 
1640, Gibco, Merelbeke, Belgium) supplemented with 10% fetal calf serum (FCS, Greiner 
Bio-One, Belgium), 200 mM L-glutamin (Gibco), 100 U/ml penicillin and 100 μg/ml 
streptomycin (P/S; Gibco), 100 mM non-essential amino acids (Gibco) and 100 µg/ml 
kanamycin (Gibco). 
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4.3.7 Isolation of enterocytes from the intestine 
At euthanasia, duodenal, jejunal and ileal segments without PP of approximately one 
meter were sampled, flushed three times with Krebs buffer (0.12 M NaCl, 0.014 M KCl, 
0.001 M KH2PO4, 0.025 M NaHCO3, pH 7.4) at room temperature and filled for 95% with 
Hank's Buffered Salt Solution (HBSS) supplemented with 1.5mM EDTA + 1mM 1,4-
dithiothreitol (DTT) and pre-heated at 37 °C. Then the segments were incubated in 2 liter PBS 
for 15 min at 37°C. Thereafter the contents were collected and placed at 4°C. This process 
was repeated twice. The isolated cells were pooled and washed three times with HBSS 
supplemented with 0.1mM phenylmethylsulfonyl fluoride (PMSF). PMSF is a serine protease 
inhibitor that prevents proteolytic degradation of proteins (James, 1978). After centrifugation 
for 10 min at 1800 x g and 4°C, the cell pellets were resuspended at a final concentration of 
10
7
 cells/ml in complete medium. 
4.3.8 Detection of parasites in cell populations by real-time PCR 
DNA was extracted from cell suspensions using the Qiagen QIAmp DNA Mini kit 
(Qiagen GmbH, Hilden, Germany), according to the manufacturer’s instructions. After that, 
the presence of T. gondii DNA was determined by duplex qPCR analysis as described before 
(Kijlstra et al., 2008): the T. gondii repeat element (AF146527) was used as target for the 
detection of the parasite’s DNA and the amplification of the cellular 18S rRNA gene. Since 
host cells are always present in the sample, the latter reaction should always be positive. 
Tenfold dilutions of a counted number of RH tachyzoites and cultured swine kidney cells 
(SK-6) were used to generate a standard line for the quantification of T. gondii parasites and 
one for the cells, respectively. Real-time qPCR was performed with an initial 3 min 
denaturation step at 95 °C, followed by 45 cycles at 95°C for 15 s and at 60°C for 20 s. 
4.3.9 Restimulation of isolated mononuclear cells with T. gondii antigens 
The MCs were seeded in 96-well flat bottom cell culture plates (Greiner bio-one) at 
10
6
 cells per 100 μl complete medium and per well. After an initial incubation of 12 h, the 
mitogen concanavalin A (Con A) (5 µg/ml) (BD Biosciences) or 10 µg/ml of one of the 
following antigens was added: rEC2, rGRA7, rMIC3 or, total lysate antigen (TLA). The 
recombinant proteins were diluted in complete medium, supplemented with 10 µg/ml 
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polymyxin B to neutralize potentially contaminating endotoxin (Cardoso et al., 2007). After a 
6 h incubation in the presence of Con A at 37°C in a humidified atmosphere with 5% CO2 or 
96 h with one of the antigens, the cell-free supernatant was removed and stored at -20°C until 
analysis for the IFN-gamma concentration by ELISA. 
4.3.10 Cytokine ELISA 
To determine the IFN-gamma and interleukin 12 (IL-12) concentrations in the cell-free 
culture supernatants, 96-well Nunc maxisorp immunoplates (Life Technologies) were coated 
overnight at 4°C with a mouse anti-bovine IFN-gamma monoclonal antibody (mAb) (CC330; 
AbD Serotec) at 5 µg/ml or a mouse anti-bovine IL-12 mAb at 2.5 µg/ml (CC301; AbD 
Serotec), respectively. The plates were blocked for 2 h at room temperature (RT) with PBS 
containing 0.05% Tween
®
 20 and 3% non-fat milk powder. In subsequent steps we added, 
each for 1 h at RT, 100 µl of a cell culture supernatant 1:2 in PBS supplemented with 0.05% 
Tween
®
 20 and 1% non-fat milk powder, a biotin-labelled mouse anti-bovine IFN-gamma 
mAb (CC302b; AbD Serotec) or biotin-labelled mouse anti-bovine IL-12 mAb (CC326; AbD 
Serotec) and horseradish peroxidase (HRP)-conjugated streptavidin (Serotec, Belgium). In 
between each step, plates were washed 5 times with PBS 0.05% Tween
®
 20. Then, a HRP 
substrate solution (3,3’,5,5’-tetramethylbenzidine (TMB, Sigma – Aldrich)) was added for 30 
min at RT in the dark. The reaction was stopped by adding 50µl H2SO4 (2N) and the optical 
density (OD) was measured at 450 nm.  
The IFN-gamma and IL-12 concentrations in the samples were calculated from the 
regression line calculated using DeltaSoft JV 2.1.2 software. This regression line was 
obtained by including in the tests 10-fold dilutions of recombinant ovine IFN-gamma or 
recombinant IL-12 starting from 4000 pg/ml and 320 u/ml, respectively. The recombinant 
ovine IFN-gamma and ovine IL-12 were prepared as a serum-free conditioned medium from 
transfected CHO cells, according to a protocol described for the production of recombinant 
ovine IL-4 (Hope et al., 2005). The recombinant ovine IFN-gamma was quantified using the 
recombinant bovine IFN-gamma standard sold by Endogen, Thermo-scientific (Rockford, 
USA) and the anti-bovine mAbs (AbD Serotec) clones CC330 and CC302b in a species cross-
reactive ELISA (personal communication with Sean Wattegedera, Moredun Research 
Institute). 
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4.4 Results 
4.4.1 Neospora caninum antibodies 
None of the experimental infected or control animals showed an IgG response against 
N. caninum at euthanasia. 
4.4.2 Presence of T. gondii in tissues 
The presence of T. gondii in the various tissues collected after euthanasia was evaluated 
by qPCR (Table 4.1). Parasite DNA could be found sporadically in tissues of two out of three 
sheep euthanized at 4 days post infection (dpi). These sheep had T. gondii DNA in their 
epithelium (enterocytes, lamina propria) and in the organized lymphoid tissue of the small 
intestine (PP) or the mesenterial lymph nodes draining the small intestine (MLN), mostly in 
the cranial parts. In one sheep euthanized at 4 dpi parasite DNA could be detected in 
peripheral blood mononuclear cells (PBMC). No T. gondii DNA could be detected in the third 
sheep, suggesting that the parasite had not yet invaded the gut at this time point, had already 
left this site, or that the parasitic load was still below the detection limit. In the two sheep 
euthanized at 8 dpi, more tissues were positive for the presence of T. gondii DNA. The 
epithelium and draining lymph nodes of both sheep were positive throughout the small 
intestine, the lamina propria and Peyer’s patches in the duodenum. Parasite DNA was 
demonstrated in other parts of the small intestine, popliteal lymph nodes and spleen in only 
one sheep. The appearance of DNA in the systemic tissues indicates that dissemination had 
taken place. At 10 dpi a similar pattern was seen for the intestinal tissues and MLN, but at this 
time point the two euthanized animals showed parasite DNA in their popliteal lymph nodes, 
confirming the dissemination observed at day 8 in one sheep. The animal euthanized at 14 
dpi, had parasite DNA in all its intestinal tissues with the highest amounts in the Peyer’s 
patches and MLN. Popliteal lymph nodes and spleen were negative. In the three sheep killed 
one week later (21 dpi), the parasite load had dropped below the detection limit in most 
tissues. Parasite DNA could still be detected in two animals. One was positive for the 
presence of T. gondii DNA in its MLN only, with the greatest amounts observed in the jejunal 
MLN. The other animal had low levels of parasite DNA in its jejunal epithelium and duodenal 
lamina propria. The third sheep tested completely negative. This suggests that either most of 
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the parasites had left the intestinal and lymphoid tissues or were cleared from these tissues at 
this time point. 
When comparing the parasitic load in the tissues of the four animals euthanized at 8 and 
10 dpi, a trend could be observed in cranial versus caudal intestinal tissues. For each of the 
four animals, one or more of the tested duodenal tissues or its associated draining lymph 
node, showed the highest or second highest amount of parasite DNA, while the tested ileal 
tissues often showed the lowest amount. In 5 of 12 ileal tissues samples no parasite DNA 
could be detected at all. Overall, the ileal Peyer’s patches showed the lowest amount of 
parasite DNA. These data suggest that the parasite invades the gut primarily in the cranial 
small intestine shortly upon release from the cysts.  
The two sham infected animals remained T. gondii-free in all tissues. 
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4.4.3 Humoral immune response 
Serum samples were collected on a daily basis to determine the kinetics of the antibody 
response after the oral infection. Toxoplasma-specific IgM and IgG IFA’s as well as TLA, 
rGRA7 and rROP2-specific IgG, IgG1, IgG2 and IgA ELISAs were performed. Data of the 
TLA and rROP2-specific IgG ELISAs are presented in Figure 4.1. The data of the rGRA7 
ELISA did not give meaningful responses. Therefore, these data are not included in this 
chapter. The cut-off values for the other ELISAs were as follows: IgG: TLA: 0.117; rROP2: 
0.167; IgG1: TLA: 0.321, rROP2: 0.306; IgG2: TLA: 0.348, rROP2: 0.159; IgA: TLA: 0.071, 
rROP2: 0.113 
Toxoplasma-specific IgM was detected for the first in three out of the six not euthanized 
sheep at 9 dpi (3/6), two out of four at 12 dpi (2/4) and two out of three at 15 dpi (2/3). In one 
out of the three sheep, euthanized 3 weeks after infection, no Toxoplasma-specific IgM could 
be detected. IgG was detected by IFA in one sheep at 9 dpi (1/6) and in another at 12 dpi 
(1/4). These animals remained seropositive until euthanasia.  
In the TLA ELISA, the T. gondii-specific IgG levels rose from 7, 8, 9 and 15 dpi onwards, 
each time in one animal and remained present in these animals until euthanasia (Fig. 4.1). 
Interestingly, in one animal no TLA-specific IgG response could be observed although its 
tissues were positive for the presence of parasite DNA at euthanasia, 21dpi. TLA-specific 
IgG1 appeared in one sheep 15 dpi and in another sheep 17 dpi. TLA-specific IgG2 appeared 
in the same two animals, but slightly earlier, namely on 12 and 15 dpi.  
In the rROP2 ELISA, T. gondii-specific IgG appeared in four out of the five animals at 10, 
12 and 14 dpi (Fig. 4.1). Interestingly, two sheep showed an IgG response against either TLA 
or rROP2, but not against both. Sh11 in which no TLA-specific serum IgG could be detected, 
showed a serum IgG response against rROP2 from 16 dpi on, while Sh7, with a response 
against TLA at 8 dpi, did not react against rROP2. Although the T. gondii-specific IgG1 and 
IgG2 responses against rROP2 were comparable with those against TLA, they showed a 
slightly delayed increase. Furthermore, one extra animal showed rROP2-specific antibodies. 
Toxoplasma-specific serum IgA was not detected in any sheep.  
The two sham-infected control sheep neither showed T. gondii-specific antibodies in IFA, 
nor in ELISA. 
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Figure 4.1: TLA and rROP2-specific IgG responses of sheep infected with T. gondii tissue cysts in 
function of time measured by ELISA. The dashed green and red lines indicate the cut-off values 
defined with pre-immune sera for TLA and rROP2, respectively. 
4.4.4 Interferon-gamma and interleukin-12 cytokine response 
At euthanasia, MCs were isolated from blood, Peyer’s patches, MLN, popliteal LN and 
spleen and restimulated with rGRA7, rEC2, rMIC3 and total lysate antigen (TLA) to 
determine the antigen-specific IFN-gamma and/or IL-12 responses. 
At 4 dpi, TLA, rEC2 and rMIC3 consistently induced high IFN-gamma concentrations in 
the MLN cultures of all 3 animals, with the highest responses against rMIC3 (DMLN: 80,637 
ng/ml (mean) ± 61,951 (SEM); JMLN: 1,313,771 ng/ml ± 735,659; IMLN: 2,963,760 ng/ml ± 
2,275,224); followed by rEC2 (DMLN: 5,400 ng/ml ± 2,204; JMLN: 129,964 ng/ml ± 
119,802; IMLN: 298,194 ng/ml ± 155.314) and TLA (Fig. 4.2). In contrast, rGRA7 induced 
less consistently IFN-gamma (Fig. 4.2). Two out of three animals showed IFN-gamma 
production in jejunal and ileal MLN and one of them in duodenal MLN too (Fig. 4.2). IFN-
gamma was also induced in popliteal LN and spleen, but mainly by rMIC3 and to a lesser 
extent by TLA (Fig 4.4). Responses in PP (Fig 4.3) and PBMC were absent.  
At 8 and 10 dpi, the IFN-gamma pattern was different in that low or no responses were 
detectable in MLN (Fig. 4.2). Indeed, neither rEC2 nor rMIC3 induced IFN-gamma responses 
in the MLN cell cultures, whereas a low response was observed in one animal at 10 dpi. In 
contrast, rGRA7 stimulated IFN-gamma in MLN of all four animals with the lower 
concentrations at 8 dpi (Fig. 4.2). More IFN-gamma response occurred in PP (Fig. 4.3), 
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PBMC and popliteal LN (Fig. 4.4) cultures, with a higher response after TLA stimulation than 
after rGRA7 stimulation. Only TLA induced IFN-gamma in PP cell cultures of all three small 
intestinal sites in two out of four animals. The same two animals showed TLA-induced IFN-
gamma in popliteal LN and PBMC cultures. rGRA7-induced IFN-gamma production was 
seen in popliteal LN cell cultures of three out of four animals, and in PBMC and spleen cell 
cultures in two out of four animals, but not or very weak in PP cell cultures.  
At 14 and 21 dpi, only rMIC3 consistently induced high IFN-gamma in MLN cell cultures 
of all four animals, whereas the other antigens induced IFN-gamma in 50 to 67% of the 
cultures. These responses were less pronounced than at 4 dpi. In PP, popliteal LN and PBMC 
cultures rGRA7 and TLA induced responses were mostly absent, whereas responses could be 
seen in spleen cell cultures of three out of four animals for TLA (one sheep euthanatized at 14 
dpi and two at 21 dpi) and of two out of four animals for rMIC3 and for rEC2 (at 21 dpi).  
There was no induction of IFN-gamma in the MCs of the control animal. 
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Figure 4.2: IFN-gamma responses (log10 scale) in duodenal (D), jejunal (J) and ileal (I) mesenteric 
lymph nodes (MLN), against rGRA7, TLA and rMIC3 in function of time following oral infection 
with T. gondii tissue cysts in sheep. The lines present the mean OD-value at each time point. 
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Figure 4.3: IFN-gamma responses (log10 scale) in duodenal (D), jejunal (J) and ileal (I) Peyer’s 
patches (PP), against rGRA7, TLA and rMIC3 in function of time following oral infection with 
T. gondii tissue cysts in sheep. The lines present the mean OD-value at each time point. 
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Figure 4.4: IFN-gamma responses (log10 scale) in popliteal LN, PBMC and splenocytes against 
rGRA7, TLA and rMIC3 in function of time following oral infection with T. gondii tissue cysts in 
sheep. The lines present the mean OD-value at each time point. 
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Similar to IFN-gamma, the IL-12 production (Fig. 4.5) at day 4 pi was most consistently 
induced in the MLN cell cultures. However, whereas rGRA7 was the weakest inducer of IFN-
gamma, it was the best inducer of IL-12 (0.50 u/ml ± 0.16 (SEM)), followed by rEC2 
(0.29 u/ml ± 0.07 (SEM)), rMIC3 (0.26 u/ml ± 0.06 (SEM)) and TLA (0.06 u/ml ± 0.02 
(SEM)). TLA induced low amounts of IL-12 in the DMLN of one animal and in the JMLN of 
another. Besides, low amounts of IL-12 were induced in the PP by rMIC3 in two animals and 
by TLA in the third animal and by rEC2 in the popliteal LN of one animal. 
At 8 and 10 dpi, the responses of MLN were in general lower except for one animal in 
which TLA induced 7.4 u/ml in jejunal and rEC2 10.1 u/ml in ileal MLN. At least one antigen 
induced IL-12 in at least one of the MLN cell cultures of each animal, although none of the 
antigens could consistently induce IL-12 responses in the MLN cell cultures. The same was 
seen for the PP cell cultures. In popliteal LN cell cultures and spleen, IL-12 was produced 
following restimulation with different antigens in two of the 4 animals. PBMCs remained 
IL-12 negative. Accordingly, at these time points more variation was seen in the IL-12 
response than in the IFN-gamma response. At 14 dpi, IL-12 was induced by rEC2 in cell 
cultures of all tissues except for the spleen. High amounts were observed in duodenal MLN 
(40.9 u/ml) and very high in popliteal LN cell cultures (635.6 u/ml). None of the other 
antigens induced IL-12 in MLN cell cultures. For the PP, rGRA7 and rMIC3 induced IL-12 in 
duodenal, rEC2 in jejunal and rMIC3 and TLA in ileal PP cell cultures. rEC2 as well as TLA 
induced also high IL-12 concentrations in the popliteal LN cell cultures (32.8 u/ml). 
Recombinant MIC3, rGRA7 and TLA induced IL-12 in PBMCs and splenocytes (1.7 - 
6.1 u/ml). So, in particular the IL-12 response in popliteal LN and PBMCs gave a noteworthy 
difference with the IFN-gamma response.  
At 21 dpi, neither in the popliteal LN nor in the PBMCs, IL-12 was detectable. On the 
other hand, IL-12 was induced by rEC2 and rMIC3 in the splenocyte culture of one animal, 
and was induced, in very low concentrations, by the recombinant antigens and TLA in most 
duodenal and jejunal MLN cultures and even less in the ileal MLN cultures. 
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Figure 4.5: IL-12 response (u/ml) in duodenal (D), jejunal (J) and ileal (I) mesenteric lymph nodes 
(MLN), against rGRA7, TLA and rMIC3 in function of time following oral infection with T. gondii 
tissue cysts in sheep. The lines present the mean OD-value at each time point. 
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4.5 Discussion 
T. gondii seropositive sheep are probably latently infected for life and harbour tissue cysts 
in various tissues. Therefore, the consumption of raw or undercooked meat from seropositive 
animals is a high risk for humans (Buxton et al., 2007b). In the present study a type II strain 
was used for experimental infection of sheep since type II strains are most commonly found 
in animals in Europe and are most commonly identified as a cause of human toxoplasmosis 
world-wide (Sibley et al., 2009). A commercially available, live intramuscular vaccine 
(Toxovax®, MSD Animal Health) can prevent congenital toxoplasmosis in sheep. However, 
no current vaccine can prevent infection, suggesting that new vaccination strategies are 
needed. Induction of a mucosal immune response would be of interest since sheep become 
infected orally. Therefore, an important research goal is to identify the acute events in the 
small intestine following oral infection (Esteban-Redondo and Innes, 1997; Tenter et al., 
2000). Whereas several natural and experimental T. gondii infections have been performed in 
sheep, none focused in the same detail on the initial phase of the infection at the intestinal 
mucosa and lymphoid tissues and its local cytokines response as we did in our study 
(Benavides et al., 2011; Buxton et al., 2007a, b; Dubey, 2009a; Falcon and Freyre, 2009; 
Gutierrez et al., 2010; Innes et al., 2009b). In our study, sheep were orally infected with 3000 
tissue cysts. Because infectious oocysts are more difficult to obtain in sufficient quantities, 
lead to environmental contamination and are a serious risk for laboratory personnel, tissue 
cysts where used even though oral infection in sheep mostly occurs via ingestion of oocysts 
during grazing (Race et al., 1998). Nevertheless infection with tissue cysts can occur, 
although rare, when sheep eat the placenta or aborted tissues from ewes that aborted as a 
result of toxoplasmosis (Dubey, 1987). As mentioned above, only few studies analyzed the 
immune response in sheep, three of them after oral inoculation with oocysts (Benavides et al., 
2011; Coughlan et al., 1995; Gutierrez et al., 2010) and four following intraperitoneal 
injection with tachyzoites of the RH strain or the S48 strain (Buxton et al., 1994; Innes et al., 
1995a; Innes et al., 1995b; Wastling et al., 1993). One other study examined the immune 
response following a subcutaneous inoculation with tissue cysts (McColgan et al., 1987). 
T. gondii bradyzoites entered preferentially the cranial small intestine around 4 dpi. Most 
likely, infection occurs at the same site when oocysts are given orally. Indeed, Dubey and 
Sharma (1980) found that excystation of oocysts and the release of sporozoites takes place in 
the small intestine. 
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Since parasites were detected simultaneously in epithelial cells, lamina propria, MLN and 
blood in one sheep at 4 dpi, our findings suggest that some parasites most likely directly 
passed the epithelial barrier to reach the MLN and the blood. The early detection of parasite 
DNA in blood in our study could be a consequence of the use of tissue cysts for oral infection; 
bradyzoites released from tissue cysts might pass the epithelial layer earlier than sporozoites 
released from oocysts. Indeed, Dubey and Sharma (1980) found that parasitemia occurs 
between 6 and 11 days after oral inoculation of sheep with oocysts.  
Four days after infection sheep were still seronegative in IFA as well as in TLA and 
rROP2 ELISA. Although the mesenteric lymphocytes and splenocytes produce more IFN-
gamma in response to antigen stimulation 4 dpi than later during infection, this response is too 
early to be derived from antigen-specific CD4+ and/or CD8+ T lymphocytes. A T- cell 
independent IFN-gamma production by NK-cells (Sher et al., 1993) has been described in 
mice and is dependent on the production of IL-12 and tumor necrosis factor-alfa (TNF-alfa) 
by macrophages (Gazzinelli et al., 1993). However, in the present study, a generalized but 
low IL-12 production was measured in the MLN cultures at 4 dpi. During this early infection 
stage, the parasite triggers several components of the innate immune system resulting in the 
release of cytokines such as IL-12 and IFN-gamma by macrophages, NK cells, dendritic cells 
as well as neutrophils. Previous studies in mice have demonstrated that IL-12 production is 
critical in inducing an early IFN-gamma production, which most likely plays an important 
role in the host-resistance (Bhopale, 2003; Gazzinelli et al., 1994). Indeed, in IL-12 knockout 
mice, severely decreased IFN-gamma levels led to an uncontrolled replication of T. gondii 
tachyzoites, which caused the early death of the IL-12 deficient mice (Vossenkamper et al., 
2004). While triggering the innate immune system, parasite antigens are also taken up and 
presented by antigen-presenting cells, inducing a parasite-specific T-cell immunity (Denkers 
and Gazzinelli, 1998). At 8 dpi, parasite DNA was highly present in the tissues of the cranial 
small intestine and MLN and this remained so until 14 dpi, suggesting that replication of the 
parasite occurs in the small intestinal mucosa, mucosa-associated lymphoid tissues and 
associated draining lymph nodes. This finding is in accordance with the observations of 
Dubey and Sharma (1980) who found tachyzoites in the mesenteric lymph nodes of sheep 
from 7 dpi onwards. Similarly in mice, an increase in parasite burden occurs in PP, MLN, IE 
and LP between 4 and 9 dpi (Morampudi et al., 2011). Specific IgM and IgG antibodies 
appeared almost simultaneously at 9 dpi. Specific antibodies in the presence of complement 
can lyse extracellular tachyzoites (Bhopale, 2003). Parallel with the appearance of antibodies, 
a significant decrease in the IFN-gamma response and a decrease in the IL-12 response were 
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observed. Different antigens induced IL-12 responses in various gut tissues of different sheep, 
which was not the case for IFN-gamma. Recombinant GRA7 induced quite consistent IFN-
gamma responses in MLN lymphocyte cultures of the four animals tested at 8 and 10 dpi, 
whereas TLA clearly induced IFN-gamma in the PP lymphocyte culture of two of the four 
euthanized animals. This suggests that various antigens are involved in the induction of the 
IFN-gamma responses in PP versus MLN. Homing of the activated T cells from both 
lymphoid tissues to other sites could explain why both antigen preparations induced responses 
in PBMC as well as in the popliteal LN cell cultures. Such homing at 8 dpi is consistent with 
the increase of IFN-gamma producing CD4+ lymphocytes in efferent lymph of surgically 
cannulated experimentally infected lymph nodes at 11 dpi (Innes et al., 1995a). Our results 
suggest that a T cell independent response becomes replaced by an antigen-specific T 
lymphocyte response around 8 dpi. The finding that, in popliteal lymph nodes, spleen cell 
cultures and distant systemic lymphoid tissues, IFN-gamma and IL-12 responses can be 
induced by several antigens at 8 dpi supports the hypothesis that a systemic migration of the 
parasites occurs at that time. 
Our observation that the parasite DNA disappears from the small intestine, popliteal LN, 
PBMC and spleen, 3 weeks after infection, indicates that the parasite load drops below the 
detection limit of the PCR. Indeed, a negative result in PCR does not imply that these tissues 
are completely free of parasite DNA. However, the finding that most of the tested tissues 
became PCR negative could be an indication that the parasite is either suppressed in these 
tissues, or is cleared from these tissues or otherwise is leaving these tissues between 2 and 3 
weeks post infection. This coincided with an increase of IgG antibodies between 9 and 21 dpi. 
In previous studies, the immune response was studied following oral inoculation with oocysts 
or following intraperitoneal injection of tachyzoites of the RH strain (Tenter et al., 1992; 
Verma et al., 1989). Whereas antibodies were detectable 14 days after oral inoculation with 
5.000 or 50.000 oocysts (Tenter et al., 1992), they only appeared 1 month after intraperitoneal 
injection of tachyzoites (Verma et al., 1989). In our study the oral inoculation with tissue 
cysts resulted in a more rapid antibody response. However, this response was similar to the 
one observed by Mc Colghan et al (1987), who observed appearance of IgG 9 days after 
experimental infection with tissue cysts. This again supports the hypothesis that the parasite 
passes the intestinal epithelial barrier more quickly after an oral infection with tissue cysts 
although it cannot be excluded that the earlier response was a result of strain differences 
(Dubey, 2009b; Dubey and Sharma, 1980; Esteban-Redondo and Innes, 1997). While the 
antibody response increased and the parasite seems to disappear from systemic lymphoid 
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tissues, the IL-12 response in these tissues decreased or became absent. This coincided with a 
decreased or negative antigen-specific IFN-gamma response in PP, PBMC and popliteal LN 
cell cultures. Interestingly, these observations are in accordance with the findings of Innes et 
al. (1995) who infected sheep subcutaneously with tachyzoites. IFN-gamma could not be 
detected anymore in the lymph from lymph nodes draining the subcutaneous region from 11 
dpi onwards. At that time they noticed a switch from predominantly CD4
+
 proliferating 
lymphocytes to CD8
+
 proliferating lymphocytes. In our study, antigen-specific IFN-gamma 
responses were still present in MLN and spleen cell cultures 21 dpi. Since MLN not only 
drain the gut, but also the systemic sites such as the peritoneal cavity, and since the spleen is 
the secondary lymphoid organ draining the blood, both responses could play a role in 
controlling a systemic infection occurring at this stage (Innes et al., 1995a).  
Although our experimental animal groups were too small to warrant firm conclusions, our 
data show a strong agreement with previous results. Further studies with larger number of 
animals are needed to confirm the obtained results and conclusions. 
4.6 Conclusions 
Our results indicate that parasites enter the cranial small intestine the first days after 
infection. Three weeks later T. gondii DNA could not be recovered anymore from the 
intestine. This coincided with the increase of IgG1 and IgG2 antibodies and a decrease of the 
antigen-specific IFN-gamma response in PP, PBMC and popliteal LN. The experiments 
support a collaborate role of humoral and cellular immunity in acute T. gondii infections in 
sheep. 
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5.1 Abstract 
Livestock animals are a potential risk for transmission of toxoplasmosis to humans. Sheep 
and pigs still remain an important source because their meat is often consumed undercooked, 
which is increasingly been regarded as a major route of infection in many countries. 
Moreover, porcine tissues are processed in many food products.  
In the current study, the IFN-gamma (T-helper 1 cells), IL-4 (Th2 cells) and IL-10 mRNA 
(Treg cells) expression by blood mononuclear cells, and the serum antibody response against 
Toxoplasma gondii total lysate antigen, recombinant T. gondii GRA1, rGRA7, rMIC3 and 
rEC2, a chimeric antigen composed of MIC2, MIC3 and SAG1, was studied in sheep the first 
two months after a T. gondii infection and compared with these responses in pigs. At the end 
of this period, the parasite distribution in heart, brain and two skeletal muscles was studied in 
sheep and pigs.  
Whereas the parasite distribution was similar in sheep and pigs, the antibody response 
differed considerably. In sheep, antibodies appeared against all tested T. gondii antigens, but 
mainly against rGRA7, rMIC3234-307 and TLA, whereas in pigs only rGRA7-specific 
antibodies could be demonstrated. Also, the cytokine response differed. Both in sheep and 
pigs an IFN-gamma response occurred, which seemed to be a slightly more pronounced in 
sheep. In sheep, also IL-10 and IL-4 mRNA expression increased, but later than IFN-gamma 
and with more variation. However, in pigs no such increase was seen.  
Concerning diagnosis of a T. gondii infection, results indicate that, in live sheep and pigs, 
serum antibodies for a rGRA7 ELISA, and in euthanized animals, heart tissue for bioassay 
and qPCR, are the best biological samples to demonstrate presence of T. gondii infection.  
5.2 Introduction 
Toxoplasma gondii, an obligate intracellular protozoan parasite, is one of the most 
common parasitic zoonoses worldwide (Tenter et al., 2000). The parasite can establish a 
chronic infection in animals and humans. By estimation, 5 × 10
8
 people worldwide or one 
third of the world population has been infected (Denkers and Gazzinelli, 1998; Montoya and 
Liesenfeld, 2004). Livestock animals are a potential risk for transmission of toxoplasmosis to 
humans. Consumption of raw or undercooked meat is regarded as a major route of infection in 
many countries (Cook et al., 2000; Kijlstra and Jongert, 2008). Seroprevalence studies 
showed that in certain countries 90% of the sheep are infected (Dubey, 2009). In contrast the 
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seroprevalence in pigs is very low to almost zero (Kijlstra et al., 2004). Nevertheless, sheep 
and pigs still remain an important source of human infection because their meat is often 
consumed undercooked and porcine tissues are processed in many food products.  
Following oral ingestion of oocysts/tissue cysts by sheep, the parasites transform into 
tachyzoites, which invade the small intestine, where they rapidly replicate in the epithelial 
cells (Chapter 4). Simultaneously, they spread to other gut-associated tissues. This is 
accompanied with the induction of cellular and humoral immune responses. Cellular 
responses occur first with the interferon gamma (IFN-gamma) responses peaking in 
mesenteric lymph nodes (MLN) and splenocytes 4 days post infection (dpi) and the IL-12 
responses in MLN most-likely as a result of innate immune responses (Chapter 4). A second 
peak occurs 1 to 3 weeks later and is most-likely due to T-cell responses (Chapter 4). These 
T-cell responses are necessary for the survival of the host and as a result the tachyzoite stage 
of the parasite transforms into the bradyzoite stage, which escapes the immune system and 
persists in cysts in the host tissues (Denkers and Gazzinelli, 1998). Since the parasite becomes 
undetectable in most intestinal and systemic lymphoid tissues around 3 weeks post infection 
(PI) (Chapter 4), we postulated that this is the result of clearance of the parasite from these 
tissues by an immune response. Appearance of tissue cysts in visceral organs such as lungs, 
liver and kidneys, but predominantly in the central nervous system
 
and in muscle tissue, has 
been observed 7 to 10 dpi (Black and Boothroyd, 2000). Here, they may stay for the entire 
host’s life. 
The objectives of the present study were to determine the distribution of the parasite and 
to assess the status of the adaptive immune response in sheep 4 to 8 weeks PI, which is 
shortly after the parasite left the intestinal tissues. Furthermore we wanted to compare the 
immune response in sheep with those in pigs. As mentioned above, humans become infected 
among others by ingesting tissue cysts from undercooked meat. Just like sheep, pigs are not 
tested for T. gondii infection at slaughter which makes them at risk for humans. Moreover, 
sheep and pigs are considered as the main source of infected meat in European countries and 
correlation between serological results and contamination with cysts has not been investigated 
(EFSA, 2007). Differences in antibody and cytokine responses against different antigens 
could reflect differences in host-pathogen interaction. Furthermore we aimed to obtain 
information on candidate antigen(s) for sero-diagnosing infection in both species.  
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5.3 Material and Methods 
5.3.1 Parasites 
T. gondii Prugniaud (PRU, type II) for infecting the sheep (Martrou et al., 1965) and IPB-
G strain (Type II, III) for the pig study (Vercammen et al., 1998a) are routinely maintained by 
mouse passage. Both strains were previously used in sheep (Isabelle Moiré, personal 
communication) and pigs (Jongert et al., 2008; Vercammen et al., 1998a), and were harvested 
from the brains of chronically infected Swiss mice. Mice were euthanized by cervical 
dislocation, and T. gondii brain cysts were counted by phase-contrast microscopy. For 
experimental infection, the mouse brain homogenates were diluted in PBS at a concentration 
of 300 cysts per ml. 
5.3.2 Animals 
Four adult Belgian cross-breed sheep and six indoor-born Belgian Landrace pigs were 
weaned at an age of 4 weeks and housed in isolation units. The animals were T. gondii 
seronegative as determined by an indirect immunofluorescence assay (IFA). Three sheep were 
orally infected with 3000 tissue cysts of the T. gondii PRU strain and five pigs with 3000 
tissue cysts of the T. gondii IPB-G strain. The remaining sheep and pig served as negative 
controls and were each given orally half a brain of a non-infected mouse. 
All pigs were bled weekly from infection till euthanasia; 6 weeks PI. Sheep were bled 
before infection and weekly from 4 weeks PI till euthanasia, 8 weeks PI. In a previous study 
on sheep the antibody response had been determined on sera sampled daily from infection till 
3 weeks PI (Chapter 4). Euthanasia was performed by intravenous injection of an overdose 
natriumpentobarbital 20% (Kela, Hoogstraten, Belgium).  
Animal experiments were performed with the prior approval of the animal ethics 
committee of the faculties of Bioscience Engineering and Veterinary Medicine 
(EC 2007/103). 
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5.3.3 Detection of parasites by bio-assay and real-time quantitative PCR 
After euthanasia of the animals, 100 grams of brain, heart, Musculus gastrocnemius 
(M. gastr) and Musculus longissimus dorsi (M. longd) were collected from each animal for 
detection of parasites by bioassay and quantitative real-time PCR (qPCR). Hereto, the tissues 
were homogenized in 15 ml 0.9% NaCl, and the tissue suspensions were incubated 1-2 hrs in 
a 250 ml acidic pepsin solution (0.8 g l
-1
 pepsin and 7 ml l
-1 
HCl) at 37°C. Thereafter, the 
suspension was filtered, centrifuged at 1180 g, and the pellets were resuspended in 5 ml PBS 
with 0.04% gentamicin. Eighty-five microliter of each suspension was used for qPCR 
quantification and the rest was used for the bioassay in which per tissue suspension, 5 mice 
were intraperitoneally inoculated with 1 ml tissue suspension each. Lungs and brains of mice 
that died from acute toxoplasmosis were examined for T. gondii parasites cysts by phase-
contrast microscopy and for T. gondii DNA by qPCR. From surviving mice, serum was 
sampled at day 45 PI for testing T. gondii antibodies with the IFA whereafter mice were 
euthanized. Their brain tissues were sampled and processed for demonstrating T. gondii 
infection by qPCR as described by Kijlstra et al. (2008) and Rosenberg et al. (2009).  
For qPCR, DNA was extracted with the QIAamp DNA Mini kit (Qiagen GMBH, Hilden, 
Germany) from 85 µl of tissue suspension according to manufacturer’s instructions. As a 
reference for the quantification of T. gondii parasites, two standard lines of 10-fold dilutions 
were used: one with a counted number of RH-tachyzoites and one with a counted number of 
cultured swine kidney cells (SK-6) as described previously (Rosenberg et al., 2009). DNA 
was tested by duplex Taqman-based qPCR on a BioRad iCycler (Biorad, Hercules, CA) using 
the T. gondii repeat element (AF146527) as the first target. The second target was based on 
the ribosomal 18s rDNA of the host cells. The reaction was performed as described by 
Kijlstra et al. (2008). 
5.3.4 Indirect Immunofluorescence Antibody Test (IFA) 
The presence of IgM and IgG antibodies against T. gondii in sera was evaluated by the 
IFA. Fifty microliters of a 1 50 in PBS diluted serum sample was applied for 30 minutes at 37 
°C on a slide coated with formalin-treated tachyzoites from the RH strain (Toxo-Spot IF, Bio-
M rieux, Marcy-l Marcy-, France). Subsequently the slides were washed with PBS and 
incubated for 30 minutes at 37°C with 30 μl of 1 50 in PBS-Evans Blue diluted fluorescein 
isothiocyanate (FITC) conjugated anti-sheep IgM or anti-sheep IgG, or with anti-pig IgM or 
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anti-pig IgG (KPL, Maryland, USA). After washing and drying, the slides were read with a 
fluorescence microscope (Carl Zeiss). The cut-off read-out of the fluorescence test was 
established with T. gondii seronegative and seropositive sheep and porcine reference sera 1/50 
diluted in PBS. For detection of seroconversion in the mouse bio-assay, sera from these mice 
were tested at a 1:25 dilution and a secondary Alex 488 anti-mouse IgG antibody (Invitrogen, 
Merelbeke, Belgium) (1/500) was used as conjugate. 
5.3.5 Purification of recombinant antigens 
Recombinant GRA1, rGRA7 and rEC2 were purified as described previously (Bivas-
Benita et al., 2003; Jongert et al., 2007; Jongert et al., 2008). The mic3234-307 fragment was 
amplified from pcEC2 with forward primer 5’gcgcggatccctcccccaggatgccatt 3’ and reverse 
primer 5’ gcgcggatccaggactggatgtcatgcc 3’. The amplicon was purified with the PCR 
purification kit (QIAGEN GmbH, Hilden, Germany) and digested overnight with BamHI and 
HindIII, and ligated into the pQE80 expression vector (QIAGEN GmbH, Hilden, Germany). 
A clone was identified by colony PCR using the same primers and sequencing confirmed the 
presence of mic3234-307. Expression of rMIC3234-307 was confirmed by SDS-PAGE and 
Western blot with serum from infected mice. The his-tagged rMIC3234-307 was produced at 
large scale and purified according to a protocol described previously by Bivas-Benita et al. 
(2003). 
5.3.6 Antibody ELISA 
To measure total antigen-specific IgG antibodies, Nunc maxisorp immunoplates (Life 
Technologies, Ghent, Belgium) were coated for 2 hours at 37°C with TLA, rGRA1, rGRA7, 
rEC2 or rMIC3 at a concentration of 10 µg/ml
-1
 in bicarbonate coating buffer (pH 9.7). 
Sheep study: In subsequent steps, the ELISA plates were blocked during 2 hours at 37°C 
in 1% non-fat milk powder in PBS, incubated for 1h at 37°C with 100-fold dilutions of ovine 
serum in PBS with 0.05% Tween® 20 and 1% non-fat milk powder and for 1 h at 37°C with 
rabbit anti-sheep IgG- or IgM-horseradish peroxidase (AbD Serotec, Belgium), after which a 
3,3’,5,5’-tetramethylbenzidine solution (TMB)(Sigma – Aldrich, Diegem, Belgium) was 
added. In between each step plates were manually washed 5 times with PBS 
0.05% Tween® 20.
 
The reaction
 
was stopped by adding 50 µl 2 N H2SO4 (stop solution). 
Absorbance was read at 450
 
nm using an iMARK Microplate reader (Biorad, Nazareth, 
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Belgium). Positive and negative control sera were included on each plate. The cut-off value 
was calculated from pre-immune sera (day 0), with as cut-off value the mean 
OD450 + 3×STDEV. The cut-off values were: TLA: 0.409; rGRA1: 0.577; rGRA7: 0.558 
rMIC3234-307: 0.4517; rEC2: 0.567 
Pig study: In subsequent steps, ELISA plates were blocked overnight at 37°C in PBS 
0.2% Tween®80, incubated for 1 h at 37°C with porcine serum diluted 1/50 in PBS and for 
1h at 37°C with horseradish peroxidase conjugated rabbit ant-porcine gamma heavy chain 
antibodies (Ig; 1/1,000) (Serotec, Belgium). After this, an o-phenylenediamine 
dihydrochloride tablet (Sigma Fast; Sigma) in H2O2 solution was added. In between each 
step, plates were washed with PBS 0.2% Tween®20. The reaction was also stopped by 
addition of 2 N H2SO4. Absorbance was read at 450/692 10 nm in an iMARK Microplate 
reader (Biorad, Nazareth, Belgium). Positive and negative control sera were included on each 
plate. The cut-off value was calculated from pre-immune sera (day 0) at a 1/50 dilution, with 
as cut-off value the mean OD450 + 3×STDEV. Cut-off values for ELISA were as follows: 
TLA: 0.095; rGRA1: 0.123; rGRA7: 0.146; rMIC3234-307: 0.136; rEC2: 0.07. 
5.3.7 Real-time quantitative PCR for cytokines 
Peripheral blood mononuclear cells (PBMC) were isolated by density gradient 
centrifugation using Lymphoprep (Nycomed, Brussels, Belgium). Ovine and porcine 
lymphocytes were harvested and resuspended at a concentration of 5.10
6
 cells ml
-1
 in RLT 
buffer (Qiagen, Nazareth, Belgium) and kept at -80 °C for later isolation of cytokine mRNA. 
mRNA was extracted using an RNAeasy kit (Qiagen GMBH, Hilden, Germany). Reverse 
transcription into total cDNA was performed with the iScript kit (Biorad, Nazareth, Belgium) 
following the manufacturer’s protocol. The obtained single-stranded cDNA was diluted 100 
times for amplification in quantitative real-time PCR (qPCR). The qPCR reactions were set 
up in 96-well optical microtiter plates with 25 µl mixture of iQ SYBR Green Supermix (Bio-
Rad, Hercules, CA). The oligonucleotide primers used for the detection of IL-4, IL-10, IFN-
gamma, and the two housekeeping genes glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) and Beta actin, and those for 18s rDNA are presented in Table 5.1. 
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Table 5.1: Oligonucleotide primers used in cytokine qPCR. 
Cytokine Primers (5’-3’)  S = sense  AS= antisense 
IL-10 (S) CCTGGGTTGCCAAGCCTT 
(AS) GCTTTGTAGACACCCCTCTCTT 
IFN-gamma (S) GAGCCAAATTGTCTCCTTCTACT 
(AS) CTGACTTCTCTTCCGCTTTCT 
IL-4 (S) CTGGTCTGCTTACTGGYATGTA 
(AS) CTGTCAAGTCCGCYCAGGA 
GAPDH (S) CCATCACTGCCACCCAGAA 
(AS) CAGGGATGACCTTGCCCA 
ß - actine (S) GGCATCCTGACCCTCAAGTA 
(AS) GCCTCGGTCAGCAGCA 
Ribosomal 18 S (S) GTTGATTAAGTCCCTGCCCTTT 
(AS) GATAGTCAAGTTCGACCGTCTT 
 
Each sample of cDNA was tested in duplicate, and non-template reactions were included 
in the runs as an internal control. For each sample, the target gene was amplified in parallel 
with the three house keeping control genes in separate wells. Amplification conditions were 
identical for all genes: a first activating cycle of the Taq polymerase of 95°C for 2 min and 45 
cycles of 2 steps: 95°C for 15 sec and 60°C for 30 sec. qPCR data were analyzed using a 
mathematical model described by Vandesompele (2002), based on the qPCR efficiencies and 
the mean threshold value (Ct) deviation between the sample and control group. The 
normalization was done relative to the geometric average of ß-actin, GADPH and 18s rDNA 
genes, and data is represented as the normalized cytokine gene expression compared to the 
geometric mean number of housekeeping genes. 
5.3.8 Statistical analysis 
To determine whether an increase in antibodies or difference between the normalized 
quantities of cytokines post infection and these at baseline (sheep) or two weeks PI (pigs) 
could be observed, a Friedman two-way analysis of variance by ranks (GraphPad Prism) was 
performed. The same test was used for the determination of differences in the number of 
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Tissues Brain Heart M. gastr M. longd Brain Hear M. gastr M. longd
Sheep 3/3 3/3 3/3 1/3 2/3 3/3 3/3 3/3
Pig 5/5 5/5 4/5 5/5 4/5 5/5 3/5 3/5
Bio-assay qPCR
(positive/total number) (positive/total number)
parasites among the tissue samples of the animals. Differences were considered significant if 
the P value was <0.05. 
5.4 Results 
5.4.1 Isolation of parasites by bio-assay and detection of bradyzoites in the tissues  
of infected animals 
Evaluation of tissue infectivity was carried out by bio-assay on tissues obtained after 
euthanasia of the animals.  
Sheep study 
Bio-assay and qPCR were positive for all three sheep in heart and M. gastr (Table 5.2). 
However, differences in results were observed for brain and M. longd. The live parasite was 
isolated by bio-assay from brain of all and from M. longd of one out of the three sheep, 
whereas parasite DNA could be detected in 2 out of the 3 brains and all 3 M. longd. The brain 
of one sheep, positive in bio-assay, could not be confirmed by qPCR (negative result) 
Table 5.2: Infectivity of ovine and porcine tissues, determined by bio-assay and detection of 
bradyzoites by qPCR. 
 
The control sheep remained T. gondii free as demonstrated by bio-assay and qPCR (data 
not shown).  
Pig study 
The live parasite was isolated by bio-assay from all tested tissues from all the inoculated 
animals six weeks after infection, except from the M.gastr of one pig (Table 5.2). These 
results were confirmed by qPCR for heart, but detection of parasite DNA seems to be less 
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sensitive since for brain, M. gastr and M. longd 1, 2 and 2 out of 5 animals, respectively, were 
found negative. 
5.4.2 Quantification of the parasite load in tissues at euthanasia 
In order to determine whether parasite load was different between tissues, the numbers of 
bradyzoites were determined by qPCR in brain, heart, M. gastr and M. longd samples for 
sheep and pigs.  
In sheep, brain, heart and M. gastr contained similar amounts namely 12.76 ± 5.74 (SEM), 
10.78 ± 1.24 (SEM) and 11.02 ± 5.01(SEM) bradyzoites per 10
8
 cells, respectively. However, 
M. longd contained a clearly lower amount namely 3.27 ±0.70 (SEM) bradyzoites per 10
8
 
cells (Fig. 5.1).  
In pigs euthanized 6 weeks PI, the parasite load was as follows: brain: 80.8 ± 51.3 (SEM), 
heart 64.1 ± 36.0 (SEM) and M. longd 112.7 ± 79.9 (SEM) bradyzoites per 10
8 
porcine cells. 
In pigs the parasites were clearly less prominent in the M. gastr, with 12.0 ± 6.2 (SEM) 
bradyzoites per 10
8
 cells (Fig. 5.1). 
The negative control animals remained T. gondii-free in all tissues (data not shown). 
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Figure 5.1: Bradyzoite load in tissues from sheep and pigs orally infected with T. gondii PRU and 
IPB-G respectively, determined by qPCR. The number of bradyzoites per 10
8
 ovine/porcine cells are 
presented in dot plots. The horizontal lines present the mean number of parasites in each tissue at 
euthanasia. M. gastr = Musculus gastrocnemius. M. longd = Musculus longissimus.  
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Weeks    PI 0 4 5 6 7 8
IgM 0 0/3 0/3 0/3 0/3 0/3
IgG 0 3/3 3/3 3/3 3/3 3/3
5.4.3 Humoral response after infection 
In order to evaluate kinetics of the antibody response elicited during chronic infection 
with T. gondii bradyzoites, sera were collected and tested in the Toxoplasma-specific 
IgM/IgG IFA and in the rGRA1, rGRA7, rMIC3234-307 and rEC2-specific IgG ELISAs. 
Sheep study 
A previous study showed that most sheep become IgG positive between 1 and 3 weeks PI 
(Chapter 4). In the present study all three infected sheep were anti-T. gondii IgG seropositive 
in IFA 4 weeks PI. IgM was not detected between 4 and 8 weeks PI (Table 5.3). 
Table 5.3: Toxoplasma seroconversion rates in IFA from sheep experimentally infected with PRU. 
 
 
In the previous study, the IgG response against T. gondii TLA was determined by ELISA 
the first 3 weeks PI (Chapter 4). In the present study, the IgG response against TLA, rGRA1, 
rGRA7, rEC2 or rMIC3 was studied by ELISA between 4 and 8 weeks PI (Fig. 5.2 and 
Fig. 5.3). The infected sheep showed similar IgG responses against TLA and the recombinant 
antigens. These responses were characterized by high IgG at four weeks PI, followed by a 
decline at 6 weeks PI, whereafter IgG increased again until euthanasia at 8 weeks PI. This was 
most pronounced for rGRA7 and rMIC3234-307, followed by TLA whereas the lowest 
responses were observed against rEC2 and rGRA1. 
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Figure 5.2: Kinetics of the antibody responses against TLA, rGRA7 and rMIC3234-307 presented as 
OD-values for the different sheep. The lines present the mean OD-value at each time point. The 
dashed lines indicate the cut-off values defined with pre-immune serum. *, **, *** present 
significance differences at P <0.05, P <0.01, P <0.001, respectively, in comparison with pre-immune 
sera  
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Weeks PI 0 1 2 3 4 5 6
IgM 0/5 nd 5/5 4/5 3/5 2/5 0/5
IgG 0/5 nd 5/5 3/5 4/5 5/5 5/5
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Kinetics of the antibody responses against rEC2 and rGRA1 presented as OD-values for 
the different sheep. The lines present the mean OD-value at each time point. The dashed lines indicate 
the cut-off values defined with pre-immune serum. 
Pig study 
In IFA, all infected pigs were seropositive two weeks post infection (PI) for both IgG and 
IgM, after which a gradual decline in IgM positive animals was observed (Table 5.4). 
IgM disappeared by week 6 PI, while animals were still IgG positive. 
 
Table 5.4: Toxoplasma gondii seroconversion rates in IFA from pigs experimentally infected with 
IPB-G 
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By ELISA, no or only a weak IgG response against the different recombinant antigens and 
TLA, was observed in pigs (Fig. 5.4) compared to sheep (Fig. 5.2), except for rGRA7. 
Antibodies against the dense granule protein rGRA7 appeared quickly in 3 animals as soon as 
2 weeks PI. This initially moderate antibody response gradually increased so that all animals 
seroconverted against rGRA7 at 4 weeks PI. Interestingly, as in sheep this was followed by a 
moderate decline in the rGRA7-specific OD value in most pigs, whereafter the values 
increased again. For the other antigens either no (for TLA and rEC2) or a temporary early but 
very weak response was seen (for rMIC3234-307 in 4 out of 5 pigs at 1 week PI and 2 out of 3 at 
2 weeks PI; for rGRA1 in 1 of 5 pigs at 2 weeks PI (Fig. 5.5)). At 6 weeks PI, a tendency for 
increase in antibodies against most antigens, except against rGRA1, could be seen, even 
though values mostly remained below the cut-off.  
 
Control pig and sheep orally infected with T. gondii negative brain tissue did not become 
seropositive in IFA or the ELISAs at any time (data not shown). 
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Figure 5.4: Kinetics of the antibody responses against TLA, rGRA7 and rMIC3234-307 presented as 
OD-values for the different pigs.  
The lines present the mean OD-value at each time point. The dashed lines indicate the cut-off values 
defined with pre-immune serum. *, ** present significance differences at P < 0.05, P <0.01, 
respectively in comparison with pre-immune sera. 
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Figure 5.5: Kinetics of the antibody responses against rEC2 and rGRA1 presented as OD-values for 
the different pigs.  
The lines present the mean OD-value at each time point. The dashed lines indicate the cut-off values 
defined with pre-immune serum.  
5.4.4 Kinetics of cytokine responses in peripheral blood mononuclear cells 
In order to evaluate whether a T. gondii infection could elicit IFN-gamma, IL-10 and/or 
IL-4 in the circulating lymphocytes, PBMCs were isolated on a weekly basis until 7 weeks PI 
for sheep and 5 weeks PI for pigs. Relative normalized IFN-gamma, IL-4 and IL-10 mRNA 
levels were determined by qPCR. The cytokine levels of the control animal remained stable 
during the whole study period. 
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Sheep study  
Figure 5.6 show the evolution in IL-10, IFN-gamma and IL-4 expression by PBMCs after 
infection of sheep. Although changes over the time after infection were not significantly 
different for any of the cytokines, a tendency towards increased expression could be observed. 
This incline was most consistent for IFN-gamma where it occurred already 2 weeks PI and 
persisted until the end of the observation period, even though the increase was minimal in 
sheep 3 at 7 weeks PI. For IL-10 and IL-4 mRNA, expression decreased in all 3 sheep at 2 
weeks PI, followed by an increase between 3 and 6 weeks PI for IL-10 mRNA and between 4 
and 6 weeks for IL-4 mRNA. Seven weeks PI, similar expression levels as two weeks post 
infection were seen (7 weeks PI). 
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Figure 5.6: Relative normalized IL-10 (A), IFN-gamma (B) and IL-4 (C) cytokine expression in 
PBMCs from sheep orally infected with T. gondii PRU are presented in scatter dot plots. 
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Pig study (Fig. 5.7) 
In contrast to sheep, no tendency towards an increased expression was seen in pigs for IL-10 
and IL-4 mRNA. IL4 mRNA even remained at basal levels in two animals throughout the 
observation period. IFN-gamma mRNA expression seemed to increase slightly, but later and 
less homogenously than in sheep, with some animals negative at all tested time points. This 
increase was significant at 4 weeks PI, with 4 out of 5 animals producing IFN-gamma mRNA, 
in comparison with 1 out of 5 IFA-seropositive animals at 2 weeks PI. Thereafter, the IFN-
gamma mRNA expression declined in most animals. 
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Figure 5.7: Relative normalized IL-10 (A), IFN-gamma (B) and IL-4 (C) cytokine expression in 
PBMCs from pig orally infected with T. gondii IPB-G are presented in scatter dot plots. * presents a 
significant difference at P < 0.05 in comparison with 2 weeks post infection.  
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5.5 Discussion 
Antibodies to T. gondii have been found in sheep all over the world (Dubey, 2010). The 
seroprevalence can be up to 90 % or even more in some countries (Dubey, 2009; Hutchinson 
et al., 2011) (Chapter 1). Since infected sheep remain carriers of the parasite in their tissues, 
mutton forms a risk for humans, especially because it is often consumed undercooked. Hence, 
a vaccine that could prevent infection of sheep could have a high economic value. Such a 
vaccine should, optimally, block infection at the site of entrance. Therefore, we previously 
studied the initial phase of a T. gondii infection and observed that the parasite disappears from 
intestinal tissues around 3 weeks PI (Chapter 4). Since the parasite appeared shortly after 
infection in blood cells and systemic lymphoid tissues, we presumed that the parasite had 
moved to the systemic tissues. Denkers and Gazinelli (1998) mentioned the clearance of host 
tissues from the tachyzoite stage and the appearance of the bradyzoite stage in tissue cysts 
when the immunity builds up.  
One of the aims of the present study was to demonstrate the localization of the parasite in 
the systemic tissues after the initial phase of infection in intestinal tissues. Furthermore, we 
wanted to see if the immune response and the distribution of bradyzoites in pigs were 
comparable to those in sheep. And thirdly, by analyzing the antibody response against 
different antigens, we aimed to determine the most optimal antigen to be used in an antibody 
ELISA.  
Eight weeks after the experimental infection of sheep, parasites were detected by bio-
assay and qPCR in the heart, brain, M. gastrocnemius and M. longissimus dorsi of the 
majority of the animals. Similar amounts of parasite DNA were detected in ovine brain, heart 
and M. gastrocnemius, whereas the amounts were lower in the M. longissimus dorsi. This was 
also reflected by the results of the bioassay in which only one out of the three M. longissimus 
dorsi were positive. The finding of unequal distribution of the parasites in the tissues has been 
described previously (Denkers and Gazzinelli, 1998; Dubey et al., 1998). Bradyzoites were 
predominantly found in the central nervous system and heart but - depending on the host - 
other tissues such as liver, diaphragm and skeletal muscles are also infected (Denkers and 
Gazzinelli, 1998; Dubey et al., 1998). The parasite distribution in our studies suggests indeed 
that in sheep the parasite leaves the gut during the initial phase of infection in order to spread 
towards the systemic tissues (Chapter 4). In pigs, almost a similar distribution was observed, 
but here, the amounts of parasite DNA in M. gastrocnemius were the lowest, followed by 
these in the M. longissimus dorsi. Heart was consistently positive in all 8 infected animals in 
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qPCR as well as in bioassay, showing that the heart seems to be the most reliable tissue for 
demonstrating the presence of the parasite in this phase of the infection.  
Additional goals of the present study were to assess the antibody and cytokine responses. 
In a previous study, sheep T. gondii-specific IgG responses against TLA were detectable from 
7dpi onwards (Chapter 4). In this follow-up study, a significant IgG response was observed in 
sheep against TLA, rMIC3234-307 and rGRA7 four weeks after the T. gondii infection. A 
similar but weaker response was observed against rEC2, a chimeric antigen encoding MIC2-
MIC3-SAG1 and the weakest response against rGRA1. However, both latter responses were 
not statistically significant. It has been shown that TLA-specific IgM antibodies peaked three 
weeks PI and preceded an IgG response which remains lifelong (Dubey, 2009). T. gondii-
specific ELISAs based on whole tachyzoites and other recombinant T. gondii proteins such as 
rSAG1, rGRA7, H4/GST, H11/GST were previously used to detect antibody responses in 
experimentally infected sheep (da Silva, 2002; Glor et al., 2013; Tenter et al., 1992; 
Velmurugan et al., 2008) or goats (Conde et al., 2001). Our study demonstrates that TLA, 
rMIC3234-307 and rGRA7 can be used to demonstrate the infection in sheep, whereas rEC2 and 
rGRA1 were not reliable candidate antigens. However in pigs, rGRA7 was the only of the 5 
candidate antigens against which antibodies could be demonstrated. Given that sheep were 
infected with a T. gondii type II strain and pigs with a T. gondii type II-III strain, we could not 
determine if this difference was related to the host species or to the parasite strain.  
It is known that the humoral and cellular immune responses cooperate against T. gondii 
(Innes and Vermeulen, 2006; Sher et al., 1995). Sustaining strong T helper 1 (Th1)-mediated 
immunity, characterized by the production of IFN-gamma by CD4
+
 and CD8
+
 T cells, is 
crucial in preventing the emergence of T. gondii (Denkers, 1999; Gazzinelli et al., 1993). The 
production of IL-4 by Th2 lymphocytes is associated with disease progression and 
reactivation of latent disease (Hope et al., 2005). Interleukin-10 has been shown to 
down-regulate acute inflammatory responses against this intracellular parasite and to inhibit 
the IFN-gamma production (Appelberg et al., 1992; Denkers, 1999). During the acute phase 
of the infection (4 days PI), we studied the amounts of IFN-gamma produced in supernatants 
following restimulation of mononuclear cells from blood, spleen, duodenal, jejunal and ileal 
mesenteric lymph nodes, popliteal lymph nodes and from duodenal, jejunal and ileal Peyer's 
patches with different T. gondii antigens. We observed an early increase in IFN-gamma 
especially in lymphocytes of the mesenteric lymph nodes, followed by a decrease and a 
second increase 2 to 3 weeks PI (Chapter 4). In the follow-up study, looking at changes in 
mRNA expression in PBMCs directly isolated from blood, a clear increase was seen at 2 
A 
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weeks PI which remained present until the last sampling 7 weeks PI. In contrast, the IL-10 
and IL-4 mRNA expression did not show a consistent increase in all animals. This is in line 
with the Th1 response already described in sheep (Innes et al., 1995) and mice (Roberts et al., 
1996). In sheep, cannulation of the efferent duct of a lymph node, draining the infection site, 
showed T-cells (CD4+ and/or CD8+) and IFN-gamma to be essential for host resistance 
during primary infection with T. gondii and both were seen as an important component of the 
protective immunity against the parasite (Innes et al., 1995). Similarly, we observed an IFN-
gamma response in pigs, but this response did not seem to occur as quickly as in sheep. 
 
In conclusion, the results in this study demonstrate that the parasite is already present in brain, 
heart and skeletal muscles of sheep and pigs eight and six weeks PI, respectively. The parasite 
was most consistently demonstrated in heart tissue with bioassay and qPCR. Interestingly, the 
antibody response differed considerably between sheep and pigs with significant antibody 
responses mainly against rGRA7, rMIC3234-307 and TLA in sheep and only against rGRA7 in 
pigs. If this difference is species-related or due to infection with different T. gondii strains 
needs to be further studied. Nevertheless, both species showed a clear IFN-gamma response 
in the first weeks of infection and a seropositive response in rGRA7 ELISA. In the next 
studies it will be interesting to determine if this response persists in the animals and whether 
either methods can be confirmed to be good candidate assays for diagnosis in meat animals. 
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6.1 Introduction 
The objectives of this doctoral thesis were to generate baseline data on the seroprevalence 
of ovine toxoplasmosis in Belgium and to gain insight in the acute and subacute Toxoplasma 
infection in sheep. In this Chapter, I will discuss some interesting findings generated by my 
research and will present future prospects as well as limitations of my work. 
6.2 Seroprevalence and risk factors for ovine toxoplasmosis in Belgium 
As described in the literature review, the sexual cycle of Toxoplasma gondii only occurs 
in Felidae and results in the faecal excretion of oocysts. After sporulation, oocysts become 
highly infectious for all other warm-blooded animals, including humans and Felidae. In all 
these species, infection results in an asexual multiplication phase, which sometimes leads to 
clinical signs and symptoms and rarely to death, but mostly results in a latent infection with 
the persistence of tissue cysts in various tissues. However, when infection occurs during 
pregnancy, vertical transmission can occur which can lead to congenital disease and foetal 
mortality depending on species, immune status and stage of gestation. Ingestion of sporulated 
oocysts, but also ingestion of raw or undercooked meat containing T. gondii tissue cysts 
results in infection. In humans, the most important risk factor for infection is considered to be 
the consumption of raw or undercooked infected meat. However, water, raw vegetables and 
soil contaminated with oocysts may also play a role in the transmission to humans; indeed, in 
several studies T. gondii seropositive individuals have been identified among vegetarians 
(Dabritz and Conrad, 2010; Hall et al., 1999). Hence, waterborne as well as food-borne 
outbreaks have been reported from countries with diverse cultural, social and ethnic 
backgrounds (Bowie et al., 1997; Choi et al., 1997). About one third of the world’s human 
population is probably latently infected (Montoya and Liesenfeld, 2004). Severe pathology as 
a result of T. gondii infection most frequently occurs in immunocompromised patients and in 
cases of congenital infection. The accompanying clinical effects are associated with huge 
economic and medical costs. 
Similarly, toxoplasmosis in livestock can create economic disasters for breeders, mainly 
due to production losses. Ovine toxoplasmosis is widespread. The seroprevalence in sheep 
flocks amounts to 90% or more in some countries (Dubey, 2009). However, the infection 
passes often without any clinical signs. Nevertheless, based on data collected by the 
Veterinary Investigation Diagnosis Analysis in 2009, T. gondii was ranked as the second most 
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important abortifacient agent in the sheep industry after Chlamydia abortus (VIDA, 2009). 
The symptoms of congenital toxoplasmosis in sheep vary from early embryonic death to 
spontaneous abortion, mummified lambs and the birth of weak lambs with growth retardation. 
The economic impact due to loss of lambs has been calculated for a few countries and was 
estimated at about € 15.43 million per year for Great Britain (Bennett et al., 1999), 
€ 8.62 million per year for New Zealand (Charleston, 1994), € 11.06 million for Wales 
(Blewett and Trees, 1987) and € 1.11-3.71 million for Uruguay (Freyre et al., 1999). T. gondii 
can thus indeed be considered as an important disease with a huge economic impact.  
In Belgium very little is known about the seroprevalence of T. gondii in livestock. The 
study done in Chapter 3 showed that, at the moment of sampling, the flock prevalence in 
Belgium ranged from 65.2% in Antwerp to 97.8% in Flemish Brabant. A huge overall 
seroprevalence of 87.4% in Belgian sheep together with the identification of seropositive 
animals in most of the farms confirm the widespread occurrence of this parasite in sheep 
flocks and thus suggests an underestimation of the problem of toxoplasmosis in Belgian 
sheep, which could be expected since infections mostly occur subclinical and therefore mostly 
unnoticed. Furthermore, the methods for demonstrating the parasite in animals and their 
tissues (examination of tissue samples by PCR or bioassay) are too expensive and 
cumbersome for routine screening of sheep. Serological tests demonstrating T. gondii-specific 
antibodies (e.g. ELISA for Toxoplasma-antibody detection) are more feasible in routine 
diagnosis, but the currently used tests lack standardization, harmonization and reference 
material to set-up monitoring programs (EFSA, 2007), even though the EFSA Panel on 
Biological Hazard recommends such programs since mutton is considered to be an important 
source of toxoplasmosis for humans (Scorza et al., 2003). 
The two possible infection routes for sheep are the vertical route from mother to foetus 
during pregnancy, which represents a serious risk for congenital disease (Dubey, 2009), and 
the horizontal route due to the ingestion of either oocysts during grazing or, tissue cysts by 
eating aborted tissues (placenta, foetus) (Race et al., 1998). The placenta as well as the 
aborted foetus can contain tissue cysts and are a risk factor for ovine toxoplasmosis (Dubey, 
1987; Williams et al., 2005). This agrees with studies of Riyadh (2005) and Abu-Dalbouh et 
al. (2012) showing that feeding aborted foetuses to dogs can cause T. gondii infection and that 
proper disposal of foetuses on a farm decreases the risk of seroconversion of sheep with 8 
percent. Eating the placenta by ewes is aimed at hiding the evidence of lambing to predators 
in order to protect their offspring. Nevertheless, ingestion of oocysts is considered a more 
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important route of transmission in sheep since lambs usually seroconvert at a very young age 
(unpublished observation).  
The high population density in Belgium, the associated dense cat population - 26% of the 
households have at least one cat (Directorate-General Statistics, 2007) - the high 
seroprevalence of the parasite in Belgian house and stray cat populations (De Craeye et al., 
2008) and the scattered distribution of farm land over many villages, are factors that are likely 
to cause a contamination of pastures with oocysts. Besides the human and cat population 
density, many other factors, among which some management factors on sheep farms, such as, 
insufficient hygiene measures (the non-removal of aborted tissues), no efficient cat and rodent 
control in the direct environment of feedstuff, surface water as the source of drinking water 
and farm size have proven to increase the risk of infection.  
The high prevalence in sheep underlines the need for the development of more efficient 
diagnostic methods, which can be used to monitor the infection. Since no information exists 
in Belgium on the risk factors for sheep to become infected with T. gondii, these diagnostic 
methods should be used in combination with studies or questionnaires, which assess these risk 
factors for sheep kept under different management conditions. Furthermore, in many 
countries, including Belgium, vaccination is not applied, due to the disadvantages of the 
available commercial live vaccine such as the infection risk for the veterinarian and the 
limited shelf life. Therefore, risk assessment studies are crucial for the development of 
efficient measures to control infection and disease in our sheep population. 
6.3 The acute and subacute immune response against T. gondii 
In Chapter 4 and 5, respectively the acute and subacute T. gondii infection in sheep was 
studied. Many aspects such as, the parasite distribution and load, and the cellular and humoral 
immune responses were measured during both infection phases.  
First of all we want to highlight the limitation of our studies in these chapters: (1) The 
numbers of animals used in our groups were very small; (2) Although we observed 
differences between the groups, these differences were not always statistically significant, so 
more data are clearly needed; (3) we were not able to determine the specificity and sensitivity 
of our in house ELISAs due to the lack of negative control samples. In spite of these 
drawbacks, we believe that we obtained some interesting results.  
Host protection against T. gondii is complex. In mouse and sheep studies, cooperation 
between humoral and cellular immune mechanisms to control the infection was demonstrated 
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(Dubey et al., 1997; Gazzinelli et al., 1992; Sher et al., 1995). Antibodies play a role in killing 
extracellular tachyzoites (Hammouda et al., 1995; Kang et al., 2000), whereas cell-mediated 
immunity plays a major role in resistance against the parasite (Gazzinelli et al., 1991; 
Johnson, 1992). Parasite-specific CD8+ T-cells are considered the most significant effector 
cells, they play a crucial role in detecting T. gondii (profilin) and in the subsequent induction 
of IL-12 production. Furthermore, they produce IFN-gamma in response to the infection, 
while the parasite-specific CD4+ T-cells play a more synergistic role (Gaddi and Yap, 2007; 
Yarovinsky, 2014). Natural killer (NK) cells are also believed to be important to control a 
T. gondii infection (Ge et al., 2014). Some experiments showed that T. gondii antigens had a 
direct effect on NK cells (Dannemann et al., 1989), while others supported a role for 
activation of accessory cells in the production of IFN-gamma by NK cells (Sher et al., 1993). 
However, there is no evidence that NK cells can directly suppress T. gondii infection. It is 
known that they can influence the development of an immune response through the cytokines 
they produce (Ge et al., 2014). 
In our studies (Chapters 4 and 5), restimulating mesenteric lymph node lymphocytes with 
TLA, rEC2 and rMIC3 four days after infection induced high interferon-gamma responses. It 
has been mentioned that this early produced IFN-gamma is crucial for initiating resistance 
against the parasite (Bhopale, 2003; Gazzinelli et al., 1994). This IFN-gamma response only 
four days after infection is too early to be the result of antigen-specific CD4
+
 and/or 
CD8
+
 T lymphocyte responses. During this early stage, the parasite triggers several cells of 
the innate immune system, such as macrophages, natural killer cells, dendritic cells as well as 
neutrophils. Upon activation of these cells by T. gondii, some of them release cytokines such 
as, interleukin-12 (IL-12) and interferon-gamma (IFN-gamma) (Hunter et al., 1994a; Hunter 
et al., 1994b). T cell-independent IFN-gamma production by NK-cells (Sher et al., 1993) has 
been described in mice and is dependent on IL-12 and Tumour Necrosis Factor-alfa 
(TNF-alfa) production by macrophages (Gazzinelli et al., 1993). When in vitro purified 
NK cells were stimulated with T. gondii antigens and IL-12, they produced high levels of 
IFN-gamma.  
Previous studies in mice have demonstrated that IL-12 production is critical to induce 
IFN-gamma production and protection against T. gondii (Vossenkamper et al., 2004). In our 
study, a generalised but low IL-12 production was measured in the mesenteric lymph nodes 
four days after infection. IL-12 rapidly induces IFN-gamma in naïve T-helper (Th) cells and 
promotes the development of a Th1 response, which is known from mice as well as sheep 
studies to be the most important response for host resistance against T. gondii (Buxton et al., 
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2007; Innes et al., 2009; Innes and Vermeulen, 2006; Trinchieri, 2003; Trinchieri et al., 2003; 
Yarovinsky, 2014). In IL-12 deficient mice, T. gondii tachyzoites undergo uncontrolled 
replication, causing death (Vossenkamper et al., 2004).  
We observed that rGRA7 could induce the secretion of IFN-gamma by lymphocytes 
isolated 10 days post infection from different mucosal and systemic lymphoid tissues, which 
indicates the presence of T. gondii–specific memory T-cells in these tissues. Moreover, two 
and three weeks post infection, IFN-gamma could be induced but more against TLA and/or 
rMIC3, indicating that GRA7 is one of the early recognized antigens and that subsequently 
also other antigens became recognized by T cells, broadening the immune response.  
During the subacute phase of the infection (Chapter 5) high IFN-gamma mRNA levels 
could be detected, most likely produced by parasite-specific T lymphocytes which can 
prevent cyst reactivation (Denkers and Gazzinelli, 1998). The first two weeks after infection, 
the IFN-gamma mRNA expression by PBMCs gradually increased and subsequently 
remained elevated until 7 weeks post infection. This is in accordance with the strong Th1 
response in sheep described by Innes et al. (1995). They concluded that CD4+ and CD8+ T-
cells as well as IFN-gamma were essential for host resistance during a primary infection. IL-
10 responses were also increased in all sheep, however, less consistently. Furthermore, each 
sheep showed a peak at a different time point between 3 and 6 weeks PI. IL-4 mRNA also 
increased, but slightly later than IL-10, namely between 4 and 6 weeks PI. IL-10 can be 
produced by many cell types, among which T regulatory lymphocytes and T-helper 2 (Th2) 
lymphocytes, whereas IL-4 is mainly produced by Th2 cells. Why IL-10 and IL-4 showed 
such a variation at different time points is not clear. Both cytokines antagonize much of the 
pro-inflammatory effects of interferon-gamma and inhibit the proliferation of Th1 cells, so 
that both cytokine responses could be seen as an attempt to control the inflammation induced 
by the parasitic infection. On the other hand, IFN-gamma secreted by Th1 cells blocks the 
proliferation of Th2 cells (Gajewski and Fitch, 1988), which could be another reason for the 
observed variation in production of IL-10 and IL-4. Importantly, Th2 cytokines steer the 
immune response towards a B cell response with antibody production. In Chapter 4 
considerable variation was seen between sheep in the first appearance of T. gondii-specific 
antibodies, which could be the result of the strong early IFN-gamma response, which 
suppresses the Th2 responses steering the B cell response.  
Interestingly, pigs did not show a clear response in IL-10 and IL-4 and the IFN-gamma 
response occurred slower, which could suggest a lower susceptibility of pigs to the IPB-G 
strain than sheep to the Prugniaud strain, which resulted in a slower immune reaction. This 
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difference between host species could also explain the more restricted antibody response in 
pigs, which only clearly recognized rGRA7, compared to sheep responding against all tested 
antigens. Repeating our study with an experimental infection of sheep with the IPB-G-strain 
and pigs with the Prugniaud strain could help to answer this hypothesis.  
From the induction of the cytokine gene, its transcription into a protein, its processing, 
trafficking and excretion, and finally the binding to its receptor and the associated induction 
of a response combined with many unknowns such as how many molecules will be 
synthetized from one mRNA and its half-life, makes it a very difficult to study protein, 
needing crucial planning and the use of various, performant and expensive tests. 
The accurate measurement of cytokine levels is thus subject to many difficulties. Cytokines 
are not preformed factors but are produced as an answer on cellular activation. Then, released 
cytokines interact with their receptors on target cells, which are often neighbouring cells, thus 
only small quantities are secreted that are furthermore very short lived so that highly sensitive 
assays are needed for their detection (Bienvenu et al., 2000). Often sandwich ELISAs are 
used for measurement of cytokines, as was the case in Chapter 4 where IFN-gamma levels 
were measured in cell culture supernatant of in vitro restimulated lymphocyte or mononuclear 
cell cultures. This stimulation induces cytokine production by memory T cells. The measured 
concentrations not only depend on the cytokine secretion but also on their half-life: binding to 
and uptake by target cells as well as the degradation in the cell culture.  
Cytokine induction can also be measured at the level of mRNA by qRT-PCR as was done 
in Chapter 5. The mRNA is often expressed at very low concentrations (Giulietti et al., 2001) 
and there is no 100% similarity between these concentrations and the actual amounts of 
protein secreted by the cells (Verfaillie et al., 2001).  
In our study we did not identify the cells responsible for the cytokine production nor the 
availability of a cytokine-receptor on the target cells, which could be downregulated or even 
not expressed. Therefore, we are not able to define the biological activity of the measured 
cytokines. Different methods could be used to identify cytokine producing cells such as, cell 
sorting in combination with qPCR, multicolour fluorescent staining for CD markers and 
intracellular cytokines combined with flow cytometric analysis (Stinn et al., 1998), or 
immunohistochemistry, which has the advantage to identify the cytokine secreting cell types 
and to detect the cytokine proteins directly (Salguero et al., 2002).  
In Chapter 4, we also determined the presence and distribution of the T. gondii parasites in 
the acute phase of the infection. At 4 days post infection, T. gondii-specific DNA was 
sporadically detected in enterocytes, lamina propria, mesenteric lymph nodes or Peyer’s 
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patches and this mainly cranially in the small intestine. Four days later, the parasite seemed to 
have spread to more intestinal and systemic lymphoid tissues. Nevertheless, at 3 weeks post 
infection, the parasite seemed to disappear from most small intestinal sites, but also from 
popliteal lymph nodes, peripheral blood mononuclear cells and spleen. Whether this is caused 
by the maturation of the parasite or by the host immune response, or both is not clear. 
Nevertheless, at this time-point a high T. gondii-specific IFN-gamma memory response could 
be detected in the mesenteric lymph nodes, but not or less pronounced in the other tissues 
(Chapter 4). Five weeks later, parasites were detected by bio-assay and qPCR in heart, brain, 
m. gastrocnemius and m. longissimus dorsi of the majority of the sheep (Chapter 5). This 
distribution suggests that the parasites left the gut during the acute phase of infection to 
spread to the systemic tissues, where it could not be cleared by the host’s immune response.  
Similarly, in pigs, parasites were detected in heart, brain, m. gastrocnemius and m. 
longissimus dorsi. Here, qPCR was less sensitive than bio-assay to detect the parasite. A 
reason could be that a smaller amount of digested tissue is used in qPCR than in the bio-assay. 
However in sheep, this difference in sensitivity was not observed, which suggests a species-
specific difference or a difference in cyst density of the inoculated strain. This finding is in 
agreement with previous studies in which a similar difference in sensitivity of both tests was 
observed in pigs (Garcia et al., 2006; Hill et al., 2006). These authors demonstrated that DNA 
from pig tissues interferes with the sensitivity of the T. gondii PCR, which is somewhat 
unexpected as this would rather cause more false positives than false negatives. A more 
plausible explanation may be that during the pepsine digestion and following DNA extraction 
some PCR inhibitory factors could be co-purified. It is important also to know that a negative 
result in PCR does not directly imply that these tissues are completely parasite free. Negative 
reactions can also occur due to unequal distribution of parasite cysts in the tissue samples. 
Dubey et al. (2010) demonstrated that the parasite load is most often higher in brain and heart 
or skeletal muscles than in visceral organs. In our study, the heart was consistently positive in 
qPCR as well as in bioassay, suggesting either a slightly higher infection load or a more equal 
parasite distribution in this tissue compared to others. Furthermore, heart tissue proved to be 
very easy to digest with pepsine, efficiently concentrating the released bradyzoites for further 
analyses. Therefore, the heart seems to be the most reliable tissue for demonstrating the 
presence of the parasite in sheep and pigs, at least this phase of the infection.  
To study the kinetics of the antibody response in sheep during the acute phase of the 
infection we used a T. gondii-specific IgM and IgG IFA and also TLA- and rROP2-specific 
IgG ELISAs (Chapter 4). In Chapter 5, the serum IgG response of sheep and pigs against 
Chapter 6 
 
166 
TLA, rGRA1, rGRA7, rEC2 and rMIC3was also tested by ELISA. It is important to stress 
that there is no validated or standardized serological test available for the detection of ovine 
toxoplasmosis. Various ELISA methods using crude, fractionated or recombinant proteins, 
and various antigen preparing methods are used by different labs and research groups 
(Chapter 2, table 2.1), which makes it difficult to compare the results.  
We found that the T. gondii-specific IgM response measured by IFA started between 9 dpi 
and 15 dpi. Nearly simultaneously IgG was detected by IFA, whereas TLA-specific IgG 
appeared somewhat earlier, namely between 7 and 15 dpi, suggesting a slightly higher 
sensitivity of this ELISA test compared to the IFA. Tenter et al (1992), who infected sheep 
with oocysts, also found antibodies for the first time 14 days after infection. However, in two 
other studies in which sheep were infected with oocysts, antibody titers in IFA (Trees et al., 
1989) or ELISA (Esteban-Redondo and Innes, 1997, 1998) emerged at least one week later. 
The slower antibody response in the latter studies is probably due to the actual infection dose: 
before dosing sheep with oocysts it is advisable to verify the infectivity of the inoculum by 
bioassay in mice as some oocysts may not be viable anymore, resulting in a lower actual 
inoculated infection dose. All viable stages of the parasite can infect sheep, irrespective of the 
dose (Dubey, 2010), but, to exclude that this difference in appearance of antibodies is due to 
the parasite stage used in the experimental infection, we should perform comparative 
infection of sheep with oocysts and tissue cysts of the same strain.  
Differences in specificity and sensitivity between different serological tests will play a 
role in early diagnosing an antibody response: In a study on 300 ovine serum samples, four 
serological assays were compared: the Sabin-Feldman dye test (SFDT), the modified 
agglutination test (MAT), the TLA ELISA and the indirect fluorescent antibody test (IFA). 
The SFDT showed a sero-positivity for T. gondii in 34% samples, followed by IFA (37%), 
ELISA (41.7%) and MAT (43.7%). The IFA is highly specific but showed a low sensitivity, 
on the other hand the TLA ELISA demonstrated a high sensitivity, which is in accordance 
with our observations (Shaapan et al., 2008).  
In Chapter 5, experimentally infected sheep and pigs were tested for their serum antibody 
response against different recombinant T. gondii antigens. TLA, rMIC3234-307 and rGRA7 
could be used to demonstrate the infection in sheep, whereas rEC2 and rGRA1 were not 
reliable antigens. However, in pigs, rGRA7 was the only of the 5 candidate antigens against 
which antibodies could be demonstrated consistently. The fact that the TLA ELISA gave poor 
results in pigs is somewhat unexpected as it is a crude extract prepared from T. gondii RH 
tachyzoites and should therefore contain a large repertoire of antigens. Also, since sheep and 
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pigs were infected with different T. gondii strains, we could not determine if this difference 
could be related to the host or to the infecting strain. 
Most of homemade assays for the sero-diagnosis of T. gondii use the whole Toxoplasma 
soluble extract as the antigen, as we used in our ELISAs. Due to a lack of a purified 
standardized Toxoplasma antigen, or methods for the preparation of the antigen and the risk 
of zoonotic transmission during preparation, the availability of the use of recombinant 
antigens for the serological diagnosis of T. gondii infection would be desirable. Or 
alternatively, a standardized method for the preparation and use of T. gondii antigens should 
be validated and made available. 
Our results of the rGRA7 ELISA were consistent with previous studies demonstrating the 
usefulness of T. gondii GRA7 as a sero-diagnostic marker of acute and chronic toxoplasmosis 
(Aubert et al., 2000; Bonhomme et al., 1998; Jacobs et al., 1999). Indeed, an overall 
sensitivity of 81 to 88% and a specificity of 98 to 100% were found for human sera in a 
rGRA7-specific antibody ELISA (Beghetto et al., 2006; Jacobs et al., 1999). Moreover, this 
ELISA had the highest positivity rates in comparison with other recombinant proteins, 
including the rhoptry proteins, surface antigen P30 and GRA8, another member of the dense 
granule proteins. Furthermore, the rGRA7 ELISA was already used to evaluate the 
seropositivity in pigs and showed higher positivity rates in comparison with a SAG2 and 
GRA14 ELISA (Terkawi et al., 2013). This difference between rGRA7 and the other 
recombinant proteins can be explained by the fact that the Gra7 gene is expressed by all 
infectious stages of T. gondii and appears plentiful on the surface of the host cells, the host 
cell cytosol, the parasitophorous vacuolar membrane and the lumen (Holec-Gasior, 2013). 
After rupture of the host cells, high amounts of GRA7 come in contact with the host immune 
system, triggering strong antibody responses (Fischer et al., 1998). 
Chimeric antigens, like rEC2, are new recombinant products. They include multiple 
epitopes in compound polypeptide sequences (Rosenberg et al., 2009). rEC2 is a chimeric 
antigen composed of MIC2, MIC3 and SAG1. Nowadays, only a few studies in humans have 
shown the usefulness of these chimeric recombinant proteins for the serological diagnosis of 
T. gondii. In infants born to mothers with a primary T. gondii infection, GST-EC2 improved 
the serological diagnosis (Beghetto et al., 2006). We are the first to demonstrate a clear 
antibody response against this chimeric antigen in sheep, but none was observed in our 
experimental infected pigs. 
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6.4 Conclusions 
The host-parasite interface forms a delicate homeostasis between host defence and 
parasite survival strategies. Through our work, we aimed to provide quantitative data on the 
real Toxoplasma prevalence in sheep. Furthermore, we evaluated in this thesis whether 
humoral and/or cellular immunity are playing a role in this host-parasite interaction. As 
reported above, a high T. gondii seroprevalence was found in Belgian sheep. These findings 
draw the attention to the fact that a good risk assessment study in combination with 
questionnaires about farm management is indispensable for developing useful strategies to 
control the infection. Antibody ELISAs are applied as in-house diagnostic tests which are 
neither standardised nor harmonized. As a consequence, those tests are not reliable for routine 
surveillance in sheep as long as no validation of sensitivity and specificity has been 
performed. Such validation should be performed by various laboratories internationally using 
the same reference material. 
Although the results of the present work have added new insights on the host-parasite 
interaction, such as the parasite distribution in the intestine and some lymphoid tissues during 
the acute phase of the infection and the associated antibody and cytokine responses, many 
elements in the immune response remain obscure. Further studies on the host-parasite 
interaction during the acute, subacute and even chronic infection stage might hopefully give 
some answers to unsolved problems such as what is triggering the IFN-gamma release in the 
very early phase and in the subacute phase of infection and what makes T. gondii disappear 
from the intestinal tissue. 
Gaining insight into the cellular and humoral immunity during infection and the 
associated parasite distribution, has been the cornerstone of this thesis. During the analysis of 
the humoral and cellular immunity, we encountered some major obstacles: A first major 
obstacle for T. gondii infection studies in sheep was the huge seroprevalence, making it 
difficult to find seronegative animals for experimental infections and to obtain enough 
negative sera to perform the validation of our serological tests. Another important obstacle 
was the lack of tools: the lack of standardised serological tests and of secondary antibodies 
against sheep immunoglobulins and interleukins so that secondary antibodies with 
demonstrated cross-reactivity had to be used. 
The used techniques are another focus of attention. ELISAs will assist in unravelling the 
role of cytokines such as IFN-gamma and other interleukins in cooperation with the 
antibodies against different antigens. However, in order to identify the cell types involved in 
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the cytokine response and to identify the antigens of the parasite responsible for a protective 
immune response, more sophisticated techniques have to be applied such as, multicolour flow 
cytometry to combine detection and quantification of cytokine production with the 
identification of the secreting cell type and parasite protein purification, in vitro proliferation 
and flow cytometric proliferation assays to identify parasite proteins important for stimulating 
the host immune cells.  
Furthermore, we have to investigate if the antibody responses we found persist in the 
animals for a longer time and whether the rGRA7 ELISA can be confirmed to be a good assay 
for sero-diagnosing a T. gondii infection in meat producing animals throughout the acute, 
subacute and chronic infection stages.  
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According to The Scientific Opinion of the Panel on Biological Hazards, toxoplasmosis 
has the highest human incidence amongst the parasitic zoonoses. Toxoplasmosis is considered 
to be an under-detected and underreported disease in the European Union. Epidemiological 
data and case-control reports identify un- or undercooked meat as an important source of 
human toxoplasmosis. The same panel highlighted the limitation of quantitative data on 
toxoplasmosis contamination levels in Belgian sheep flocks as an important information gap 
in Belgium, as well as in some other countries. Aside from the gap in quantitative data, 
significant gaps still exist in our knowledge on the host-immune response during acute and 
chronic T. gondii infection.  
In the first two chapters an overview was given of the life cycle, pathogenesis, economic 
aspects and diagnostic tools of T. gondii, with specific focus on sheep.  
The general aims of this PhD thesis were a) to provide data on the prevalence of 
Toxoplasma gondii in Belgian sheep flocks, and b) to have a better insight in the parasite-host 
interaction, with specific focus on the correlation between the host-immune response on one 
hand and the parasite distribution on the other hand.  
In Chapter 3, we provide the first data on the prevalence of a T. gondii infection in 
Belgian sheep flocks. A total of 3170 serum samples were tested for antibodies against 
T. gondii in a total parasitic lysate (TLA)-specific antibody enzyme-linked immunosorbent 
assay (ELISA). Almost 2400 (87.4%) out of the 3170 samples were positive for T. gondii. 
The province of Antwerp showed the lowest seroprevalence (65.2%), followed by the 
Walloon region (68.6%), East Flanders (96.6%), West Flanders (96.8%) and Limburg 
(97.3%). Flemish Brabant noted the highest seroprevalence of 97.8%. Only 8 of the 209 tested 
flocks were seronegative. The study revealed a significantly lower T. gondii seroprevalence in 
Antwerp and Wallonia than in the other Flemish provinces (p < 0.05). The overall high 
prevalence in Belgium demonstrates that more attention has to be given to mutton as a potential 
source of human toxoplasmosis. 
In Chapter 4, the parasite distribution and immune response, following oral ingestion by 
sheep of tissue cysts of the T. gondii PRU strain was studied during the acute phase of the 
infection. The presence of parasite DNA as well as parasite-induced interferon-gamma and 
interleukine-12 responses were determined at 4, 8, 10, 14 and 21 days post infection in the 
small intestinal mucosa, draining mesenteric lymph nodes, popliteal LN, spleen and blood 
mononuclear cells. Furthermore, the level of T. gondii-specific serum antibodies was tested 
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daily by indirect immunofluorescence assay for IgM and IgG and by a total parasitic lysate-
specific ELISAs for IgG, IgG1, IgG2 and IgA. Results indicate that tachyzoites already enter 
the cranial small intestinal mucosa the first days after infection while the sheep are still 
seronegative. Simultaneously, high IFN-gamma responses and IL-12 are induced mainly in 
mesenteric lymph nodes. IgG1, first seen at 8dpi, and IgG2 at 11 dpi, are accompanied with a 
decrease or even disappearance of the IFN-gamma and IL-12 response in PP, PBMC and 
popliteal LN. Meanwhile the parasite DNA could be recovered from most mucosal and 
systemic tissues to become undetectable in the small intestine, popliteal LN, PBMC and 
spleen 3 weeks after infection, suggesting that the parasite is leaving these tissues. Our results 
suggest a role for both cytokines in controlling the infection. 
In Chapter 5 we performed a follow up study to see how the IFN-gamma (T-helper 1 
cells), IL-4 (Th2 cells) and IL-10 mRNA (Treg cells) expression by blood mononuclear cells, 
and the serum antibody response against T. gondii total lysate antigen, recombinant GRA1, 
rGRA7, rMIC3 and rEC2, evolved in sheep the first two months after a T. gondii infection. 
Furthermore, we compared these responses with the responses in pigs to see if important 
species differences occurred. At the end of this period, the parasite distribution, in heart, 
brain and two skeletal muscles in sheep was compared with that in pigs, with the aim to relate 
differences in immune responses between both species with differences in parasite load. Both 
antibody and cytokine responses differed between the two species. In sheep, antibodies 
appeared against all tested T. gondii antigens, but mainly against rGRA7, rMIC3 and TLA, 
whereas in pigs only rGRA7-specific antibodies could be demonstrated. Similarly, the 
cytokine response seemed to be more pronounced in sheep than in pigs. In all sheep an IFN-
gamma response occurred already two weeks post infection and persisted throughout the 
seven week observation period, whereas in pigs IFN-gamma increased later and seemingly 
for a shorter period. Furthermore, also IL-10 and IL-4 increased in sheep, but later than 
IFN-gamma and with more variation. However, in pigs no such increase was seen. These 
differences in immune response between sheep and pigs did not seem to affect the parasite 
distribution, since it was similar in both species 6 to 8 weeks post infection. Interestingly, 
only heart tissue was consistently positive in sheep and pigs using either bioassay or qPCR.  
Results of our study therefore suggest that serum antibodies against GRA7 in live sheep 
and pigs and heart tissue for bioassay and qPCR in slaughtered animals seem to be excellent 
ways to diagnose the presence of a T. gondii infection between one and two months post 
infection. It still needs to be examined if this is also the case in chronically infected animals.  
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Chapter 6 represents the general discussion and conclusions with respect to the obtained 
results. In this thesis, for the first time the seroprevalence of T. gondii in the Belgian sheep 
population was measured. Nevertheless, critical considerations can be made concerning the 
assays used for testing sheep serum. The IFA used is not validated and standardized for sheep 
and the TLA-specific ELISA we used, is an in house made test and needs further evaluation 
to be used as a screening test for identifying infected animals. Furthermore, the high 
seroprevalence of T. gondii in sheep stresses an urgent need for risk assessment studies on 
Belgian sheep farms with different management systems. 
Additionally, we demonstrated that, during an acute infection, high interferon-gamma 
responses occurred, first most likely as a result of NK cell activation but later via Th1 
response. At 3 weeks post infection the parasite disappeared from intestinal tissues. Even 
though T. gondii-specific serum antibody concentrations and the Th1 cytokine response 
increased, it is unclear if the immune response is responsible for the parasites disappearing 
from the small intestinal and systemic lymphoid tissues or if the parasite lost tropism for gut 
cells. Nevertheless, the parasite could be detected in brain, hart and skeletal muscles around 
two months post infection showing that the immune response could not clear the parasite from 
these tissues. 
Some important remarks have to be taken into account when interpreting the immune 
response. First of all, the amount of cytokines measured in the cell culture supernatant by 
ELISA does not always correspond with the cytokine mRNA level detected by a real-time 
polymerase chain reaction. Furthermore it does not identify the cells responsible for the 
cytokine production. Identifying the cells responsible for the cytokine production in different 
phases of the infection is needed to better understand the host-parasite interaction. Secondly it 
is important to know that a negative result in PCR does not directly imply that these tissues 
are completely parasite free. One of the reasons for false negative PCR results is that only 
small samples are tested and that the parasite can be unequally distributed over a tissue. 
Thirdly, it is important to stress that there are no validated or standardized serological tests 
available in sheep to sero-diagnose the infection. Fourthly, since sheep and pigs were infected 
with different type II T. gondii strains, we could not determine if the observed differences 
were related to the host or to the T. gondii strain.  
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This thesis was a first step towards new insights in T. gondii infections in sheep in 
Belgium, in the host-parasite interaction in the small intestine during the acute phase of the 
infection and of antibody and cytokine responses during the first months of infection in 
relation to parasite distribution. However, there is much yet to be done, such as identifying 
risk factors of infection on Belgian sheep farms, identifying the immune cells responsible for 
the cytokine responses and perhaps for clearing the parasite from intestinal tissues during 
acute T. gondii infection in sheep and improving and standardizing tests to detect T. gondii in 
live and slaughtered animals. 
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Volgens de Scientific Opinion of the Panel on Biological Hazards heeft toxoplasmosis de 
hoogste humane incidentie van de parasitaire zoönosen. Desalniettemin wordt toxoplasmose 
beschouwd als een ondergediagnosticeerde en -gerapporteerde ziekte binnen de Europese 
unie. Epidemiologische data en case-control studies aanzien de inname van rauw of 
onvoldoende doorbakken vlees als een belangrijke oorzaak van humane toxoplasmosis. 
Risico-analyses, uitgevoerd door hetzelfde panel, duiden het gebrek aan van kwantitatieve 
data op Belgisch niveau.  
Naast dit gebrek aan epidemiologische gegevens in België, is er ook nog steeds weinig 
gekend over de immuunrespons bij het schaap tijdens een T. gondii infectie. De doelstellingen 
van deze doctoraatsthesis waren a) het bekomen van basisgegevens over de seroprevalentie in 
de Belgische schapenhouderij b) het verkrijgen van een beter inzicht in de parasiet – gastheer 
interactie, met focus op de correlatie tussen de immuunrespons van de gastheer enerzijds en 
de parasitaire distributie anderzijds.  
Het proefschrift bestaat uit twee grote delen, een literatuuroverzicht en een beschrijving 
van de experimentele studies. 
In de literatuurstudie wordt in een eerste hoofdstuk een algemeen overzicht gegeven van 
Toxoplasma gondii, met speciale aandacht voor de levenscyclus. Vervolgens wordt in een 
tweede hoofdstuk de nadruk gelegd op T. gondii infecties bij schapen. Hierin wordt een orale 
infectie door oöcysten uit de omgeving, en de verticale overdracht door de parasiet samen met 
de pathogenese besproken. Daarna wordt een overzicht gegeven van de seroprevalentie van 
T. gondii bij schapen in verschillende landen. Dit toont aan dat toxoplasmosis wereldwijd 
voorkomt bij schapen waar het één van de belangrijkste oorzaken is van abortus. Hierdoor 
heeft deze infectie een grote economische impact op de schapenhouderij. Vervolgens wordt 
de aard van de immuunrespons beschreven waarbij de cruciale rol van celgemedieerde 
immuniteit in het controleren van de infectie wordt benadrukt. De meeste data over de 
immuunrespons tegenover T. gondii zijn afkomstig van studies in muismodellen en moeten 
bij schapen nog aangetoond worden. Bij de preventieve maatregelen om infectie te 
voorkomen worden naast vaccinatie en medicatie, het in acht nemen van bedrijfshygiëne en 
aanpassingen in het bedrijfsmanagement behandeld. Ofschoon een commercieel geattenueerd 
vaccin beschikbaar is voor gebruik bij schapen, wordt dit in veel landen - waaronder België - 
niet toegelaten omdat het gebruik gepaard gaat met risico’s op infectie voor de dierenarts. 
Bovendien biedt dit vaccin wel bescherming tegen spontane abortus tijdens de dracht maar 
biedt het geen steriele immuniteit voor de foetus noch voor het moederdier, waardoor 
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onderzoek naar vaccinatie nog steeds nodig is. Profylactische behandeling van ooien tijdens 
de dracht is effectief maar duur. Tenslotte wordt in dit hoofdstuk dieper ingegaan op de 
verschillende diagnostische detectiemethoden. Het belang van de verschillende 
serodiagnostische testen, met elk hun eigen voor- en nadelen, wordt uiteengezet. Daarnaast 
worden de technieken voor het aantonen van parasitair DNA besproken. Methodes voor de 
directe detectie van T. gondii zijn meestal technisch moeilijker en worden in veterinaire 
diagnostiek bijna uitsluitend gebruikt ter bevestiging van een Toxoplasma infectie in 
geaborteerde foeti of dode dieren. Het gebrek aan een gevalideerde en gestandardiseerde 
diagnostische test wordt in het laatste deel belicht. 
In hoofdstuk 3 worden de resultaten van de Toxoplasma seroprevalentie studie op 
Belgische schapenbedrijven besproken. Deze studie werd uitgevoerd in samenwerking met de 
Dierengezondheidszorg van Vlaanderen en deze van Wallonië. Serumstalen van 3170 schapen 
werden getest voor T. gondii antilichamen in een totaal lysaat antigeen (TLA) enzyme-linked 
immunosorbent assay (ELISA). Bijna 2400 (87,4%) stalen werden positief bevonden voor 
T. gondii. Antwerpen bezat de laagste seroprevalentie (65,2%), gevolgd door Wallonië 
(68,6%), Oost-Vlaanderen (96,7%), West-Vlaanderen (96,8%) en Limburg (97,3%). 
Vlaams-Brabant noteerde de hoogste seroprevalentie (97,8%). Enkel 8 van de 209 geteste 
schapenkuddes waren seronegatief. De seroprevalentie in Antwerpen en Wallonië was 
significant lager dan deze in andere provincies (P < 0.05). Dit is de eerste 
seroprevalentiestudie in België. De hoge prevalentie toont aan dat er meer aandacht moet 
besteed worden aan schapenvlees als mogelijke bron voor humane toxoplasmosis.  
In hoofdstuk 4 worden de parasitaire distributie en de immuunrespons tijdens de acute 
fase van infectie bestudeerd. De schapen werden oraal geïnfecteerd met 3000 weefselcysten 
van de T. gondii PRU stam. Zowel de aanwezigheid van parasitair DNA als de 
parasiet-geïnduceerde interferon-gamma en interleukine-12 respons werden op 4, 8, 10, 14 en 
21 dagen na infectie (dpi) onderzocht in de dunne darmmucosa, en de drainerende 
mesenteriale lymfeknopen, de popliteus lymfeknoop, de milt en leukocyten. Verder werd het 
verschijnen van T. gondii-specifieke antilichamen in serum dagdagelijks opgevolgd met 
behulp van een indirecte immunofluorescentietest voor IgM en IgG en met behulp van TLA-
specifieke ELISA’s voor IgG, IgG1, IgG2 en IgA. De resultaten tonen aan dat tachyzoieten 
reeds de eerste dagen na infectie de mucosa van het craniaal deel van de dunne darm 
binnendringen, terwijl de schapen nog steeds serologisch negatief zijn. Tegelijkertijd wordt 
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een hoge IFN- respons en IL-12 respons geïnduceerd, en dit voornamelijk in de mesenteriale 
lymfeknopen. De opkomst van IgG1, op 8dpi, en IgG2, op 11 dpi, gaat gepaard met een 
afname, of zelfs verdwijnen van de IFN- en IL-12 respons in de Peyerse Platen, de perifere 
bloed mononucleaire cellen (PBMC) en de popliteus lymfeknoop. Ondertussen kon T. gondii 
DNA worden gedetecteerd in de meeste mucosale en systemische weefsels. Het kon echter 
drie weken na infectie niet meer teruggevonden worden in de dunne darm, de popliteus 
lymfeknoop, perifere bloed mononucleaire cellen en de milt, wat erop zou kunnen wijzen dat 
de parasiet op dat moment deze weefsels verlaten had of eruit verwijderd werd door de 
immuunrespons. We veronderstellen dat IFN-gamma en IL-12 beide een rol spelen bij het 
controleren van de infectie.  
In hoofdstuk 5 volgden we de expressie van IFN-gamma (T-helper 1 cellen), IL-4 (Th2-
cellen) en IL-10 mRNA (Treg cellen) door bloed mononucleaire cellen en de 
antilichaamrespons in serum tegen T. gondii totaal lysaat, T. gondii recombinant GRA1, 
rGRA7, rMIC3 en rEC2 in schapen gedurende de eerste 2 maanden na een T. gondii infectie. 
De immuunrespons in schapen werd vergeleken met de respons bij het varken om na te gaan 
of er species verschillen optraden en om te zien of dat dit de infectie kon beïnvloeden werd 
parasitaire load in het hart, de hersenen en 2 skeletspieren van schapen bepaald in 
vergelijking met deze in varkens. Hoewel de parasitaire load in schapen en varkens 
vergelijkbaar was, zagen we toch een duidelijk verschil in de antilichaam- en cytokine 
respons. Bij de schapen trad er een antilichaamrespons op tegen alle geteste T. gondii 
antigenen, maar voornamelijk tegenover rGRA7, rMIC3 en TLA terwijl bij de varkens enkel 
rGRA7-specifieke antilichamen konden worden aangetoond. Ook de cytokine respons leek 
meer uitgesproken bij schapen dan bij varkens. Zowel bij schapen als bij varkens trad er een 
IFN-gamma respons op al leek deze bij schapen vroeger op te treden en langer te blijven dan 
bij varkens. Ook de IL-10 en IL-4 mRNA expressie vertoonde in schapen een toename, maar 
later dan de IFN-gamma expressie en met meer variatie. In varkens werd echter geen 
toename gezien. 
Wat betreft de diagnose van T. gondii suggeren de resultaten dat rGRA7-specifieke 
serumantilichamen bij levende schapen en varkens en bio-assay en qPCR op hartspierweefsel 
van geslachte dieren de beste testen zijn om besmetting met T. gondii te detecteren. 
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Hoofdstuk 6 bevat de algemene discussie en de belangrijkste conclusies. In dit 
proefschrift werd voor het eerst de T. gondii seroprevalentie in de Belgische schapenhouderij 
bestudeerd. Echter dienen toch enkel kritische beschouwingen in acht genomen te worden 
omtrent de methodes gebruikt om het schapenserum te testen. De gebruikte 
immuunfluorescentie antilichaamtest (IFA) is niet gevalideerd noch gestandardiseerd voor 
schapen. De TLA-ELISA, die werd aangewend, is een in-huis ontwikkelde test en dient 
verder geëvalueerd te worden om in de toekomst als screeningstest te kunnen gebruikt 
worden. Desalniettemin benadrukt de hoge seroprevalentie van T. gondii in schapen de 
noodzaak tot het uitvoeren van risico-analyses op Belgisch schapenhouderijen met 
verschillende managementsystemen, om al zo maatregelen te kunnen nemen ter controle van 
de infectie.  
Vervolgens werd in dit proefschrift aangetoond dat, tijdens de acute infectie, hoge 
interferon-gamma responsen en lagere interleukine-12 responsen optraden. Tegelijkertijd was 
er sporadisch parasitair DNA detecteerbaar in de dunne darm, voornamelijk in het craniale 
deel. Vervolgens ging T. gondii zich meer spreiden in de darm en naar de systemische 
lymfoïde weefsels, dit tot twee weken na infectie, waarna bijna geen parasitair DNA meer kon 
worden aangetoond in de intestinale weefsels. Dit zou er kunnen op wijzen dat T. gondii de 
darm verlaat tijdens de acute fase van infectie om zich te spreiden naar meer systemische 
weefsels tijdens de subacute fase en dat de gastheer-immuunrespons niet in staat is deze 
verspreiding te stoppen noch te vrijwaren van parasieten. Inderdaad, tijdens de 
daaropvolgende subacute fase van infectie konden niet alleen hoge IFN-gamma worden 
waargenomen maar vertoonden ook IL-10 and IL-4 mRNA de neiging te stijgen, terwijl 
parasitair DNA werd aangetoond in het hart, de hersenen en skeletspieren. Ook bij varkens 
werden er in dezelfde weefsels, vergelijkbare hoeveelheden parasitair DNA aangetoond 
tijdens de subacute fase van de infectie en nam de IFN-gamma respons toe, maar iets later en 
minder lang dan bij het schaap. Echter IL-10 en IL-4 mRNA stegen niet. 
Bij het evalueren van deze resultaten dient toch met enkele bemerkingen rekening 
gehouden te worden. Ten eerste, de hoeveelheid cytokines, vrijgesteld in het supernatans van 
de celcultuur, gedetecteerd door de cytokine ELISA zijn niet 100% vergelijkbaar met de 
mRNA niveaus gedetecteerd in real-time PCR. Daarenboven zou het nuttig zijn uit te breiden 
naar technieken gericht op het identificeren van cellen verantwoordelijk voor de 
cytokineproductie. Ten tweede, is het belangrijk te weten dat een negatief resultaat in PCR 
niet noodzakelijk een garantie biedt op parasitair vrij weefsel. Een PCR negatief resultaat kan 
te wijten zijn aan een ongelijkmatige verdeling van de parasiet over een weefsel omdat voor 
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PCR slecht zeer kleine hoeveelheden weefsel nodig zijn. Ten derde is het noodzakelijk te 
benadrukken dat er geen gevalideerde, noch gestandaardiseerde serologische testen voor 
handen zijn om toxoplasmosis in schapen te diagnosticeren. Ten vierde, aangezien schapen en 
varkens geïnfecteerd werden met verschillende type II T. gondii stammen, konden we niet 
aantonen dat de bekomen verschillen in immuunrespons te wijten zijn aan de gastheer of aan 
de stam.  
Er is nog verder onderzoek nodig om de immuunrespons tijdens acute en chronische 
toxoplasmosis bij schapen volledig op te helderen en om diagnostische testen voor detectie 
van T. gondii op levende en geslachte dieren verder op punt te stellen. 
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Diergeneeskunde van de Universiteit Gent. Waarna ze aansluitend een doctoraatsonderzoek, 
gefinancierd door het IWT, startte. Tevens behaalde zij recent het getuigschrift van de 
Doctoral School of Life Sciences and Medicine van de Universiteit Gent. Delfien Verhelst is 
auteur of mede-auteur van wetenschappelijke publicaties in nationale internationale 
tijdschriften. Zij was spreker en nam de voorbije jaren actief deel aan meerdere nationale en 
internationale congressen. 
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Regrets, I’ve had a few, 
But then again, too few to mention, 
I did, what I had to do: 
I did it my way! 
 
Aan het einde van een periode in je leven, is het toch altijd leuk om even je tijd te nemen, 
even terug te blikken op kleine successen en grote mislukkingen, alvorens met een tevreden 
gevoel een nieuwe start te nemen. Een van die kleine dingen die ik in de voorbije jaren heb 
opgestoken, is dat vele ‘lezers’ van een werk als dit niet verder raken dan deze pagina. 
Daarom houd ik er me aan om toch ook wat tijd te spenderen aan dit stukje. Wie had lang 
geleden ooit verwacht dat ik vandaag dit stukje zou schrijven? Ik niet in het minst: ik was 
immers niet meteen de allergrootste uitblinker als het over studieresultaten ging, misschien 
ook niet altijd even geconcentreerd, dus doctoreren was voor mij niet meteen een optie die er 
lang op voorhand zat aan te komen. Daarom, en dat durf ik toch wel toegeven, ben ik best een 
beetje trots, blij, gelukkig en zelfs vereerd dat ik vandaag dit laatste stukje tekst mag 
schrijven. Nog eenmaal krijg ik hier de kans om mijn verhaal te doen. 
Je schrijft dit boekje niet alleen en je haalt geen doctoraat zonder begeleiding van mensen 
met ervaring in de wetenschapswereld. Het is rechtstreeks en onrechtstreeks, gewild en 
ongewild het werk van een hele hoop mensen. Een aantal van hen wil ik dan ook persoonlijk 
bedanken. 
Ik wens hierbij dan ook mijn promotoren Prof Dr. Eric Cox en Prof Dr. Pierre Dorny te 
bedanken voor de kans die zij mij gaven! Ook Dr. Stéphane De Craeye wil ik hier bedanken 
voor zijn engelengeduld en de vele uren die hij in mijn experimenten stak! Uren heb ik in 
Brussel gesleten voor PCR’s en IFA’s, uren heb je aan mij gespendeerd om de technieken aan 
te leren en inzicht te krijgen in resultaten. Jouw hulp was onmisbaar bij het vervolledigen van 
dit proefschrift. Ook hier: Bedankt Stef! 
Vervolgens zou ik ook alle leden van de lees en examen commissie willen bedanken voor 
het, met een kritisch oog, nalezen van dit werk en de constructieve opmerkingen. 
Veel dank en respect gaat uit naar de mensen waarmee je de werkvloer en de gekende 
ups-and-downs deelt, mijn mede-immunologen en Hermanologen. 
Bureaugenoten, jullie hebben de laatste loodjes van heel dichtbij meegemaakt toch hebben we 
samen heeeel toffe kletsmomenten gehad en gezellige avonden. Thary en Korneel, jullie zijn 
diegenen die volgen, ik kan jullie nu enkel succes wensen met het schrijven van jullie 
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doctoraat! Kim nog heel veel chance met uw onderzoek en natuurlijk ook met het koken . 
Christophe ook jij heel veel succes met je doctoraat. 
Bert, respect voor jouw kennis, voor jouw ochtendhumeur daarentegen… Gosia, gaandeweg 
werd je partner in crime, jou wens ik het beste! Ut, you are the next one, success with your 
doctorate! 
Joanna and Evelien, the “calve colleagues” Maria, Elisa, Yu, C line, Jochen, Cliff, Manon 
en Herman, het was fijn met jullie het verdiep te delen.  
Rudy, Griet, Hanne, Simon jullie zijn van onschatbare waarde voor het labo. Rudy, bedankt 
voor al jouw hulp met de schapen en de varkens. Ik apprecieer dat ik steeds op jouw hulp kon 
rekenen bij de slachtingen in de vroege uurtjes en bij alle staalnames. Griet, Hanne, Simon: 
bedankt voor de ELISA’s, de helpende handen bij de slacht, het maken van weefselcoupes, de 
sfeer en zoveel meer…. 
Als ik terugkijk op de afgelopen jaren zijn er nog een aantal mensen die ik niet mag 
vergeten. Erik, Vesna, Annelies, Michaëla, Bakr, Edith, Eva, Maryam, Philippe, Kris, Nina, 
Pieter, Tine, Maaike, Rienske, Anastasia, Marjolein, Denise bedankt voor jullie raad en daad! 
Sarah, Ann en Gert, bedankt voor de administratieve beslommeringen. Ann, de 
boekhoudende steunpilaar, maar voor mij was en ben je nog v  l meer dan dat …. Echt 
onmisbaar!! Mieke, ISPC maatje, aan jouw organisatorisch talent kon niemand raken. Je deed 
alles om het telkens opnieuw volledig naar ons zinnen geregeld te krijgen. Dank je voor al 
mijn administratieve zorgen op te lossen, we missen je! Sarah ook jij bedankt voor al het 
organisatorische en administratieve werk om mijn doctoraat in orde te krijgen. Charlotte 
bedankt om alle proefversies tot de laatste letter te willen verbeteren op taalfouten; er staat 
nog een dessertbuffet op jou te wachten! Professor Van Broekhoven, ook U zou ik willen 
bedanken voor de constructieve aanpassingen. Dirk op het werk, Matthias naast het werk, 
dank je om de combinatie van een panikerende ik en crashende computers altijd terug tot een 
geruststellende samenwerking te kunnen brengen. 
Mona, Isabelle, Mait , Alex, merci de m’avoir accueilli si cordiallement à Pasteur ou WIV 
de Bruxelles. Les sept ann es que j’ai pass  chez vous m’ont appris plein de choses, non 
seulement scientifiques mais aussi personnelles. Tous les thesards que j’ai eu l’honneur de 
rencontrer: c’est grâce à vous que j’ai vecu un agr able sejour. Mona et Isabel merci pour la 
patience et les explications que tu m’as donn es sur l’IFA et sur le PCR. C’etait toujours 
amusant de passer au bureau 106 et 110! 
Jurgen ook jij bedankt voor de toffe dagen in Brussel gedurende de laatst maanden! 
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Dit is echter ook het resultaat van de steun die ik al vele jaren krijg van mijn familie. Ik 
weet dat het melig klinkt maar dit is echt het moment om het te zeggen: mama, papa, zus 
bedankt om er te zijn voor mij. Mama, papa, ik weet niet waar te beginnen. Jullie hebben van 
mij gemaakt wie ik ben en mij alle kansen gegeven en anderzijds, even belangrijk, van mij 
gemaakt wie ik niet ben. Ook al was het laatste jaar en vooral de laatste maanden zeer zwaar 
voor jullie, dit proefwerk was absoluut niet ontstaan zonder jullie extra oppeppende woorden. 
Mama, niemand had een aantal maanden geleden gedacht dat je dit kon bijwonen, maar nu 
ben ik blij dat ik, ondanks alles en met veel steun, jouw wens heb kunnen waar maken! Dit is 
dan ook deels van en voor jullie! Zus, je bent zo anders en toch ook vaak schokkend 
hetzelfde! Johan en Chris, ook jullie wil ik bedanken voor het immer paraat staan voor ons 
gezin zeker in de afgelopen maanden. Het heeft de combinatie gezin/doctoreren 
gemakkelijker gemaakt. 
Mijn familie en vrienden: Pedro, Amelie, Gilles, Mieke, Wim, Els, Peter, Sarah, Cédric, 
Ann, Karel bedankt om me op te lappen, te bellen en me op het einde ook af en toe eens uit 
mijn huis te komen halen om eens samen op stap te gaan. Allemaal heel erg bedankt! 
Tenslotte komt het bedankje voor de belangrijkste personen. Aurélie en Maïté, jullie 
beseffen het waarschijnlijk nog niet, maar jullie hebben mijn ganse leven in positieve zin op 
zijn kop gezet. Jullie lach en knuffels hielpen om het toch vol te houden en jullie hebben er 
altijd mee voor gezorgd dat ik mij nooit oversliep. Een knuffel en dikke duim van de mama. 
Bart, jouw optimisme was grenzeloos, net als je vertrouwen in mijn kunnen. Jij hebt als 
geen ander met me meegeleefd gedurende mijn doctoraat, ook al snapte je er naar het einde 
toe als maar minder van. Ik besef ten volle dat ik op bepaalde momenten niet de makkelijkste 
persoon ben geweest om mee samen te leven en ik weet dat jij net zo blij bent als ik, dat dit 
erop zit! Samen hebben we onze opleiding, de verbouwingen en nu mijn doctoraat doorstaan. 
Hopelijk breken er nu iets rustigere tijden aan waarin we wat meer van ons gezin kunnen 
genieten, zonder aan een project bezig te zijn. Bedankt voor je onvoorwaardelijke steun 
gedurende de voorbije 13 jaar, laat de rest maar volgen! Bedankt Bolle! 
 
“Science seldom proceeds in the straight forward logical manner imagined by outsiders. Instead, its 
steps forward (and sometimes backward) are often very human events in which personalities and 
traditions play major roles.” 
(James Watson) 
 
